This is a Validated Antibody Database (VAD) review about mouse Ly6a2, based on 721 published articles (read how Labome selects the articles), using Ly6a2 antibody in all methods. It is aimed to help Labome visitors find the most suited Ly6a2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ly6a2 synonym: I830127L07Rik

BioLegend
brown rat monoclonal (E13-161.7)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 2a
BioLegend Ly6a2 antibody (Biolegend, 122516) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 2a). Nat Metab (2019) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Ly6a2 antibody (Biolegend, 122514) was used in flow cytometry on mouse samples (fig s2a). Cell (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 3c). elife (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s3a
BioLegend Ly6a2 antibody (Biolegend, 108420) was used in flow cytometry on mouse samples (fig s3a). Cell (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2e
BioLegend Ly6a2 antibody (Biolegend, 108424) was used in flow cytometry on mouse samples (fig s2e). Cell (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:150; loading ...; fig s3d
BioLegend Ly6a2 antibody (Biolegend, 128018) was used in flow cytometry on mouse samples at 1:150 (fig s3d). Nat Commun (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...; fig s3d
BioLegend Ly6a2 antibody (Biolegend, 127622) was used in flow cytometry on mouse samples at 1:200 (fig s3d). Nat Commun (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 7a
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 7a). J Clin Invest (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s7c
BioLegend Ly6a2 antibody (Biolegend, 108431) was used in flow cytometry on mouse samples (fig s7c). Cell (2019) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1l
BioLegend Ly6a2 antibody (Biolegend, 108127) was used in flow cytometry on mouse samples (fig s1l). Cell (2019) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1a
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in immunohistochemistry - frozen section on mouse samples (fig 1a). elife (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...; fig 4b
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples at 1:200 (fig 4b). J Clin Invest (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig s3b
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples at 1:200 (fig s3b). J Clin Invest (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend Ly6a2 antibody (Biolegend, 127618) was used in flow cytometry on mouse samples (fig 3b). Cell (2019) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - frozen section; mouse; 1.25 ug/ml; loading ...; fig 3b
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in immunohistochemistry - frozen section on mouse samples at 1.25 ug/ml (fig 3b). Stroke (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples . elife (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • immunocytochemistry; mouse; loading ...; fig s1f
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in immunocytochemistry on mouse samples (fig s1f). Cell (2019) ncbi
brown rat monoclonal (1A8)
  • immunocytochemistry; mouse; loading ...; fig s1d
BioLegend Ly6a2 antibody (BioLegend, 127605) was used in immunocytochemistry on mouse samples (fig s1d). Cell (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend Ly6a2 antibody (Biolegend, 128037) was used in flow cytometry on mouse samples (fig 1e). Cell (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1 ug/ml; loading ...; fig s12
BioLegend Ly6a2 antibody (BioLegend, 108416) was used in flow cytometry on mouse samples at 1 ug/ml (fig s12). Science (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1d
BioLegend Ly6a2 antibody (BioLegend, 108401) was used in immunohistochemistry - paraffin section on mouse samples (fig 1d). Cancer Cell (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; human; 1:100; loading ...; fig 11a
BioLegend Ly6a2 antibody (BioLegend, 127624) was used in flow cytometry on human samples at 1:100 (fig 11a). Nat Commun (2019) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend Ly6a2 antibody (Biolegend, 108106) was used in flow cytometry on mouse samples (fig 1f). EMBO J (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 6c
BioLegend Ly6a2 antibody (Biolegend, 128015) was used in flow cytometry on mouse samples (fig 6c). Cell (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 6c
BioLegend Ly6a2 antibody (Biolegend, 127625) was used in flow cytometry on mouse samples (fig 6c). Cell (2019) ncbi
brown rat monoclonal (D7)
  • immunocytochemistry; mouse; loading ...; fig ev3a
BioLegend Ly6a2 antibody (BioLegend, D7) was used in immunocytochemistry on mouse samples (fig ev3a). EMBO J (2019) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig s1a). J Exp Med (2019) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 4a). Blood (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 3a). Blood (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s6a
BioLegend Ly6a2 antibody (Biolegend, 128014) was used in flow cytometry on mouse samples (fig s6a). Cell (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Ly6a2 antibody (Biolegend, 127622) was used in flow cytometry on mouse samples (fig 6a). Cell (2019) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Ly6a2 antibody (BioLegend, 122508) was used in flow cytometry on mouse samples (fig s1a). Cell (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; loading ...; fig 6s2
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples at 1:200 (fig 6s2). elife (2019) ncbi
brown rat monoclonal (HK1.4)
BioLegend Ly6a2 antibody (Biolegend, 128028) was used . Cell (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:100; loading ...; fig 5c
BioLegend Ly6a2 antibody (Biolegend, 128035) was used in flow cytometry on mouse samples at 1:100 (fig 5c). Nat Cell Biol (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...; fig 5c
BioLegend Ly6a2 antibody (Biolegend, 12761) was used in flow cytometry on mouse samples at 1:200 (fig 5c). Nat Cell Biol (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 1a). Glia (2019) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:100; loading ...; fig 4d
BioLegend Ly6a2 antibody (Biolegend, 127608) was used in flow cytometry on mouse samples at 1:100 (fig 4d). Neurochem Int (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s5f
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s5f). Science (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig e1b
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig e1b). Nature (2019) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s3c
BioLegend Ly6a2 antibody (biolegend, 108126) was used in flow cytometry on mouse samples (fig s3c). Cell Rep (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s20b
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig s20b). Nat Commun (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig s1). Proc Natl Acad Sci U S A (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2f, s2e
BioLegend Ly6a2 antibody (Biolegend, 128015) was used in flow cytometry on mouse samples (fig 2f, s2e). Cell Rep (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 2f, s2e
BioLegend Ly6a2 antibody (Biolegend, 127612) was used in flow cytometry on mouse samples (fig 2f, s2e). Cell Rep (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ly6a2 antibody (BioLegend, 108126) was used in flow cytometry on mouse samples (fig 1d). Cell Stem Cell (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Ly6a2 antibody (BioLegend, 127606) was used in flow cytometry on mouse samples (fig 1b). Cell Stem Cell (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig s13k
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples at 1:200 (fig s13k). Nat Commun (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:100; loading ...; fig 4a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples at 1:100 (fig 4a). Nat Commun (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s8a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s8a). JCI Insight (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s8a
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s8a). JCI Insight (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s2a). PLoS ONE (2018) ncbi
brown rat monoclonal (HK1.4)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4d
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in immunohistochemistry - frozen section on mouse samples (fig 4d). J Clin Invest (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 3a). Nat Commun (2018) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Ly6a2 antibody (eBiosciences, E13-161.7) was used in flow cytometry on mouse samples (fig 1b). EMBO J (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 5p
BioLegend Ly6a2 antibody (Biolegend, 128028) was used in flow cytometry on mouse samples (fig 5p). Cell Rep (2018) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry; mouse; loading ...; fig s2a
BioLegend Ly6a2 antibody (Biolegend, 127601) was used in immunohistochemistry on mouse samples (fig s2a). Sci Rep (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ly6a2 antibody (BioLegend, 127624) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ly6a2 antibody (BioLegend, 128032) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 5d). Front Immunol (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s2a). Front Immunol (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s6b
BioLegend Ly6a2 antibody (BioLegend, 108412) was used in flow cytometry on mouse samples (fig s6b). Immunity (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 4c). J Neuroinflammation (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 2.5 ug/ml; loading ...; fig s4
BioLegend Ly6a2 antibody (Biolegend, 128011) was used in flow cytometry on mouse samples at 2.5 ug/ml (fig s4). Nat Commun (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig 2c). Sci Rep (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; human; loading ...; fig s1a
BioLegend Ly6a2 antibody (Biolegend, 128030) was used in flow cytometry on human samples (fig s1a). Immunity (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s4a
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s4a). Nature (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 2d
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 2d). Nature (2018) ncbi
brown rat monoclonal (E13-161.7)
  • immunohistochemistry - frozen section; mouse; fig 2a
BioLegend Ly6a2 antibody (Biolegend, e13-161.7) was used in immunohistochemistry - frozen section on mouse samples (fig 2a). Nature (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 5b). J Neurosci (2018) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Ly6a2 antibody (BioLegend, E13-161.7) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 3d). J Cell Biol (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend Ly6a2 antibody (Biolegend, 128032) was used in flow cytometry on mouse samples (fig 4b). J Clin Invest (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend Ly6a2 antibody (Biolegend, 127608) was used in flow cytometry on mouse samples (fig 4b). J Clin Invest (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ly6a2 antibody (Biolegend, 108408) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig s3b
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s3b). J Immunol (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig s3b
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s3b). J Immunol (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 2c). J Clin Invest (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 2c). J Clin Invest (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:1000; loading ...; fig s3e
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples at 1:1000 (fig s3e). Circulation (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:1000; loading ...; fig s3e
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples at 1:1000 (fig s3e). Circulation (2018) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Ly6a2 antibody (BioLegend, 122505) was used in flow cytometry on mouse samples (fig s1a). EBioMedicine (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...; fig s2a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples at 1:200 (fig s2a). J Exp Med (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig 4d). J Immunol (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1s1a
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 1s1a). elife (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1s3a
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 1s3a). elife (2018) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Ly6a2 antibody (BioLegend, 122520) was used in flow cytometry on mouse samples (fig s2a). Nat Genet (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 1b
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 1b). Oncoimmunology (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ly6a2 antibody (BioLegend, 127608) was used in flow cytometry on mouse samples (fig 2a). PLoS Pathog (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ly6a2 antibody (BioLegend, 128012) was used in flow cytometry on mouse samples (fig 2a). PLoS Pathog (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s5
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig s5). Eur J Immunol (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; fig s1a
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples at 1:200 (fig s1a). Exp Mol Med (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; fig s1a
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples at 1:200 (fig s1a). Exp Mol Med (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s11
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig s11). Oncoimmunology (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Ly6a2 antibody (Biolegend, 108113) was used in flow cytometry on mouse samples (fig s1a). Cell (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:300; loading ...; fig s3a
BioLegend Ly6a2 antibody (BioLegend, 127622) was used in flow cytometry on mouse samples at 1:300 (fig s3a). PLoS Biol (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s2c
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s2c). PLoS ONE (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 2b
BioLegend Ly6a2 antibody (BioLegend, 108402) was used in immunohistochemistry on mouse samples at 1:50 (fig 2b). J Immunol Res (2018) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 4b
BioLegend Ly6a2 antibody (BioLegend, 127605) was used in immunohistochemistry on mouse samples at 1:50 (fig 4b). J Immunol Res (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 7s1a
BioLegend Ly6a2 antibody (BioLegend, 127645) was used in flow cytometry on mouse samples (fig 7s1a). elife (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; loading ...; fig 1b
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Oncotarget (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...; fig 1b
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Oncotarget (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig 1b
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Oncotarget (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend Ly6a2 antibody (BioLegend, IA8) was used in flow cytometry on mouse samples (fig s2b). Cell Metab (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig s1c). Proc Natl Acad Sci U S A (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 1a). Proc Natl Acad Sci U S A (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 4a). Mucosal Immunol (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s1). Front Microbiol (2018) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4b
BioLegend Ly6a2 antibody (Biolegend, 127601) was used in immunohistochemistry - paraffin section on mouse samples (fig 4b). Int J Cancer (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:100; loading ...; fig s4a
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples at 1:100 (fig s4a). Front Immunol (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:300; loading ...; fig 6e
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples at 1:300 (fig 6e). Nat Commun (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s3b
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s3b). J Immunol (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s3b
BioLegend Ly6a2 antibody (BioLegend, 1A85) was used in flow cytometry on mouse samples (fig s3b). J Immunol (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Ly6a2 antibody (Biolegend, 1A-8) was used in flow cytometry on mouse samples (fig 3a). Infect Immun (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 3a). Infect Immun (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:600; loading ...; fig 1a
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples at 1:600 (fig 1a). Nat Commun (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1c
  • immunohistochemistry; mouse
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 1c) and in immunohistochemistry on mouse samples . Proc Natl Acad Sci U S A (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ly6a2 antibody (BioLegend, 128024) was used in flow cytometry on mouse samples (fig 1d). Nature (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ly6a2 antibody (BioLegend, 127606) was used in flow cytometry on mouse samples (fig 1d). Nature (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3i
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in immunohistochemistry on mouse samples at 1:500 (fig 3i). Mol Pain (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:20; loading ...; fig 3c
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples at 1:20 (fig 3c). Mol Pain (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; loading ...; fig s5e
BioLegend Ly6a2 antibody (BioLegend, 108424) was used in flow cytometry on mouse samples at 1:200 (fig s5e). J Clin Invest (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 2c
BioLegend Ly6a2 antibody (BioLegend, 128037) was used in flow cytometry on mouse samples (fig 2c). Cell (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 2b
BioLegend Ly6a2 antibody (BioLegend, 127605) was used in flow cytometry on mouse samples (fig 2b). Cell (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 2b
BioLegend Ly6a2 antibody (BioLegend, 128015) was used in flow cytometry on mouse samples (fig 2b). Cell (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s2d
BioLegend Ly6a2 antibody (BioLegend, 108120) was used in flow cytometry on mouse samples (fig s2d). Cell (2018) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; fig 1a
BioLegend Ly6a2 antibody (BioLegend, 122514) was used in flow cytometry on mouse samples (fig 1a). Cell (2018) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Ly6a2 antibody (Biolegend, El3-161.7) was used in flow cytometry on mouse samples (fig 1a). Cell Res (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 4e). Nat Commun (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig 1a). Nat Commun (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 5a). Exp Hematol (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 3c). J Immunol (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Ly6a2 antibody (BioLegend, 108111) was used in flow cytometry on mouse samples (fig s2a). Cancer Cell (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ly6a2 antibody (BioLegend, 108407) was used in flow cytometry on mouse samples (fig 1d). Cancer Cell (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...; fig 5h, 5i
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples at 1:200 (fig 5h, 5i). J Immunol (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 3a). Infect Immun (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 2a). Infect Immun (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend Ly6a2 antibody (Biolegend, 108109) was used in flow cytometry on mouse samples (fig 1e). Cell Stem Cell (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s7g
BioLegend Ly6a2 antibody (BioLegend, 108120) was used in flow cytometry on mouse samples (fig s7g). Cell (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s5a
BioLegend Ly6a2 antibody (BioLegend, 108430) was used in flow cytometry on mouse samples (fig s5a). Cell (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 5a). J Lipid Res (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s3a
BioLegend Ly6a2 antibody (Biolegend, Hk1.4) was used in flow cytometry on mouse samples (fig s3a). Science (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 4f). Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 4f). Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 2). Exp Neurol (2018) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 3a
In order to research the roles of C5aR1 and C5aR2 in bone repair, BioLegend Ly6a2 antibody (BioLegend, 127620) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3a). Sci Rep (2017) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry; mouse; loading ...; fig 4c
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in immunohistochemistry on mouse samples (fig 4c). Science (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:20; loading ...; fig s1d
BioLegend Ly6a2 antibody (BioLegend, 108134) was used in flow cytometry on mouse samples at 1:20 (fig s1d). Leukemia (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; loading ...; fig s1d
BioLegend Ly6a2 antibody (BioLegend, 108430) was used in flow cytometry on mouse samples at 1:200 (fig s1d). Leukemia (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s4e
BioLegend Ly6a2 antibody (BioLegend, 108116) was used in flow cytometry on mouse samples (fig s4e). J Clin Invest (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 3
In order to study to role of Sigma-1 receptors in peripheral opioid analgesia during inflammation, BioLegend Ly6a2 antibody (BioLegend, 127602) was used in flow cytometry on mouse samples (fig 3). Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2b
In order to evaluate mouse models of hepacivirus infection, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 2b). Science (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...
In order to investigate the role of type I interferons in diet-induced obesity and insulin resistance, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples . Diabetologia (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...
In order to investigate the role of type I interferons in diet-induced obesity and insulin resistance, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples . Diabetologia (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 4a). Cancer Res (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 4a). Cancer Res (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s6a
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s6a). Cancer Res (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:100; fig s2d
BioLegend Ly6a2 antibody (BioLegend, 127612) was used in flow cytometry on mouse samples at 1:100 (fig s2d). J Endocrinol (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 3b
In order to characterize murine monocytes through transcriptome and genome analyses, BioLegend Ly6a2 antibody (BioLegend, 128006) was used in flow cytometry on mouse samples (fig 3b). Immunity (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 3b
In order to characterize murine monocytes through transcriptome and genome analyses, BioLegend Ly6a2 antibody (BioLegend, 127623) was used in flow cytometry on mouse samples (fig 3b). Immunity (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig st1
In order to investigate the effect of PD-1 expression on phagocytosis and tumour immunity, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig st1). Nature (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1e
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig s1e). Nature (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 2b). Nature (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:100; loading ...; fig s5
In order to study the role of APBA3/Mint3 in metastatic niche formation, BioLegend Ly6a2 antibody (BioLegend, 127613) was used in flow cytometry on mouse samples at 1:100 (fig s5). Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; tbl s1
In order to elucidate the effect of S100 calcium-binding proteins A8/A9 on thrombocytosis and atherogenesis in diabetes, BioLegend Ly6a2 antibody (BioLegend, 108120) was used in flow cytometry on mouse samples (tbl s1). J Clin Invest (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s2b
In order to characterize the control of apoptosis of pathogen-engaged neutrophils during bacterial infection, BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig s2b). J Clin Invest (2017) ncbi
brown rat monoclonal (1A8)
  • blocking or activating experiments; mouse; loading ...
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in blocking or activating experiments on mouse samples . Cell Mol Immunol (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s6a
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s6a). Cell Mol Immunol (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2d
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s2d). Cell Mol Immunol (2018) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate the role of IL-4Ralpha-mediated macrophage activation promote in lung and liver wound repair, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s2a). Science (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate the role of IL-4Ralpha-mediated macrophage activation promote in lung and liver wound repair, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s2a). Science (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 3e
In order to study the role of interleukin-4 and -13 in tissue repair and remodeling, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 3e). Science (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1a
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate the role of endothelial TLR4 and the microbiome in cerebral cavernous malformations, BioLegend Ly6a2 antibody (Biolegend, 127624) was used in flow cytometry on mouse samples (fig s2a). Nature (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 6c
In order to investigate the efficacy of a bispecific antibody against Pseudomonas aeruginosa infection, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 6c). J Clin Invest (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 5b). J Clin Invest (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s3c
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig s3c). J Clin Invest (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 1f). J Exp Med (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig st1a
In order to investigate the similarity between interferon gamma-induced tumor ischemia and physiological blood vessel regression, BioLegend Ly6a2 antibody (BioLegend, 108424) was used in flow cytometry on mouse samples (fig st1a). Nature (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s2b). J Exp Med (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 3a
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 1b). Nat Med (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 7a
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend Ly6a2 antibody (biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 7a). J Exp Med (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 7a
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend Ly6a2 antibody (biolegend, 1A8) was used in flow cytometry on mouse samples (fig 7a). J Exp Med (2017) ncbi
brown rat monoclonal (1A8)
  • other; mouse; fig s2a
In order to study intestinal immune responses during acute graft-versus-host disease, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in other on mouse samples (fig s2a). J Clin Invest (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1a
In order to study the impact of granulocyte/macrophage progenitor on myelopoiesis and leukemia, BioLegend Ly6a2 antibody (BioLegend, 108120) was used in flow cytometry on mouse samples (fig s1a). Nature (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s2d
In order to study the impact of granulocyte/macrophage progenitor on myelopoiesis and leukemia, BioLegend Ly6a2 antibody (BioLegend, 108418) was used in immunohistochemistry - frozen section on mouse samples (fig s2d). Nature (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
In order to clarify the mechanisms by which miR-21 contributes to oncogenesis, BioLegend Ly6a2 antibody (BioLegend, 108405) was used in flow cytometry on mouse samples . Oncogene (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:300; fig 5d
In order to test if oncolytic poxvirus treatment improves anti-PD-L1 immunotherapy, BioLegend Ly6a2 antibody (BioLegend, 128012) was used in flow cytometry on mouse samples at 1:300 (fig 5d). Nat Commun (2017) ncbi
brown rat monoclonal (HK1.4)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 6d
In order to propose that macrophage-TNF-induced AKT/beta-catenin signaling in Lgr5(+) hair follicle stem cells is important for promoting hair follicle cycling and neogenesis after wounding, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 6d). Nat Commun (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 4g
In order to propose that macrophage-TNF-induced AKT/beta-catenin signaling in Lgr5(+) hair follicle stem cells is important for promoting hair follicle cycling and neogenesis after wounding, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 4g). Nat Commun (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples . J Exp Med (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 3g, 4a, s8a
In order to explore the lung as a site of platelet biogenesis, BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig 3g, 4a, s8a). Nature (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s6b
BioLegend Ly6a2 antibody (BioLegend, 108401) was used in immunohistochemistry - paraffin section on mouse samples (fig s6b). Nature (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s3a
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s3a). Nat Commun (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Ly6a2 antibody (Biolegend, 1a8) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1g
In order to demonstrate that loss of autophagy results in the accumulation of mitochondria and an activated metabolic state of hematopoietic stem cells, BioLegend Ly6a2 antibody (BioLegend, 108120) was used in flow cytometry on mouse samples (fig s1g). Nature (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to explore the role of Nol3 in myeloproliferative neoplasms, BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 4a). J Exp Med (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; tbl 2
In order to describe how to isolate, culture, and characterize keratinocytes from murine skin, BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (tbl 2). Methods Mol Biol (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 5
In order to study a mouse model of anti-human PD-L1 for developing new cancer treatments., BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; tbl 2
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (tbl 2). Sci Rep (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:3000; loading ...; fig 2b
In order to report that neurodegenerative disease enhances arthritis development, BioLegend Ly6a2 antibody (BioLegend, 128017) was used in flow cytometry on mouse samples at 1:3000 (fig 2b). J Immunol (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:2000; loading ...; fig 2b
In order to report that neurodegenerative disease enhances arthritis development, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples at 1:2000 (fig 2b). J Immunol (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 3c
In order to analyze rapid tumor volume and spatial information on tumor-associated macrophage infiltration at the cellular level, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 3c). Nat Commun (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig 2p
BioLegend Ly6a2 antibody (BioLegend, 128033) was used in flow cytometry on mouse samples at 1:200 (fig 2p). J Neurosci (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...; fig 2o
BioLegend Ly6a2 antibody (BioLegend, 127615) was used in flow cytometry on mouse samples at 1:200 (fig 2o). J Neurosci (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 3). Eur J Immunol (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s3
In order to examine the role of herpes virus entry mediator in corneal disease during viral infection, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s3). Invest Ophthalmol Vis Sci (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 1b
In order to report the role of hypoxia inducible factors in myeloid trafficking during inflammation in a mouse model of human uveitis, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 1b). Sci Rep (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 1b
In order to report the role of hypoxia inducible factors in myeloid trafficking during inflammation in a mouse model of human uveitis, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 1b). Sci Rep (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2c
In order to test if MSI2 modulates FLT3 expression, BioLegend Ly6a2 antibody (biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 2c). Leuk Res (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4a
In order to discover that SIRPalpha is highly expressed in human renal cell carcinoma and melanoma, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 4a). JCI Insight (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4b
In order to discover that SIRPalpha is highly expressed in human renal cell carcinoma and melanoma, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 4b). JCI Insight (2017) ncbi
brown rat monoclonal (E13-161.7)
BioLegend Ly6a2 antibody (BioLegend, 122520) was used . PLoS ONE (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4b
In order to examine the effect of genetic ablation of soluble tumor necrosis factor on traumatic spinal cord injury, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 4b). Mediators Inflamm (2016) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., BioLegend Ly6a2 antibody (BioLegend, E13-161.7) was used in flow cytometry on mouse samples . Nature (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 3i
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 3i). PLoS ONE (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3h
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 3h). PLoS ONE (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...; fig 3b
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples at 1:200 (fig 3b). Nat Commun (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s4
In order to investigate the effects of a CDK4/6 inhibitor on the senescence-associated secretory phenotype, BioLegend Ly6a2 antibody (BioLegend, 108401) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s4). Mol Cancer Res (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...
In order to find the specific gene signature related to iron metabolism consisting of genes regulating iron uptake, mitochondrial FeS cluster biogenesis and hypoxic response, BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples . Oncotarget (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:160; loading ...; fig 5e
In order to explore the role of Axl in promoting a suppressive myeloid microenvironment in response to ionizing radiation therapy in combination with checkpoint immunotherapy, BioLegend Ly6a2 antibody (Biolegend, 108408) was used in flow cytometry on mouse samples at 1:160 (fig 5e). Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1d
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in immunohistochemistry - paraffin section on mouse samples (fig 1d). Cancer Sci (2017) ncbi
brown rat monoclonal (1A8)
  • other; mouse; loading ...; fig 3a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in other on mouse samples (fig 3a). Cancer Sci (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:300; fig s3c
In order to discuss how NLRC3 protects against colorectal cancer by modulating mTor signaling, BioLegend Ly6a2 antibody (BioLegend, 108426) was used in flow cytometry on mouse samples at 1:300 (fig s3c). Nature (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s3a
In order to demonstrate that bone marrow Gr-1 low immature myeloid cells are responsible for the elevated, pathological levels of soluble urokinase plasminogen activator receptor, BioLegend Ly6a2 antibody (BioLegend, 108418) was used in flow cytometry on mouse samples (fig s3a). Nat Med (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s5
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s5). PLoS ONE (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; fig s1a
In order to observe that cardiac myofibroblasts efficiently engulf dead cells, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples at 1:200 (fig s1a). J Clin Invest (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:100; fig s1a
In order to observe that cardiac myofibroblasts efficiently engulf dead cells, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples at 1:100 (fig s1a). J Clin Invest (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig s8b
In order to observe that cardiac myofibroblasts efficiently engulf dead cells, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s8b). J Clin Invest (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 7e
In order to examine skin dendritic cells from mice exposed to two different Th2 stimuli, BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 7e). J Exp Med (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 5a
In order to determine the role of IL-17A in airway fibrosis, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 5a). Am J Physiol Lung Cell Mol Physiol (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2a
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, BioLegend Ly6a2 antibody (BioLegend, RB6-8CJ) was used in flow cytometry on mouse samples (fig s2a). PLoS Pathog (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1b
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 1b). PLoS Pathog (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1b
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 1b). PLoS Pathog (2016) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...
In order to indicate that MYSM1 has an essential role in B cell lineage specification but is dispensable at later stages of development, BioLegend Ly6a2 antibody (BioLegend, E13-161.7) was used in flow cytometry on mouse samples . J Leukoc Biol (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:25; fig s8
In order to show a role for IL-beta in metabolic dysfunction and arrhythmias in diabetes mellitus, BioLegend Ly6a2 antibody (BioLegend, 128003) was used in flow cytometry on mouse samples at 1:25 (fig s8). Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend Ly6a2 antibody (BioLegend, RB-6-8C5) was used in flow cytometry on mouse samples (fig 3d). Cancer Res (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2a
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1G
In order to study epigenetic heterogeneity in hematopoietic stem cells., BioLegend Ly6a2 antibody (Biolegend, 108114) was used in flow cytometry on mouse samples (fig 1G). Cell (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1G
In order to study epigenetic heterogeneity in hematopoietic stem cells., BioLegend Ly6a2 antibody (Biolegend, 108412) was used in flow cytometry on mouse samples (fig 1G). Cell (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 5c
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 5c). J Exp Med (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s2b
In order to explore how apoptotic intestinal epithelial cells are processed and sampled, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s2b). Nature (2016) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry; mouse; 1:15,000; loading ...; fig st1
In order to use a mouse model of menstruation to examine changes in mononuclear phagocytes during endometrial repair and remodeling, BioLegend Ly6a2 antibody (Biolegend, 127611) was used in immunohistochemistry on mouse samples at 1:15,000 (fig st1). Sci Rep (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a
BioLegend Ly6a2 antibody (BioLegend, 128018) was used in flow cytometry on mouse samples at 1:200 (fig 3a). Nat Commun (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s5b
In order to use MRI to track iron oxide nanoparticles in vivo, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s5b). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 4b
In order to use MRI to track iron oxide nanoparticles in vivo, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 4b). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples . J Virol (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples . J Virol (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 3a
In order to determine the impact of myeloperoxidase during malaria infection, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 3a). Infect Immun (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s2
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s2). Oncotarget (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; human; loading ...; fig 5
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on human samples (fig 5). Nature (2016) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; human; loading ...; fig 5
BioLegend Ly6a2 antibody (BioLegend, E13-161.7) was used in flow cytometry on human samples (fig 5). Nature (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...
In order to report that macrophage-derived extra vesicle-packaged WNTs are essential for intestinal regenerative response after radiation, BioLegend Ly6a2 antibody (Biolegend, 128018) was used in flow cytometry on mouse samples . Nat Commun (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...
In order to report that macrophage-derived extra vesicle-packaged WNTs are essential for intestinal regenerative response after radiation, BioLegend Ly6a2 antibody (Biolegend, 127624) was used in flow cytometry on mouse samples . Nat Commun (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig st2
In order to demonstrate that plasmalemma vesicle-associated protein governs the seeding of fetal monocyte-derived macrophages in the tissues of mice, BioLegend Ly6a2 antibody (Biolegend, 127633) was used in flow cytometry on mouse samples (fig st2). Nature (2016) ncbi
brown rat monoclonal (D7)
BioLegend Ly6a2 antibody (Biolegend, 108112) was used . Nat Commun (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 6a
In order to optimize the delivery of drugs to the immune compartment via CD11a and generate tissue-targeted PDE4 inhibitors, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 6a). Mol Ther (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 6a
In order to optimize the delivery of drugs to the immune compartment via CD11a and generate tissue-targeted PDE4 inhibitors, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 6a). Mol Ther (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s2a
In order to use a CRISPR-Cas9 system to screen for genes involved in B-cell activation and plasma cell differentiation, BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig s2a). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2b
In order to use a CRISPR-Cas9 system to screen for genes involved in B-cell activation and plasma cell differentiation, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s2b). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:400; loading ...; fig 7b
In order to find genes that alter invariant natural killer T cell development, migration, or function, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples at 1:400 (fig 7b). Nat Commun (2016) ncbi
brown rat monoclonal (D7)
BioLegend Ly6a2 antibody (BioLegend, 108133) was used . Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
In order to investigate Fanconi anemia function in hematopoietic stem cells, BioLegend Ly6a2 antibody (Biolegend, 108408) was used . Stem Cell Reports (2016) ncbi
brown rat monoclonal (D7)
BioLegend Ly6a2 antibody (Biolegend, 108105) was used . Stem Cell Reports (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...
In order to characterize Tnip1-deficient mice as a model for psoriasis, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples at 1:200. Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...
In order to characterize Tnip1-deficient mice as a model for psoriasis, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples at 1:200. Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (E13-161.7)
  • immunocytochemistry; mouse; fig 2
BioLegend Ly6a2 antibody (Biolegend, E13-61.7) was used in immunocytochemistry on mouse samples (fig 2). PLoS ONE (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 6D
BioLegend Ly6a2 antibody (Biolegend, 108422) was used in flow cytometry on mouse samples (fig 6D). Oncoimmunology (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 6D
BioLegend Ly6a2 antibody (Biolegend, 127624) was used in flow cytometry on mouse samples (fig 6D). Oncoimmunology (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 8A
BioLegend Ly6a2 antibody (Biolegend, 12760) was used in flow cytometry on mouse samples (fig 8A). Oncoimmunology (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:100; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2016) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; 1:100; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, BioLegend Ly6a2 antibody (BioLegend, E13-161.7) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; loading ...; fig 2b
In order to investigate if CRISPR-Cas9 delivery by adeno-associated virus induces an immune response, BioLegend Ly6a2 antibody (BioLegend, 127611) was used in flow cytometry on mouse samples at 1:200 (fig 2b). Nat Methods (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; tbl 1
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples at 1:200 (tbl 1). Nat Commun (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; tbl 1
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples at 1:200 (tbl 1). Nat Commun (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 1d
In order to assess the effects of environmental enrichment on microglia, BioLegend Ly6a2 antibody (Biolegend, 127605) was used in flow cytometry on mouse samples (fig 1d). J Neurosci (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
In order to investigate the hierarchical genomic and regulatory states that lead to neutrophil or macrophage specification, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples . Nature (2016) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to elucidate how Zfp36l1 and Zfp36l2 regulate the thymic beta-Selection checkpoint, BioLegend Ly6a2 antibody (BioLegend, E13-161.7) was used in flow cytometry on mouse samples (fig 1b). J Immunol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 7f
In order to test if Mincle signaling drives intrahepatic inflammation and liver injury in Con A hepatitis, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 7f). J Immunol (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1g
In order to examine the origin and regulatory factors that maintain MHC II positive peritoneal and pleural macrophages, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 1g). J Exp Med (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 2a). Infect Immun (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig 5a
In order to investigate the contribution of neutrophils and macrophages during Rickettsia typhi infection, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples at 1:200 (fig 5a). PLoS Negl Trop Dis (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 5a
In order to investigate the contribution of neutrophils and macrophages during Rickettsia typhi infection, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 5a). PLoS Negl Trop Dis (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 4a). Oncogene (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Ly6a2 antibody (biolegend, 128006) was used in flow cytometry on mouse samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
BioLegend Ly6a2 antibody (BioLegend, 108422) was used in flow cytometry on mouse samples (fig 1). elife (2016) ncbi
brown rat monoclonal (HK1.4)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 4e
  • flow cytometry; mouse; fig 4a
In order to demonstrate that lymphotoxin beta receptor directly controls thymic endothelial cells to guide hematopoietic progenitor cell homing, BioLegend Ly6a2 antibody (BioLegend, 128017) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 4e) and in flow cytometry on mouse samples (fig 4a). Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunocytochemistry; mouse; loading ...; fig 2e
In order to investigate the roles of platelets and patrolling Ly6C low monocytes in acute vascular inflammation, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in immunocytochemistry on mouse samples (fig 2e). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (1A8)
  • immunocytochemistry; mouse; loading ...; fig s6b
In order to investigate the roles of platelets and patrolling Ly6C low monocytes in acute vascular inflammation, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in immunocytochemistry on mouse samples (fig s6b). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4a
In order to investigate the roles of platelets and patrolling Ly6C low monocytes in acute vascular inflammation, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 4a). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 4a
In order to analyze the effects of beta-lactam-plus-macrolide therapy using a lethal pneumococcal pneumonia mouse infection model, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 4a). Antimicrob Agents Chemother (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to explore the contribution of IL-33 in a model of rheumatoid arthritis, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 5a
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 5a). Am J Pathol (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 5e
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 5e). Am J Pathol (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 2
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 2
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 6a
In order to elucidate how hematopoietic ANGPTL4 deficiency increases atherogenesis, BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 6a). Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 6a
In order to elucidate how hematopoietic ANGPTL4 deficiency increases atherogenesis, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 6a). Nat Commun (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig s1
In order to develop a novel mouse model to test the mechanisms mediating transformation of chronic inflammation into fibrosis, BioLegend Ly6a2 antibody (biolegend, 1A8) was used in flow cytometry on mouse samples (fig s1). PLoS ONE (2016) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
In order to explore the role of insulin receptor substrate-1 in tumor development, BioLegend Ly6a2 antibody (BioLegend, 127601) was used in immunohistochemistry - paraffin section on mouse samples (fig 3c). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s6b
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s6b). Nat Med (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s6b
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s6b). Nat Med (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 4a). Cancer Immunol Immunother (2016) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry; mouse; 2.5 ug/ml; loading ...; fig 5f
In order to propose that autofluorescence-based imaging finds previously unknown immune cell interactions in the airway, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in immunohistochemistry on mouse samples at 2.5 ug/ml (fig 5f). Lab Invest (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1c
In order to use transgenic mice to study the effect of microglia-derived TNF in focal cerebral ischemia, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1e
In order to elucidate the molecular mechanisms that regulate doxorubicin-mediated cell death of myeloid-derived suppressor cells, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 1e). Oncogene (2017) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig s9
In order to elucidate the molecular mechanisms that regulate doxorubicin-mediated cell death of myeloid-derived suppressor cells, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s9). Oncogene (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (biolegend, HK1.4) was used in flow cytometry on mouse samples . Science (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s3a
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig s3a). PLoS Pathog (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig st2
In order to identify the origin of vascular smooth muscle cells and macrophages within atherosclerosis lesions, BioLegend Ly6a2 antibody (BioLegend, 127613) was used in flow cytometry on mouse samples (fig st2). Atherosclerosis (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig st2
In order to identify the origin of vascular smooth muscle cells and macrophages within atherosclerosis lesions, BioLegend Ly6a2 antibody (BioLegend, 128017) was used in flow cytometry on mouse samples (fig st2). Atherosclerosis (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 6a
BioLegend Ly6a2 antibody (BioLegend, 127620) was used in flow cytometry on mouse samples (fig 6a). J Immunol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 6
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 6). Oncotarget (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:400; loading ...; fig 3a
In order to test if senescent stromal cells contribute to tumorigenesis, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples at 1:400 (fig 3a). Nat Commun (2016) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6b
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in immunohistochemistry - paraffin section on mouse samples (fig 6b). Infect Immun (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:75
In order to develop an artificial niche to maintain muscle stem cells in a potent and quiescent state, BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples at 1:75. Nat Biotechnol (2016) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; fig 7
BioLegend Ly6a2 antibody (BioLegend, 122514) was used in flow cytometry on mouse samples (fig 7). Blood (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig s3
In order to characterize the cellular basis and dynamics of the inflammatory microenvironment present in glioblastomas multiforme, BioLegend Ly6a2 antibody (Biolegend/Ozyme, HK1.4) was used in flow cytometry on mouse samples (fig s3). Sci Rep (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
In order to investigate the effects of IL-1 on hematopoietic stem cells, BioLegend Ly6a2 antibody (Biolegend, 128012) was used in flow cytometry on mouse samples . Nat Cell Biol (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 5
In order to investigate the effects of IL-1 on hematopoietic stem cells, BioLegend Ly6a2 antibody (BioLegend, 108120) was used in flow cytometry on mouse samples (fig 5). Nat Cell Biol (2016) ncbi
brown rat monoclonal (HK1.4)
BioLegend Ly6a2 antibody (Biolegend, 128026) was used . Nat Commun (2016) ncbi
brown rat monoclonal (1A8)
BioLegend Ly6a2 antibody (Biolegend, 127618) was used . Nat Commun (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to test if microRNA-23a, -24-2, and 27a are essential for immune cell development, BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 4a). J Leukoc Biol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1c
In order to test if microRNA-23a, -24-2, and 27a are essential for immune cell development, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 1c). J Leukoc Biol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig st1
In order to study how bone marrow endothelial cells regulate bone marrow stem cell maintenance and leukocyte trafficking, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig st1). Nature (2016) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig st1
  • immunocytochemistry; mouse; loading ...; fig st1
In order to study how bone marrow endothelial cells regulate bone marrow stem cell maintenance and leukocyte trafficking, BioLegend Ly6a2 antibody (Biolegend, E13-161.7) was used in flow cytometry on mouse samples (fig st1) and in immunocytochemistry on mouse samples (fig st1). Nature (2016) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4i
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in immunohistochemistry - frozen section on mouse samples (fig 4i). Cancer Discov (2016) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry; mouse; 1:150
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in immunohistochemistry on mouse samples at 1:150. Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples . Oncoimmunology (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4i
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 4i). Nature (2016) ncbi
brown rat monoclonal (D7)
In order to elucidate inhibition of BCL-W and BCL-XL by directed elimination of senescent cells, BioLegend Ly6a2 antibody (Biolegend, 108113) was used . Nat Commun (2016) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; loading ...; fig 8a
BioLegend Ly6a2 antibody (BioLegend, 122514) was used in flow cytometry on mouse samples (fig 8a). J Biol Chem (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 8a
BioLegend Ly6a2 antibody (BioLegend, 108418) was used in flow cytometry on mouse samples (fig 8a). J Biol Chem (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 5b
In order to present the role of TLR10 on both MyD88-dependent and -independent TLR signaling, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 5b). J Immunol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s4
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s4). Oncotarget (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s6
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig s6). Oncotarget (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig S7
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig S7). J Clin Invest (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig S7
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig S7). J Clin Invest (2016) ncbi
brown rat monoclonal (1A8)
  • blocking or activating experiments; mouse; fig 8
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in blocking or activating experiments on mouse samples (fig 8). Oncotarget (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:500; fig 9
BioLegend Ly6a2 antibody (Biolegend, 127624) was used in flow cytometry on mouse samples at 1:500 (fig 9). J Clin Invest (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 5d
In order to observe that Suppressor of Cytokine Signaling 3-deficient bone marrow-derived macrophages display enhanced and prolonged expression of pro-inflammatory M1 cytokines when exposed to glioma tumor cell conditioned medium in vitro, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 5d). Oncotarget (2016) ncbi
brown rat monoclonal (1A8)
  • immunocytochemistry; mouse; 0.25 ug/ml; fig 3d
In order to generate and characterize two formyl peptide receptor 3 antibodies, BioLegend Ly6a2 antibody (BioLegend, 127601) was used in immunocytochemistry on mouse samples at 0.25 ug/ml (fig 3d). J Biol Chem (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 4c
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 4c). Gastroenterology (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study how a novel multi-drug metronomic chemotherapy can delay tumor growth in mice significantly, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples . J Transl Med (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig s5a
In order to find that central nervous system infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic amyotrophic lateral sclerosis mouse model, BioLegend Ly6a2 antibody (Biolegend, 128012) was used in flow cytometry on mouse samples at 1:200 (fig s5a). Acta Neuropathol (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; brown rat; fig 4
BioLegend Ly6a2 antibody (biolegend, D7) was used in flow cytometry on brown rat samples (fig 4). Sci Rep (2016) ncbi
brown rat monoclonal (1A8)
BioLegend Ly6a2 antibody (Biolegend, 127613) was used . Nat Commun (2016) ncbi
brown rat monoclonal (D7)
  • immunocytochemistry; mouse; loading ...; fig 1b
In order to identify a role for Sca-1 in mouse gastric cancer, BioLegend Ly6a2 antibody (biolegend, 108101) was used in immunocytochemistry on mouse samples (fig 1b). Stem Cells (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples . Nature (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 1
BioLegend Ly6a2 antibody (Biolegend, 12760) was used in flow cytometry on mouse samples (fig 1). Oncotarget (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...
In order to report the contribution of dendritic cell-derived thrombospondin-1 on allergic eye disease, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples . J Leukoc Biol (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...
In order to report the contribution of dendritic cell-derived thrombospondin-1 on allergic eye disease, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples . J Leukoc Biol (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:500; fig 8a
BioLegend Ly6a2 antibody (Biolegend, 127624) was used in flow cytometry on mouse samples at 1:500 (fig 8a). Sci Rep (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:1000; fig 8a
BioLegend Ly6a2 antibody (Biolegend, 128028) was used in flow cytometry on mouse samples at 1:1000 (fig 8a). Sci Rep (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s13
In order to study the response of intestinal tuft cells to parasites, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s13). Science (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
In order to discuss models of squamous lung tumors to test therapeutic regimens, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples . J Thorac Oncol (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
In order to discuss models of squamous lung tumors to test therapeutic regimens, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples . J Thorac Oncol (2016) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; 1.5:100; fig 9
BioLegend Ly6a2 antibody (BioLegend, 122507) was used in flow cytometry on mouse samples at 1.5:100 (fig 9). Nat Commun (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 10k
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 10k). J Exp Med (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 10k
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 10k). J Exp Med (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples at 1:1000. J Immunol (2016) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - frozen section; mouse; fig 1
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in immunohistochemistry - frozen section on mouse samples (fig 1). Dis Model Mech (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, 108120) was used in flow cytometry on mouse samples . Nature (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 2
In order to study the contribution of thyroid stimulating hormone beta-subunit to Listeria monocytogenes infection, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples . EMBO Mol Med (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 30 ug/ml; fig s1
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples at 30 ug/ml (fig s1). EMBO Mol Med (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to study dendritic cells in Sirt6 knock out mice, BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples . Aging (Albany NY) (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
In order to study dendritic cells in Sirt6 knock out mice, BioLegend Ly6a2 antibody (Biolegend, HK1-4) was used in flow cytometry on mouse samples . Aging (Albany NY) (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
In order to study dendritic cells in Sirt6 knock out mice, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 1). Aging (Albany NY) (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to study the importance of basal autophagy in the maintenance of the stem-cell quiescent state, BioLegend Ly6a2 antibody (Biolegend, 108113/14) was used in flow cytometry on mouse samples . Nature (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 6
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 6). PLoS Biol (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 6
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 6). PLoS Biol (2015) ncbi
brown rat monoclonal (HK1.4)
BioLegend Ly6a2 antibody (Biolegend, 128006) was used . PLoS ONE (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2
BioLegend Ly6a2 antibody (biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 2). Theranostics (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 2
BioLegend Ly6a2 antibody (biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 2). Theranostics (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 2
BioLegend Ly6a2 antibody (biolegend, 1A8) was used in flow cytometry on mouse samples (fig 2). Theranostics (2015) ncbi
brown rat monoclonal (D7)
BioLegend Ly6a2 antibody (Biolegend, 108122) was used . Nat Commun (2015) ncbi
brown rat monoclonal (D7)
BioLegend Ly6a2 antibody (BioLegend, 108120) was used . Nat Commun (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study the life span of individual memory B cells, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 2a). Arthritis Rheumatol (2016) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 2a). Arthritis Rheumatol (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
BioLegend Ly6a2 antibody (BioLegend, clone D7) was used in flow cytometry on mouse samples (fig 1). Nat Protoc (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to maintain intestinal epithelial cells after tissue damage via type 3 innate lymphoid cells, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples . J Exp Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • other; mouse; 1:100; fig 5c
BioLegend Ly6a2 antibody (Biolegend, RB6-C8C5) was used in other on mouse samples at 1:100 (fig 5c). Oncotarget (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, 1AB) was used in flow cytometry on mouse samples . Mucosal Immunol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:400; fig 1
BioLegend Ly6a2 antibody (Biolegend, 108416) was used in flow cytometry on mouse samples at 1:400 (fig 1). Nature (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:400; fig 1
BioLegend Ly6a2 antibody (Biolegend, 108114) was used in flow cytometry on mouse samples at 1:400 (fig 1). Nature (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2b
BioLegend Ly6a2 antibody (BioLegend, 108422) was used in flow cytometry on mouse samples (fig 2b). Nature (2015) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; fig s3.e,g
BioLegend Ly6a2 antibody (BioLegend, 122520) was used in flow cytometry on mouse samples (fig s3.e,g). Nature (2015) ncbi
brown rat monoclonal (HK1.4)
BioLegend Ly6a2 antibody (Biolegend, 128006) was used . PLoS ONE (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 1
In order to study how CCR2 regulates leukocyte mobilization from the bone marrow, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 1
In order to study how CCR2 regulates leukocyte mobilization from the bone marrow, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig s2
BioLegend Ly6a2 antibody (BioLegend, 127627) was used in flow cytometry on mouse samples (fig s2). PLoS Pathog (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig s2
BioLegend Ly6a2 antibody (BioLegend, 128011) was used in flow cytometry on mouse samples (fig s2). PLoS Pathog (2015) ncbi
brown rat monoclonal (1A8)
  • blocking or activating experiments; mouse; fig 7
BioLegend Ly6a2 antibody (BioLegend, 127632) was used in blocking or activating experiments on mouse samples (fig 7). Am J Respir Cell Mol Biol (2016) ncbi
brown rat monoclonal (HK1.4)
BioLegend Ly6a2 antibody (BioLegend, 128016) was used . Cancer Res (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:50; fig 1
BioLegend Ly6a2 antibody (BioLegend, #108402) was used in flow cytometry on mouse samples at 1:50 (fig 1). Exp Ther Med (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s3
In order to discuss tissue tropisms of innate lymphoid cells, BioLegend Ly6a2 antibody (biolegend, D7) was used in flow cytometry on mouse samples (fig s3). Immunity (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine if therapeutic antiviral T cells eliminate viral load in the brain of mice persistently infected from birth with lymphocytic choriomeningitis virus without causing blood-brain barrier breakdown or tissue damage, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine if therapeutic antiviral T cells eliminate viral load in the brain of mice persistently infected from birth with lymphocytic choriomeningitis virus without causing blood-brain barrier breakdown or tissue damage, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; fig 9
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples (fig 9). PLoS ONE (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 2
In order to propose that RANK dictates WNT responsiveness to hormone-induced changes in adult mammary cells, BioLegend Ly6a2 antibody (Biolegend, 108126) was used in flow cytometry on mouse samples (fig 2). Stem Cell Reports (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4b
In order to discover a new tissue macrophage subset in the thymus that is dependent on transcription factor NR4A1 for development, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 4b). Sci Rep (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to test if metformin ameliorates ionizing radiation-induced long-term bone marrow injury in a total-body irradiation mouse model, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples . Free Radic Biol Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
BioLegend Ly6a2 antibody (Biolegend, 108412) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 1
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 1). Immunity (2015) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - paraffin section; mouse; fig 8
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in immunohistochemistry - paraffin section on mouse samples (fig 8). Mol Cancer (2015) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, BioLegend Ly6a2 antibody (BioLegend, E13-161.7) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:100; fig 5g
BioLegend Ly6a2 antibody (Biolegend, 128007) was used in flow cytometry on mouse samples at 1:100 (fig 5g). Brain (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 3
In order to assess whether programmed cell death 1 regulates psoriasiform dermatitis in mice, BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 2
In order to examine the contribution of stromal cells to non-small cell lung cancer, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2015) ncbi
brown rat monoclonal (1A8)
  • blocking or activating experiments; mouse; fig 2
In order to examine the contribution of stromal cells to non-small cell lung cancer, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in blocking or activating experiments on mouse samples (fig 2). PLoS ONE (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:200; fig s2
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples at 1:200 (fig s2). PLoS ONE (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, # 108406) was used in flow cytometry on mouse samples . Biomaterials (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
BioLegend Ly6a2 antibody (Biolegend, # 108114) was used in flow cytometry on mouse samples (fig 1). Biomaterials (2015) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry; mouse; fig 4
BioLegend Ly6a2 antibody (BioLegend, 127611) was used in immunohistochemistry on mouse samples (fig 4). J Virol (2015) ncbi
brown rat monoclonal (HK1.4)
  • immunohistochemistry; mouse
BioLegend Ly6a2 antibody (BioLegend, 128011) was used in immunohistochemistry on mouse samples . J Virol (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; 1:300; fig s3
BioLegend Ly6a2 antibody (Biolegend, 127617) was used in flow cytometry on mouse samples at 1:300 (fig s3). Nat Commun (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 8
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, BioLegend Ly6a2 antibody (BioLegend, 127618) was used in flow cytometry on mouse samples (fig 8). Oncoimmunology (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 8
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, BioLegend Ly6a2 antibody (BioLegend, 128021) was used in flow cytometry on mouse samples (fig 8). Oncoimmunology (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 2
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 5
BioLegend Ly6a2 antibody (Biolegend, IA8) was used in flow cytometry on mouse samples (fig 5). J Immunol (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 5
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 5). J Immunol (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s2
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s2). PLoS Pathog (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 3a). Tuberculosis (Edinb) (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 4
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 4). Stem Cell Res (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Ly6a2 antibody (Biolegend, 108108) was used in flow cytometry on mouse samples (fig 3a). Proc Natl Acad Sci U S A (2015) ncbi
brown rat monoclonal (E13-161.7)
BioLegend Ly6a2 antibody (Biolegend, E13-161.7) was used . Nature (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig s3
In order to propose that CCL7 is a driver of TNF-alpha-dependent T cell-mediated inflammation in lesional psoriatic skin, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig s3). Exp Dermatol (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s3
In order to propose that CCL7 is a driver of TNF-alpha-dependent T cell-mediated inflammation in lesional psoriatic skin, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig s3). Exp Dermatol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s4
BioLegend Ly6a2 antibody (Biolegend, 108424) was used in flow cytometry on mouse samples (fig s4). Proc Natl Acad Sci U S A (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples . Front Immunol (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s2
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig s2). PLoS Pathog (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
BioLegend Ly6a2 antibody (BioLegend, 108108) was used in flow cytometry on mouse samples (fig 1). J Clin Invest (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:50; fig 4
BioLegend Ly6a2 antibody (BioLegend, 128030) was used in flow cytometry on mouse samples at 1:50 (fig 4). J Immunol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; brown rat
BioLegend Ly6a2 antibody (BioLegend, 108421) was used in flow cytometry on brown rat samples . Transpl Immunol (2015) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; tbl s3
BioLegend Ly6a2 antibody (Biolegend, E13-161.7) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; loading ...; fig 2c
In order to explore a macrophage TLR9-BTK-calcineurin-NFAT signaling pathway involved in impair fungal immunity, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 2c). EMBO Mol Med (2015) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse; fig s3
In order to elucidate the function of miR-29a in hematopoietic stem and progenitor cells, BioLegend Ly6a2 antibody (BioLegend, E13-161.7) was used in flow cytometry on mouse samples (fig s3). Blood (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
In order to show that MDSCs promote invasion of mammary carcinoma cells by increasing fibroblast migration, BioLegend Ly6a2 antibody (Biolegend, 127607) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to show that MDSCs promote invasion of mammary carcinoma cells by increasing fibroblast migration, BioLegend Ly6a2 antibody (Biolegend, 108407) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 4
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 4). Arthritis Rheumatol (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig s12
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s12). Nat Commun (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 6
In order to study the contribution of SEMA4D-PLXNB1 interactions to immune-cell trafficking in the tumor microenvironment, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 6). Cancer Immunol Res (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:100
In order to assess the role of CDH17 in the long-term survival of memory B cells in the bone marrow, BioLegend Ly6a2 antibody (BioLegend, 108410) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2015) ncbi
brown rat monoclonal (E13-161.7)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, E13-161.7) was used in flow cytometry on mouse samples . J Cell Mol Med (2015) ncbi
brown rat monoclonal (HK1.4)
BioLegend Ly6a2 antibody (Biolegend, 128012) was used . J Vis Exp (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, 108125) was used in flow cytometry on mouse samples . Lab Anim (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, 108406) was used in flow cytometry on mouse samples . Lab Anim (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; tbl 1
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (tbl 1). J Neuroinflammation (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 4
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 4). Biomed Mater Eng (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 3
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples (fig 3). Development (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig s1
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig s1). J Leukoc Biol (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig s1
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig s1). J Leukoc Biol (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
In order to evaluate a model of cerebral malaria pathogenesis and its effect on the blood brain barrier, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
In order to evaluate a model of cerebral malaria pathogenesis and its effect on the blood brain barrier, BioLegend Ly6a2 antibody (Biolegend, HK 1.4) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • immunocytochemistry; mouse
In order to evaluate a model of cerebral malaria pathogenesis and its effect on the blood brain barrier, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in immunocytochemistry on mouse samples . PLoS Pathog (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, 108410) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
brown rat monoclonal (1A8)
  • immunohistochemistry - paraffin section; mouse; fig 3
  • flow cytometry; mouse; fig 4
BioLegend Ly6a2 antibody (Biolegend, 127612) was used in immunohistochemistry - paraffin section on mouse samples (fig 3) and in flow cytometry on mouse samples (fig 4). EMBO Mol Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 5
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig 5). AAPS J (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s1
BioLegend Ly6a2 antibody (Biolegend, RB-8C5) was used in flow cytometry on mouse samples (fig s1). J Immunol (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 4
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 4). Mol Pharmacol (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples . FASEB J (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 6
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 6). FASEB J (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 3
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples (fig 3). Stem Cells (2015) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 5
In order to describe the pathogenesis of influenza A virus and Sendai virus in ISG15 knockout mice, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples (fig 5). J Virol (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 5
In order to describe the pathogenesis of influenza A virus and Sendai virus in ISG15 knockout mice, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 5). J Virol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples . Immunology (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 4
In order to determine the role of Foxm1 in bronchopulmonary dysplasia-associated pulmonary inflammation, BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples (fig 4). Am J Respir Cell Mol Biol (2015) ncbi
brown rat monoclonal (HK1.4)
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used . J Immunol (2014) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples . Cell Res (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples . Cell Res (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s2
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s2). Nat Immunol (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; fig 1,3,4,6
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples at 1:200 (fig 1,3,4,6). PLoS ONE (2014) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; human
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s1
In order to study why HSC function declines with age, BioLegend Ly6a2 antibody (BioLegend, 108120) was used in flow cytometry on mouse samples (fig s1). Nature (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
In order to identify a relationship between resistant cancers and myeloid-derived suppressor cells, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
brown rat monoclonal (RB6-8C5)
In order to analyze promotion of a differentiated tumor cell phenotype and inhibition of pancreatic cancer metastasis by neutralizing murine TGF-betaR2, BioLegend Ly6a2 antibody (Biolegend, 108408) was used . Cancer Res (2014) ncbi
brown rat monoclonal (RB6-8C5)
BioLegend Ly6a2 antibody (Biolegend, 108423) was used . J Vis Exp (2014) ncbi
brown rat monoclonal (E13-161.7)
BioLegend Ly6a2 antibody (Biolegend, 122513) was used . J Vis Exp (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
brown rat monoclonal (1A8)
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used . J Immunol (2014) ncbi
brown rat monoclonal (HK1.4)
BioLegend Ly6a2 antibody (Biolegend, 128015) was used . Proc Natl Acad Sci U S A (2014) ncbi
brown rat monoclonal (RB6-8C5)
BioLegend Ly6a2 antibody (Biolegend, 108412) was used . Proc Natl Acad Sci U S A (2014) ncbi
brown rat monoclonal (RB6-8C5)
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used . J Exp Med (2014) ncbi
brown rat monoclonal (1A8)
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used . J Immunol (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s1
  • flow cytometry; human; loading ...; fig s1
In order to propose that basophils exert direct innate immune effector functions in the extracellular space, BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s1) and in flow cytometry on human samples (fig s1). J Immunol (2014) ncbi
brown rat monoclonal (RB6-8C5)
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used . PLoS ONE (2014) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples . J Leukoc Biol (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, HK1.4) was used in flow cytometry on mouse samples . J Leukoc Biol (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, RB6-8C5) was used in flow cytometry on mouse samples . J Leukoc Biol (2014) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; tbl 1
  • immunocytochemistry; mouse; tbl 1
In order to study the effect of innate lymphoid cells on B cells, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (tbl 1) and in immunocytochemistry on mouse samples (tbl 1). Nat Immunol (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to show that geriatric satellite cells do not maintain their normal quiescent state in muscle homeostatic conditions and that this irreversibly affects their intrinsic regenerative and self-renewal capacities, BioLegend Ly6a2 antibody (Biolegend, 108114) was used in flow cytometry on mouse samples . Nature (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples . Diabetes (2014) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
In order to investigate mechanisms that govern neutrophil migration across the blood brain barrier, BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (BioLegend, 1A8) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:60
BioLegend Ly6a2 antibody (BioLegend, D7) was used in flow cytometry on mouse samples at 1:60. J Cell Biol (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:2300; fig 11
BioLegend Ly6a2 antibody (BioLegend, 108415) was used in flow cytometry on mouse samples at 1:2300 (fig 11). PLoS ONE (2013) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse
In order to study the effects of MIF deficiency in a model of high-fat diet-induced obesity, BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples . Obesity (Silver Spring) (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
In order to study the effects of MIF deficiency in a model of high-fat diet-induced obesity, BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples . Obesity (Silver Spring) (2014) ncbi
brown rat monoclonal (D7)
BioLegend Ly6a2 antibody (Biolegend, 108113) was used . PLoS ONE (2013) ncbi
brown rat monoclonal (1A8)
  • flow cytometry; mouse; fig 3a
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in flow cytometry on mouse samples (fig 3a). PLoS ONE (2013) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 3a
BioLegend Ly6a2 antibody (Biolegend, HK1.4) was used in flow cytometry on mouse samples (fig 3a). PLoS ONE (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s3b
BioLegend Ly6a2 antibody (Biolegend, RB6-8C5) was used in flow cytometry on mouse samples (fig s3b). PLoS ONE (2013) ncbi
brown rat monoclonal (1A8)
  • immunocytochemistry; mouse; 0.5 ug/ml
  • immunohistochemistry; mouse; 0.5 ug/ml
BioLegend Ly6a2 antibody (Biolegend, 1A8) was used in immunocytochemistry on mouse samples at 0.5 ug/ml and in immunohistochemistry on mouse samples at 0.5 ug/ml. Proc Natl Acad Sci U S A (2013) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
BioLegend Ly6a2 antibody (Biolegend, D7) was used in flow cytometry on mouse samples . Biol Proced Online (2010) ncbi
Invitrogen
brown rat monoclonal (RB6-8C5)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen Ly6a2 antibody (eBioscience, 17-5931-82) was used in flow cytometry on human samples (fig 3b). Nat Commun (2019) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 1a). PLoS ONE (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s6f
Invitrogen Ly6a2 antibody (eBioscience, 11-5931-82) was used in flow cytometry on mouse samples (fig s6f). Cell (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1s1a
Invitrogen Ly6a2 antibody (eBioscience, 25-5931-81) was used in flow cytometry on mouse samples (fig 1s1a). elife (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 4f). Immune Netw (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen Ly6a2 antibody (eBioscience, HK 1.4) was used in flow cytometry on mouse samples (fig 4f). Immune Netw (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 1b). Glia (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:100; loading ...; fig 4e
Invitrogen Ly6a2 antibody (eBioscience, 47-5932-82) was used in flow cytometry on mouse samples at 1:100 (fig 4e). Neurochem Int (2019) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 5a
Invitrogen Ly6a2 antibody (eBioscience, 25-5981) was used in flow cytometry on mouse samples (fig 5a). Cell Rep (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 4a). Proc Natl Acad Sci U S A (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:400; loading ...; fig 2a
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples at 1:400 (fig 2a). Front Immunol (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s2a). Front Immunol (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:100; loading ...; fig s2a, s2b
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples at 1:100 (fig s2a, s2b). J Pathol (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:400; loading ...; fig 8c
Invitrogen Ly6a2 antibody (Thermo Fisher, 25-5931-81) was used in flow cytometry on mouse samples at 1:400 (fig 8c). Front Immunol (2018) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen Ly6a2 antibody (Thermo Fisher, 17-9668-82) was used in flow cytometry on mouse samples (fig 6a). Nat Immunol (2019) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen Ly6a2 antibody (eBioscience, 45-5932-82) was used in flow cytometry on mouse samples (fig 6a). Nat Immunol (2019) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; loading ...; fig 5r
Invitrogen Ly6a2 antibody (eBioscience, 17-9668-82) was used in flow cytometry on mouse samples (fig 5r). Cell Rep (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 1b). Genome Biol (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s6a
Invitrogen Ly6a2 antibody (eBioscience, 25-5981-82) was used in flow cytometry on mouse samples (fig s6a). Cell Stem Cell (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 6b
Invitrogen Ly6a2 antibody (eBioscience, 48-5931-82) was used in flow cytometry on mouse samples (fig 6b). Cell Stem Cell (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 2a). Blood (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 2a). Blood (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig ev2c
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig ev2c). EMBO J (2019) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 3). Nutrients (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 6g
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 6g). Obesity (Silver Spring) (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 2g
Invitrogen Ly6a2 antibody (eBioscience, 25-5981-82) was used in flow cytometry on mouse samples (fig 2g). Cancer Cell (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:100; loading ...; fig 3a
Invitrogen Ly6a2 antibody (eBiosciences, HK1.4) was used in flow cytometry on mouse samples at 1:100 (fig 3a). Invest Ophthalmol Vis Sci (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:75; loading ...; fig 3a
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples at 1:75 (fig 3a). Invest Ophthalmol Vis Sci (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen Ly6a2 antibody (eBioscience, 12-5981-82) was used in flow cytometry on mouse samples (fig 5d). Hum Mol Genet (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2e
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples (fig 2e). Dis Model Mech (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Ly6a2 antibody (eBioscience, 25-5981-82) was used in flow cytometry on mouse samples (fig s1a). Stem Cell Reports (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Ly6a2 antibody (Thermo Fisher Scientific, 255981) was used in flow cytometry on mouse samples (fig 2a). Cancer Cell (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:40; loading ...; fig 8b
Invitrogen Ly6a2 antibody (ThermoFisher, HK 1.4) was used in flow cytometry on mouse samples at 1:40 (fig 8b). PLoS Pathog (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:50; loading ...; fig 7a
Invitrogen Ly6a2 antibody (eBioscience, 56-5981-82) was used in flow cytometry on mouse samples at 1:50 (fig 7a). Mol Cell Biol (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s1b
Invitrogen Ly6a2 antibody (eBiosciences, 17-5931) was used in flow cytometry on mouse samples (fig s1b). EBioMedicine (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1e
Invitrogen Ly6a2 antibody (eBiosciences, D7) was used in flow cytometry on mouse samples (fig s1e). Cell Stem Cell (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s1e
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig s1e). Cell Stem Cell (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 3a). J Exp Med (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 1a
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1
Invitrogen Ly6a2 antibody (Thermo Fisher Scientific, HK1.4) was used in flow cytometry on mouse samples (fig 1). J Clin Invest (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2i
Invitrogen Ly6a2 antibody (eBioscience, 25-5931-85) was used in flow cytometry on mouse samples (fig 2i). J Exp Med (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 1c). Mol Cell Biol (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Ly6a2 antibody (Affymetrix eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Ly6a2 antibody (eBioscience, 17-5981-83) was used in flow cytometry on mouse samples (fig 1a). J Biol Chem (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen Ly6a2 antibody (eBioscience, 25-5981-82) was used in flow cytometry on mouse samples (fig 1f). Cell Death Dis (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Ly6a2 antibody (eBiosciences, 45-5981-80) was used in flow cytometry on mouse samples (fig 2d). Immunity (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:400; loading ...; fig s1a
Invitrogen Ly6a2 antibody (eBioscience, 12-5931-82) was used in flow cytometry on mouse samples at 1:400 (fig s1a). J Clin Invest (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 4b
Invitrogen Ly6a2 antibody (Thermo Fisher, 11-5931-81) was used in immunohistochemistry on mouse samples at 1:50 (fig 4b). J Immunol Res (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 7s1a
Invitrogen Ly6a2 antibody (eBioscience, 45-5932-82) was used in flow cytometry on mouse samples (fig 7s1a). elife (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Ly6a2 antibody (Affymetrix, D7) was used in flow cytometry on mouse samples (fig s2a). Leukemia (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Ly6a2 antibody (ebioscience, 25-5981-82) was used in flow cytometry on mouse samples (fig 4a). Nat Med (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; loading ...; fig 8b
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in immunohistochemistry on mouse samples (fig 8b). Nat Commun (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2c
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 2c). Antimicrob Agents Chemother (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig s1a). J Exp Med (2018) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Ly6a2 antibody (eBioscience, 1A8-Ly6G) was used in flow cytometry on mouse samples (fig s1a). J Exp Med (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Ly6a2 antibody (eBioscience, 45-5932-82) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Ly6a2 antibody (eBioscience, 56-5981-82) was used in flow cytometry on mouse samples (fig 1b). J Immunol (2018) ncbi
brown rat monoclonal (D7)
  • immunohistochemistry - frozen section; mouse; fig 5a
Invitrogen Ly6a2 antibody (eBiosciences, 11-5981-81) was used in immunohistochemistry - frozen section on mouse samples (fig 5a). Cell (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Ly6a2 antibody (eBioscience, 12-5931-81) was used in flow cytometry on mouse samples (fig s2a). Nat Commun (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2k
Invitrogen Ly6a2 antibody (eBiosciences, 48-5931) was used in flow cytometry on mouse samples (fig 2k). Cell (2018) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 3b). Nature (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 3b). Nature (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s5
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig s5). Nat Commun (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 2d). Nat Commun (2018) ncbi
brown rat monoclonal (HK1.4)
Invitrogen Ly6a2 antibody (eBiosciences, 45-5932-82) was used . Cell (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig 1j, 8d
Invitrogen Ly6a2 antibody (Ebioscience, HK1.4) was used in flow cytometry on mouse samples at 1:200 (fig 1j, 8d). J Immunol (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • blocking or activating experiments; mouse; fig s2
Invitrogen Ly6a2 antibody (eBiosciences, 16-5931-82) was used in blocking or activating experiments on mouse samples (fig s2). Cell (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s4b
Invitrogen Ly6a2 antibody (eBioscience, 48-5931) was used in flow cytometry on mouse samples (fig s4b). J Clin Invest (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; human; loading ...; fig s26e
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on human samples (fig s26e). Science (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:400; loading ...
Invitrogen Ly6a2 antibody (ebioscience, RB6-8C5) was used in flow cytometry on mouse samples at 1:400. Nat Commun (2017) ncbi
brown rat monoclonal (1A8-Ly6g)
  • blocking or activating experiments; mouse; loading ...; fig s4a
Invitrogen Ly6a2 antibody (eBiosciences, 1A8) was used in blocking or activating experiments on mouse samples (fig s4a). J Clin Invest (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4d
Invitrogen Ly6a2 antibody (Invitrogen, RM3028) was used in flow cytometry on mouse samples (fig 4d). J Clin Invest (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1b
In order to characterize murine monocytes through transcriptome and genome analyses, Invitrogen Ly6a2 antibody (eBioscience, 45-5932) was used in flow cytometry on mouse samples (fig 1b). Immunity (2017) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; loading ...; fig 5a
In order to characterize murine monocytes through transcriptome and genome analyses, Invitrogen Ly6a2 antibody (eBioscience, 17-9668-80) was used in flow cytometry on mouse samples (fig 5a). Immunity (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s6g
In order to study the role of reprogrammed BCAA metabolism in the progression of myeloid leukaemia, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig s6g). Nature (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:100; loading ...; fig s5
In order to study the role of APBA3/Mint3 in metastatic niche formation, Invitrogen Ly6a2 antibody (eBiosciences, 11-5931) was used in flow cytometry on mouse samples at 1:100 (fig s5). Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:100; loading ...; fig s5
In order to study the role of APBA3/Mint3 in metastatic niche formation, Invitrogen Ly6a2 antibody (eBiosciences, 17-5932) was used in flow cytometry on mouse samples at 1:100 (fig s5). Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2b
In order to characterize the control of apoptosis of pathogen-engaged neutrophils during bacterial infection, Invitrogen Ly6a2 antibody (ThermoFisher Scientific, HK1.4) was used in flow cytometry on mouse samples (fig 2b). J Clin Invest (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s1.4b
In order to investigate the generation of macrophage populations during homeostasis and inflammation, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig s1.4b). Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 3a
In order to elucidate how cancers are distinguished from wounds, Invitrogen Ly6a2 antibody (eBioscience, 45-5981-80) was used in flow cytometry on mouse samples at 1:1000 (fig 3a). Cell (2017) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; loading ...; fig 2h
Invitrogen Ly6a2 antibody (eBiosciences, 1A8) was used in flow cytometry on mouse samples (fig 2h). J Exp Med (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2h
Invitrogen Ly6a2 antibody (eBiosciences, HK1.4) was used in flow cytometry on mouse samples (fig 2h). J Exp Med (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 4g
In order to determine the role of KDR/ID2 signaling in gliomas, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 4g). J Clin Invest (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 4a). Eur J Immunol (2017) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; loading ...; fig 5a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Ly6a2 antibody (eBiosciences, 1A8) was used in flow cytometry on mouse samples (fig 5a). J Clin Invest (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 5a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 5a). J Clin Invest (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Ly6a2 antibody (eBiosciences, D7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 5a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Ly6a2 antibody (eBiosciences, HK1.4) was used in flow cytometry on mouse samples (fig 5a). J Clin Invest (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:100; loading ...; fig 1a
In order to elucidate the role of STAT5 in B cell acute lymphoblastic leukemia, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples at 1:100 (fig 1a). Nat Immunol (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:200; loading ...
In order to show that Eros is essential for host defense via the phagocyte NAPDH oxidase, Invitrogen Ly6a2 antibody (eBioscience, 53-5932) was used in flow cytometry on mouse samples at 1:200. J Exp Med (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; loading ...
In order to show that Eros is essential for host defense via the phagocyte NAPDH oxidase, Invitrogen Ly6a2 antibody (eBioscience, 48-5931-82) was used in flow cytometry on mouse samples at 1:200. J Exp Med (2017) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; loading ...; fig 1b
In order to determine the role of RelB in classical dendritic cell and myeloid development, Invitrogen Ly6a2 antibody (eBioscience, IA8) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4h
In order to examine the relationships among the B cell receptor, TLR9, and cytokine signals that regulate B cell responses to DNA-containing antigens, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 4h). J Clin Invest (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1b
In order to examine the impact of the unfolded protein response in satellite cell homeostasis during regenerative myogenesis, Invitrogen Ly6a2 antibody (eBioscience, 12-5981-82) was used in flow cytometry on mouse samples (fig 1b). elife (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s8i
In order to explore the lung as a site of platelet biogenesis, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s8i). Nature (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 4a
In order to infer a RANKL-dependent osteoclastogenesis after debridement of osteomyelitis coinciding with elevated B cells and simultaneously decreased osteogenesis, Invitrogen Ly6a2 antibody (eBiosciences, 25-5931-82) was used in flow cytometry on mouse samples (fig 4a). J Orthop Res (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1c,d
In order to examine the contribution of stroma-derived osteopontin for hematopoietic stem cell aging, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 1c,d). EMBO J (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1c,d
In order to examine the contribution of stroma-derived osteopontin for hematopoietic stem cell aging, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 1c,d). EMBO J (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1p
Invitrogen Ly6a2 antibody (eBiosciences, 25-5981-82) was used in flow cytometry on mouse samples (fig s1p). Nature (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 5b
In order to examine the role of forkhead box P1 in transcriptional control of mesenchymal stem/progenitor cell senescence, Invitrogen Ly6a2 antibody (eBiosciences, 45-5981) was used in flow cytometry on mouse samples (fig 5b). J Clin Invest (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4a
In order to explore the role of Nol3 in myeloproliferative neoplasms, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 4a). J Exp Med (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s5b
In order to demonstrate that IGF2 secreted by inhibitor of differentiation-overexpressing oesophageal cancer cells instigates VEGFR1-positive bone marrow cells in the tumor macroenvironment, Invitrogen Ly6a2 antibody (eBioscience, 12-5931) was used in flow cytometry on mouse samples (fig s5b). Nat Commun (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 5e
In order to assess the use of anti-CCR4 antibody in a mouse model of renal cell carcinoma, Invitrogen Ly6a2 antibody (eBioscience, 35-5931) was used in flow cytometry on mouse samples (fig 5e). J Clin Invest (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:300; loading ...; fig 5e
In order to assess the use of anti-CCR4 antibody in a mouse model of renal cell carcinoma, Invitrogen Ly6a2 antibody (eBioscience, 45-5932) was used in flow cytometry on mouse samples at 1:300 (fig 5e). J Clin Invest (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to assess the roles of signal transducer and activator of transcription 3 signaling and vitamin D in skeletal muscles, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 4a). Skelet Muscle (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s3
In order to examine the role of herpes virus entry mediator in corneal disease during viral infection, Invitrogen Ly6a2 antibody (eBiosciences, HK1.4) was used in flow cytometry on mouse samples (fig s3). Invest Ophthalmol Vis Sci (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to test if MSI2 modulates FLT3 expression, Invitrogen Ly6a2 antibody (ebioscience, D7) was used in flow cytometry on mouse samples (fig 2c). Leuk Res (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4b
In order to identify myeloid cells obtained from mouse intestine., Invitrogen Ly6a2 antibody (eBioscience, 48-5932-82) was used in flow cytometry on mouse samples (fig 4b). Methods Mol Biol (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
In order to examine the role of the proresolving protein annexin A1 in healing after wire injury, Invitrogen Ly6a2 antibody (eBioscience, RB6/8C5) was used in flow cytometry on mouse samples . Arterioscler Thromb Vasc Biol (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to utilize a G2-Gata4Cre;R26REYFP mouse line to track the developmental fate of the G2-Gata4 cell lineage, Invitrogen Ly6a2 antibody (EBioscience, D7) was used in flow cytometry on mouse samples (fig 1b). Haematologica (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; loading ...; fig 4b
In order to study the role of oxidative stress in optic neuritis, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples at 1:200 (fig 4b). Mol Vis (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 3c
In order to report that ergosterol increases hematopoietic cell homing in zebrafish and mice, Invitrogen Ly6a2 antibody (eBioScience, 12-5981-82) was used in flow cytometry on mouse samples (fig 3c). Stem Cell Reports (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3C
In order to analyze the effects of a loss of autophagy in dendritic cells and B cells in a TLR7-mediated model of autoimmunity, Invitrogen Ly6a2 antibody (eBioscience, 45-5931-80) was used in flow cytometry on mouse samples (fig 3C). J Immunol (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s2a
In order to report the molecular changes involve in stem cell differentiation, Invitrogen Ly6a2 antibody (eBioscience, 11-5981-81) was used in flow cytometry on mouse samples (fig s2a). Nucleic Acids Res (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2
In order to report the molecular changes involve in stem cell differentiation, Invitrogen Ly6a2 antibody (eBioscience, 13-5931-75) was used in flow cytometry on mouse samples (fig s2). Nucleic Acids Res (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; fig s13
In order to demonstrate that SAMHD1 reduces nucleoside analog cytarabine cytotoxicity in acute myeloid leukemia cells, Invitrogen Ly6a2 antibody (eBioscience, 45-5931) was used in flow cytometry on mouse samples at 1:200 (fig s13). Nat Med (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:200; fig s13
In order to demonstrate that SAMHD1 reduces nucleoside analog cytarabine cytotoxicity in acute myeloid leukemia cells, Invitrogen Ly6a2 antibody (eBioscience, 25-5981) was used in flow cytometry on mouse samples at 1:200 (fig s13). Nat Med (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 3c
In order to demonstrate that bone marrow Gr-1 low immature myeloid cells are responsible for the elevated, pathological levels of soluble urokinase plasminogen activator receptor, Invitrogen Ly6a2 antibody (eBioscience, 11-5981) was used in flow cytometry on mouse samples (fig 3c). Nat Med (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s3
  • immunohistochemistry; mouse; loading ...; fig 5a
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig s3) and in immunohistochemistry on mouse samples (fig 5a). PLoS ONE (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; fig 3
  • flow cytometry; mouse
In order to study the role of T cells in the effector phase of antibody-mediated autoimmune dermatoses, Invitrogen Ly6a2 antibody (eBioscience, RBC-8C5) was used in immunohistochemistry - frozen section on mouse samples (fig 3) and in flow cytometry on mouse samples . Sci Rep (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...
In order to use knockout mice to determine if GRK6 contributes to hematopoiesis, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . Cell Death Dis (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
In order to use knockout mice to determine if GRK6 contributes to hematopoiesis, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Cell Death Dis (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2l
In order to characterize Nlrp2-deficient mice and identify a role for this protein in fertility, Invitrogen Ly6a2 antibody (eBioscience, 11-5931-82) was used in flow cytometry on mouse samples (fig 2l). J Exp Med (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:100; fig s1a
In order to suggest that air-pollution-induced atopic dermatitis occurs through activation of AhR, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples at 1:100 (fig s1a). Nat Immunol (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 5a
In order to use a humanized mouse model to study Middle East respiratory syndrome coronavirus, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 5a). J Virol (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4b
  • flow cytometry; mouse; loading ...; fig s10c
In order to elucidate the contribution of Ptpn11 mutations in the bone marrow microenvironment to leukaemogenesis, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples (fig 4b) and in flow cytometry on mouse samples (fig s10c). Nature (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:200; loading ...; fig 6c
In order to find C57BL/6J mice have a defect in neutrophil recruitment to a range of inflammatory stimuli via NLRP12, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples at 1:200 (fig 6c). Nat Commun (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1b
In order to explore how microRNAs modulate granulocytic myeloid-derived suppressor cells induced by Lewis lung carcinoma, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 1b). Mol Med Rep (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s2
Invitrogen Ly6a2 antibody (eBioscience, 17-5931) was used in flow cytometry on mouse samples (fig s2). Oncotarget (2016) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; loading ...; fig 1j
In order to study the function of Galectin 3 using a self-resolving model of peritonitis, Invitrogen Ly6a2 antibody (eBiosciences, 1A8) was used in flow cytometry on mouse samples (fig 1j). J Leukoc Biol (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1h
In order to study the function of Galectin 3 using a self-resolving model of peritonitis, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 1h). J Leukoc Biol (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:50; loading ...; fig s2a
In order to describe how amino acids and Lamtor1 regulate macrophage polarization, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples at 1:50 (fig s2a). Nat Commun (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4e
In order to test if the NLRP3 inflammasome plays a role in valosin-containing protein-associated diseases, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 4e). Inflammation (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s3
Invitrogen Ly6a2 antibody (eBioscience, 25-5931-82) was used in flow cytometry on mouse samples (fig s3). Sci Rep (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1e,f
In order to investigate Fanconi anemia function in hematopoietic stem cells, Invitrogen Ly6a2 antibody (eBioscience, 25-5981-81) was used in flow cytometry on mouse samples (fig 1e,f). Stem Cell Reports (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...
In order to study the effect of IL-13 and IL-33 pathways in dysregulated type 2 inflammation., Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
In order to study the effect of IL-13 and IL-33 pathways in dysregulated type 2 inflammation., Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
brown rat monoclonal (1A8-Ly6g)
  • other; mouse; loading ...; fig 2c
Invitrogen Ly6a2 antibody (eBiosciences, 1A8) was used in other on mouse samples (fig 2c). Cell Rep (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1a
In order to characterize the immunological changes in tumors induced by radiation therapy, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate how PI3Kgamma regulates macrophage polarization, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig s2a). Nature (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 8A
Invitrogen Ly6a2 antibody (eBioscience, 17-5932) was used in flow cytometry on mouse samples (fig 8A). Oncoimmunology (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1d
In order to explore the roles of IRF4 in myeloid cell differentiation, Invitrogen Ly6a2 antibody (eBioscience, RB6/8C5) was used in flow cytometry on mouse samples (fig 1d). J Leukoc Biol (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2c
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 2c). J Clin Invest (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 1d
In order to assess the effects of environmental enrichment on microglia, Invitrogen Ly6a2 antibody (eBioscience, 12-5932-82) was used in flow cytometry on mouse samples (fig 1d). J Neurosci (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1d
In order to identify Matrilin-4 (Matn4) as a negative regulator of the hematopoietic stem cell stress response, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1a
In order to elucidate how Zfp36l1 and Zfp36l2 regulate the thymic beta-Selection checkpoint, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study changes in IL-23 and IL-22 after scratching, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . J Exp Med (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1a
In order to show that Kruppel-like transcription factor 6-B cell leukemia/lymphoma 6 regulates macrophage inflammatory gene expression and function, Invitrogen Ly6a2 antibody (eBioscience, 11-5931-82) was used in flow cytometry on mouse samples (fig 1a). J Biol Chem (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 7d
In order to explore monocytes-neutrophil interactions within the glomerular microvasculature, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 7d). Proc Natl Acad Sci U S A (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 3e
In order to investigate the role of FURIN in LysM positive myeloid cells in vivo, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 3e). Oncotarget (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1b
In order to investigate the role of FURIN in LysM positive myeloid cells in vivo, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 1b). Oncotarget (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to find a role for Car enzymes in regulating mast cell lineage commitment, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . J Exp Med (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . J Clin Invest (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s3
In order to demonstrate that OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice, Invitrogen Ly6a2 antibody (eBioscience, 25-5981-81) was used in flow cytometry on mouse samples (fig s3). Cell (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 4
Invitrogen Ly6a2 antibody (eBiosciences, HK1.4) was used in flow cytometry on mouse samples (fig 4). PLoS Pathog (2016) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; fig 4
Invitrogen Ly6a2 antibody (eBiosciences, 1A8) was used in flow cytometry on mouse samples (fig 4). PLoS Pathog (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s1b
In order to examine the role of BRPF1 during hematopoiesis, Invitrogen Ly6a2 antibody (eBiosciences, 17-5981-81) was used in flow cytometry on mouse samples (fig s1b). J Clin Invest (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s1a
In order to examine the role of BRPF1 during hematopoiesis, Invitrogen Ly6a2 antibody (eBiosciences, 45-5931-80) was used in flow cytometry on mouse samples (fig s1a). J Clin Invest (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:200; loading ...; fig 7a
In order to demonstrate that endothelial production of PDGF-CC during white adipose tissue angiogenesis regulates browning, Invitrogen Ly6a2 antibody (eBioscience, 12-5981-81) was used in flow cytometry on mouse samples at 1:200 (fig 7a). Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 4
In order to use transgenic mice to study how endogenous c-Kit receptor activation affects cardiac cell homeostasis and repair, Invitrogen Ly6a2 antibody (Pharmingen, 17-5931) was used in flow cytometry on mouse samples (fig 4). Cell Death Dis (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine the role of Id3 in germinal center B cells, Invitrogen Ly6a2 antibody (BD Pharmingen or eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 2a). Mol Cell Biol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s6a
In order to find a role for RelA in regulating oncogene-induced senescence, Invitrogen Ly6a2 antibody (Thermo Fisher Scientific, RB6-8C5) was used in flow cytometry on mouse samples (fig s6a). J Clin Invest (2016) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; 1:1600; fig s2
Invitrogen Ly6a2 antibody (eBioscience, 17-9668-82) was used in flow cytometry on mouse samples at 1:1600 (fig s2). PLoS ONE (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig ex1b
In order to perform live imaging for continuous single-cell long-term quantification of the transcription factors GATA1 and PU.1 and study how these factors influence early myeloid lineage choice, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig ex1b). Nature (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig ex1b
In order to perform live imaging for continuous single-cell long-term quantification of the transcription factors GATA1 and PU.1 and study how these factors influence early myeloid lineage choice, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig ex1b). Nature (2016) ncbi
brown rat monoclonal (D7)
  • immunocytochemistry; mouse; 1:50; fig 3a
Invitrogen Ly6a2 antibody (eBiosciences, 17-5981-81) was used in immunocytochemistry on mouse samples at 1:50 (fig 3a). Stem Cell Reports (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s1h
In order to explain how glial cells impact ILC3-derived IL-22, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s1h). Nature (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; 0.25 ug/ml; fig 5e
In order to propose that autofluorescence-based imaging finds previously unknown immune cell interactions in the airway, Invitrogen Ly6a2 antibody (Invitrogen, RB6-8C5) was used in immunohistochemistry on mouse samples at 0.25 ug/ml (fig 5e). Lab Invest (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1-s1
In order to propose that the ERK-AP-1 axis is important for translating TCR signal strength into proportional activation of downstream events, Invitrogen Ly6a2 antibody (eBiosciences, 13-5931-86) was used in flow cytometry on mouse samples (fig 1-s1). elife (2016) ncbi
brown rat monoclonal (NIMP-R14)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 7a
In order to test if mucosal fluid triggers the release of outer membrane vesicles from Pseudomonas aeruginosa resulting in a compromised epithelial barrier, Invitrogen Ly6a2 antibody (Thermo Fisher, NIMP-R14) was used in immunohistochemistry on mouse samples at 1:50 (fig 7a). Front Microbiol (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s1e
In order to determine the origin of pericytes in adult angiogenesis, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig s1e). Cell Res (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 2
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 2). Immunity (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen Ly6a2 antibody (eBiosciences, HK1.4) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
In order to discuss Staphylococcus aureus-derived allergens, Invitrogen Ly6a2 antibody (eBioscience, 11-5931-82) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:400; loading ...; fig 3a
In order to test if senescent stromal cells contribute to tumorigenesis, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples at 1:400 (fig 3a). Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 2h
In order to test if senescent stromal cells contribute to tumorigenesis, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in immunohistochemistry on mouse samples at 1:400 (fig 2h). Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
In order to detail how to obtain innate lymphoid cells from isolated common lymphoid progenitors, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples . Bio Protoc (2016) ncbi
brown rat monoclonal (D7)
  • immunohistochemistry; mouse; 1:100; fig 3A
Invitrogen Ly6a2 antibody (eBioscience, 14-5981-81) was used in immunohistochemistry on mouse samples at 1:100 (fig 3A). PLoS ONE (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; 1:50; loading ...; fig s5
In order to characterize the cellular basis and dynamics of the inflammatory microenvironment present in glioblastomas multiforme, Invitrogen Ly6a2 antibody (Ebiosciences, 145931) was used in immunohistochemistry on mouse samples at 1:50 (fig s5). Sci Rep (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 6d
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 6d). PLoS ONE (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 1b). J Immunol (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:50; loading ...; fig 6d
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen Ly6a2 antibody (eBioscience, 12-5981-82) was used in flow cytometry on mouse samples at 1:50 (fig 6d). Nat Cell Biol (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:100; loading ...; fig s1a
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples at 1:100 (fig s1a). Nat Med (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s1
In order to examine the effects of mesenchymal stromal cell-derived extracellular vesicles on bone marrow radiation damage, Invitrogen Ly6a2 antibody (eBioscience, 11-5981-82) was used in flow cytometry on mouse samples (fig s1). Leukemia (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 2b
In order to discover cell-intrinsic division and differentiation differences in neonatal CD8+ T cells, Invitrogen Ly6a2 antibody (eBiosciences, 47-5932-82) was used in flow cytometry on mouse samples (fig 2b). Immunol Cell Biol (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:25; fig 1
Invitrogen Ly6a2 antibody (eBioscience, 17-5932) was used in flow cytometry on mouse samples at 1:25 (fig 1). J Clin Invest (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:400; fig s3
In order to characterize dysregulation of neuronal network activity following a stroke due to microglia protecting against brain injury and their selective elimination, Invitrogen Ly6a2 antibody (eBioscience, 25-5932-80) was used in flow cytometry on mouse samples at 1:400 (fig s3). Nat Commun (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s3
In order to elucidate induction of p53-dependent and independent apoptosis to compromise cellular proliferation and inhibition of tumor formation by dysfunctional telomeres, Invitrogen Ly6a2 antibody (eBioscience, 12-598) was used in flow cytometry on mouse samples (fig s3). Aging Cell (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to investigate the effects of IL-1 on hematopoietic stem cells, Invitrogen Ly6a2 antibody (eBioscience, 14-5931-85) was used in flow cytometry on mouse samples . Nat Cell Biol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2i
In order to test if heme oxygenase-1 mediates cardiac protection by altering mitochondrial quality control, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 2i). JCI Insight (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3a
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3c
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 3a) and in immunohistochemistry on mouse samples at 1:500 (fig 3c). Sci Rep (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, 17-5981) was used in flow cytometry on mouse samples . Biol Open (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1a
In order to implicate S100A8 and S100A9 messenger RNAs as important mediators of tumor cell aggressiveness, and highlights their therapeutic potential for interference of metastasis, Invitrogen Ly6a2 antibody (eBiosciences, 12-5931-82) was used in flow cytometry on mouse samples (fig 1a). Oncogene (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 3
Invitrogen Ly6a2 antibody (Ebioscience, 14-5931) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 3). PLoS ONE (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 3d
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 3d). J Exp Med (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 3
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:300; loading ...; fig s3d
In order to investigate the role of IL-1beta produced by a T helper 17 cell-intrinsic ASC-NLRP3-caspase-8 inflammasome in experimental autoimmune encephalomyelitis, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples at 1:300 (fig s3d). Nat Immunol (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig s18g
In order to report that the maternal microbiota shapes the offspring's immune system, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig s18g). Science (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • blocking or activating experiments; mouse; fig 7
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in blocking or activating experiments on mouse samples (fig 7). Oncotarget (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3b
In order to show that CXCR1 mediates pulmonary host defense against Pseudomonas aeruginosa, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 3b). J Innate Immun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; fig 6
Invitrogen Ly6a2 antibody (eBioscience, 14-5931-82) was used in immunohistochemistry on mouse samples (fig 6). Oncotarget (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:500
Invitrogen Ly6a2 antibody (eBioscience, 45-5981) was used in flow cytometry on mouse samples at 1:500. Science (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 2b). Nat Commun (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s4
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig s4). Nucleic Acids Res (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3
Invitrogen Ly6a2 antibody (eBioscience, 53-5931) was used in flow cytometry on mouse samples (fig 3). Int J Mol Med (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, 25-5932) was used in flow cytometry on mouse samples . Oncotarget (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig 4a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 4a). Infect Immun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 4a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 4a). Infect Immun (2016) ncbi
brown rat monoclonal (NIMP-R14)
  • immunohistochemistry - paraffin section; mouse; 1 ug/ml; fig 4
In order to investigate promotion of healing in a bacterial LPS model of delayed cutaneous wound repair by oestrogen, Invitrogen Ly6a2 antibody (Thermo Scientific, MA1-40038) was used in immunohistochemistry - paraffin section on mouse samples at 1 ug/ml (fig 4). Lab Invest (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s2
Invitrogen Ly6a2 antibody (eBioscience, 45-5931-80) was used in flow cytometry on mouse samples (fig s2). Sci Rep (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:100; fig s7a
In order to suggest that locally synthesized C1q promotes tumor growth, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples at 1:100 (fig s7a). Nat Commun (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; 1:500; fig s3
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples at 1:500 (fig s3). Nat Commun (2016) ncbi
brown rat monoclonal (HK1.4)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse; 1:100; fig 1
Invitrogen Ly6a2 antibody (eBioscience, 12-5932) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples at 1:100 (fig 1). Dis Model Mech (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, 11-5931-85) was used in flow cytometry on mouse samples . Nature (2016) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 2
In order to study the contribution of thyroid stimulating hormone beta-subunit to Listeria monocytogenes infection, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...
In order to examine the effect of E-selectin ligand 1 on hematopoietic cells, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...
In order to examine the effect of E-selectin ligand 1 on hematopoietic cells, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Nat Commun (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s3h
In order to study apoptosis inhibitor of macrophage protein, intraluminal debris clearance and acute kidney injury in mice, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s3h). Nat Med (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 6
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 6). PLoS Biol (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:428
In order to characterize TAK1 and modulation of skeletal muscle repair and satelline stem cell homeostasis, Invitrogen Ly6a2 antibody (eBioscience, 12-5981-82) was used in flow cytometry on mouse samples at 1:428. Nat Commun (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study genetic lineage tracing to identify cardiomyocytes and in situ Kit-expression, Invitrogen Ly6a2 antibody (eBioscience, 25-5931) was used in flow cytometry on mouse samples . Cell Res (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 2
In order to identify the source of obesity-induced MCP-1 and identify molecular regulators mediating MCP-1 production, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 2). Mol Metab (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:1000; loading ...; fig s1a
In order to identify microRNAs that drive malignant progression, Invitrogen Ly6a2 antibody (eBioscience, 45-5981-80) was used in flow cytometry on mouse samples at 1:1000 (fig s1a). Nat Cell Biol (2016) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig s2a
In order to explore the contributions of GATA3 to the group 3 innate lymphoid cells, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig s2a). Nat Immunol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1a
In order to explore the contributions of GATA3 to the group 3 innate lymphoid cells, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 1a). Nat Immunol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1f
In order to study how DNMT3A is involved in the function of PML-RARA, RUNX1-RUNX1T1, and MLL-AF9, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 1f). J Clin Invest (2016) ncbi
brown rat monoclonal (D7)
  • immunohistochemistry; mouse; 1:100-1:200; fig 8
In order to characterize defects in heart development and embryonic lethality due to cardiac-specific activation of IKK2, Invitrogen Ly6a2 antibody (eBioscience, 14-5981-82) was used in immunohistochemistry on mouse samples at 1:100-1:200 (fig 8). PLoS ONE (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Ly6a2 antibody (eBioscience, RB6.8) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 4g
Invitrogen Ly6a2 antibody (eBioscience, 17-5932-82) was used in flow cytometry on mouse samples (fig 4g). Mediators Inflamm (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s2e
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig s2e). Nat Med (2015) ncbi
brown rat monoclonal (NIMP-R14)
  • immunohistochemistry - frozen section; mouse; fig 8
In order to study apolipoprotein-1 during normocholesterolemic conditions, Invitrogen Ly6a2 antibody (Thermo Fisher, NIMP-R14) was used in immunohistochemistry - frozen section on mouse samples (fig 8). J Immunol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; fig 5
  • western blot; mouse; fig 5
Invitrogen Ly6a2 antibody (eBioscience, 14-5931) was used in immunohistochemistry - frozen section on mouse samples (fig 5) and in western blot on mouse samples (fig 5). PLoS Med (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Ly6a2 antibody (eBioscience, 25-5981) was used in flow cytometry on mouse samples (fig 3b). J Exp Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2f
Invitrogen Ly6a2 antibody (eBioscience, 17-5931) was used in flow cytometry on mouse samples (fig 2f). J Exp Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 6
Invitrogen Ly6a2 antibody (eBioscience, 25-5931-82) was used in flow cytometry on mouse samples (fig 6). Blood (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 7
Invitrogen Ly6a2 antibody (eBioscience, 61-5931-82) was used in flow cytometry on mouse samples (fig 7). Sci Rep (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 8a
Invitrogen Ly6a2 antibody (eBiosciences, HK1.4) was used in flow cytometry on mouse samples (fig 8a). Nat Commun (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; fig 2
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples (fig 2). PLoS ONE (2015) ncbi
brown rat monoclonal (D7)
  • immunocytochemistry; human; 1:50; fig 2
Invitrogen Ly6a2 antibody (eBioscience, 14-5981-85) was used in immunocytochemistry on human samples at 1:50 (fig 2). PLoS ONE (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:1000; loading ...; fig 3c, 3d
Invitrogen Ly6a2 antibody (eBioscience, 11-5931) was used in flow cytometry on mouse samples at 1:1000 (fig 3c, 3d). Endocrinology (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8c5) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2015) ncbi
brown rat monoclonal (D7)
  • immunocytochemistry; mouse
Invitrogen Ly6a2 antibody (eBioscience, 17-5981-81) was used in immunocytochemistry on mouse samples . Cell Res (2015) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen Ly6a2 antibody (eBioscience, 1A8) was used in flow cytometry on mouse samples (fig 3f). J Immunol (2015) ncbi
brown rat monoclonal (HK1.4)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1a
In order to discuss mechanisms by which type I interferon predisposes individuals to bacterial superinfections, Invitrogen Ly6a2 antibody (BD, 17-5932) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1a). Cell Physiol Biochem (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2d
  • flow cytometry; mouse; 1:100; loading ...; fig 1c
In order to discuss mechanisms by which type I interferon predisposes individuals to bacterial superinfections, Invitrogen Ly6a2 antibody (BD, 11-5931) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2d) and in flow cytometry on mouse samples at 1:100 (fig 1c). Cell Physiol Biochem (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 5a
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 5a). Cancer Res (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s1
Invitrogen Ly6a2 antibody (eBioscience, 48-5931-82) was used in flow cytometry on mouse samples (fig s1). Am J Respir Cell Mol Biol (2016) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; fig s1
Invitrogen Ly6a2 antibody (eBioscience, 46-9668-80) was used in flow cytometry on mouse samples (fig s1). Am J Respir Cell Mol Biol (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2e
In order to assess surface expression of C-type lectin-like receptor 2 on hematopoietic cells from peripheral blood and secondary lymphoid organs, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 2e). Eur J Immunol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; human
Invitrogen Ly6a2 antibody (eBioscience, 17-5931) was used in flow cytometry on human samples . Biochim Biophys Acta (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 8a
Invitrogen Ly6a2 antibody (eBiosciences, D7) was used in flow cytometry on mouse samples (fig 8a). elife (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s1
In order to discuss tissue tropisms of innate lymphoid cells, Invitrogen Ly6a2 antibody (Thermo Fisher Scientific, RB6-8C5) was used in flow cytometry on mouse samples (fig s1). Immunity (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study mediation of TLR7-dependent inflammation and autoimmunity by B cell autophagy, Invitrogen Ly6a2 antibody (eBiosciences, 115931-82) was used in flow cytometry on mouse samples . Autophagy (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
In order to test if metformin ameliorates ionizing radiation-induced long-term bone marrow injury in a total-body irradiation mouse model, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 1). Free Radic Biol Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to test if metformin ameliorates ionizing radiation-induced long-term bone marrow injury in a total-body irradiation mouse model, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Free Radic Biol Med (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 2
Invitrogen Ly6a2 antibody (eBioscience, 25-5981-82) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:500
Invitrogen Ly6a2 antibody (eBioscience, RB6-8c5) was used in flow cytometry on mouse samples at 1:500. Cell Res (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig s1
Invitrogen Ly6a2 antibody (eBioscience, 11-5981-82) was used in flow cytometry on mouse samples (fig s1). Cell Death Dis (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study the effect of ERK1/2 and ERK5 activation on BAFF-induced B cell survival, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . J Exp Med (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
Invitrogen Ly6a2 antibody (eBioscience, 45-5981-82) was used in flow cytometry on mouse samples (fig 1). Nat Med (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 2
In order to determine the contribution of different SP-R210 isoforms to various macrophage functions, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 4
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 4). Nature (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, 17-5931) was used in flow cytometry on mouse samples . elife (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 5a
In order to assess a CD 4 T-cell population during tuberculosis that has memory-like properties maintained by Bcl6 and ICOS-dependent pathways, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • blocking or activating experiments; mouse; fig 2b
Invitrogen Ly6a2 antibody (eBioscience, 16-5931-85) was used in blocking or activating experiments on mouse samples (fig 2b). Antioxid Redox Signal (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s2c
  • immunohistochemistry; mouse; loading ...; fig 3a
In order to determine if specific B cell subsets or if B cell-derived interleukin-10 contributes to tolerance, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s2c) and in immunohistochemistry on mouse samples (fig 3a). Transplantation (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s1
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s1). PLoS Pathog (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 3
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 3). J Exp Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 3). J Exp Med (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 3
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; 10 ug/ml; fig 4
Invitrogen Ly6a2 antibody (eBioscience, 14-5931) was used in immunohistochemistry - paraffin section on mouse samples at 10 ug/ml (fig 4). Nat Commun (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 4e
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 4e). Sci Transl Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 1:4000
Invitrogen Ly6a2 antibody (eBioscience, 17-5931-82) was used in flow cytometry on mouse samples at 1:4000. EMBO Mol Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s2
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s2). PLoS Pathog (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig s2
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig s2). PLoS Pathog (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to study the role of astroglial cx43 in immune quiescence of the brain, Invitrogen Ly6a2 antibody (Life Technologies, RM3030) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. J Neurosci (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; tbl s3
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
brown rat monoclonal (D7)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (e-Bioscience, D7) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . Oncogene (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
In order to elucidate the function of miR-29a in hematopoietic stem and progenitor cells, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 1). Blood (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse
  • flow cytometry; mouse
In order to examine the role of the mammalian acid sphingomyelinase/ceramide system in the development of lung edema caused by S. aureus, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in immunohistochemistry - paraffin section on mouse samples and in flow cytometry on mouse samples . J Mol Med (Berl) (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig s3
In order to test if blocking several checkpoint receptors boosts anti-tumor immunity in a low-dose, lymphodepleting whole body radiation model, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s3). J Immunother Cancer (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • blocking or activating experiments; mouse; fig 3b
  • flow cytometry; mouse
In order to study the contribution of Wip1 to neutrophil function during oxidative stress and inflammation, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in blocking or activating experiments on mouse samples (fig 3b) and in flow cytometry on mouse samples . Curr Mol Med (2015) ncbi
brown rat monoclonal (NIMP-R14)
  • immunohistochemistry; mouse
In order to study the contribution of Wip1 to neutrophil function during oxidative stress and inflammation, Invitrogen Ly6a2 antibody (Thermo, NIMP-R14) was used in immunohistochemistry on mouse samples . Curr Mol Med (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 0.4 ug/ml
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples at 0.4 ug/ml. Immunol Cell Biol (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:500; loading ...
In order to investigate the impact of BCL11A expression on breast cancer development, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples at 1:500. Nat Commun (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
In order to show how early events during viral infection decide the immune response and facilitate either control, clearance, or persistence of the virus, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples . PLoS Pathog (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s2
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s2). Nat Immunol (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 2
In order to assess the effects of Hspa9 haploinsufficiency on hematopoiesis using zebrafish, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 2). Exp Hematol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2
In order to assess the effects of Hspa9 haploinsufficiency on hematopoiesis using zebrafish, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 2). Exp Hematol (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
In order to identify Cd8 cis-regulatory elements, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
brown rat monoclonal (1A8-Ly6g)
  • flow cytometry; mouse; fig S9i
Invitrogen Ly6a2 antibody (eBioscience, 17-9668) was used in flow cytometry on mouse samples (fig S9i). Nat Immunol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s1
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig s1). J Immunol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 8
In order to determine the role of epithelial beta1 integrin in alveolarization and lung branching morphogenesis, Invitrogen Ly6a2 antibody (eBioscience, 11-5931) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 8). Development (2014) ncbi
brown rat monoclonal (D7)
  • immunocytochemistry; mouse; 1:500
In order to investigate the mechanisms underlying the specification of branch location, Invitrogen Ly6a2 antibody (eBioscience, 17-5981-82) was used in immunocytochemistry on mouse samples at 1:500. Nat Cell Biol (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study IkappaB kinase-induced proteolysis of NF-kappaB1 p105 in B cells using Nfkb1(SSAA/SSAA) mice, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, 2-5931) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, 17-5932-80) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:200
In order to examine the expression of Ebf2 in adipogenic precursor cells, Invitrogen Ly6a2 antibody (eBioscience, 12-5981-81) was used in flow cytometry on mouse samples at 1:200. Proc Natl Acad Sci U S A (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
Invitrogen Ly6a2 antibody (eBioscience, 12-5981-82) was used in flow cytometry on mouse samples (fig 1). Methods Mol Biol (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; 0.17 ug/ul
In order to assess the contribution of Tbx1 to thymus and parathyroid development, Invitrogen Ly6a2 antibody (Invitrogen, clone RB6-8C5) was used in flow cytometry on mouse samples at 0.17 ug/ul. Development (2014) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; fig 5
Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples (fig 5). Mucosal Immunol (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
In order to analyze the adaptor ASC and its 'prinoid' activities and extracellular activities that propagate inflammation, Invitrogen Ly6a2 antibody (eBioscience, HK1.4) was used in flow cytometry on mouse samples . Nat Immunol (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to analyze the adaptor ASC and its 'prinoid' activities and extracellular activities that propagate inflammation, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Nat Immunol (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . Sci Rep (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to analyze chronic lymphocytic leukemia and how cytokine-driven loss of plasmacytoid dendritic cell function occurs, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . Leukemia (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (tbl 1). Nat Immunol (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 2
In order to determine the origin of fibroblasts in skin connective tissue, Invitrogen Ly6a2 antibody (eBioscience, 56-5981-82) was used in flow cytometry on mouse samples (fig 2). Nature (2013) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to elucidate the immunological pathways that lead to obesity-associated asthma, Invitrogen Ly6a2 antibody (eBioscience, 56-5981-82) was used in flow cytometry on mouse samples . Nat Med (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Br J Cancer (2014) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Stem Cells (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . Stem Cells (2014) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to identify CD11b(+) classical dendritic cells as the source of IL-23 in C. rodentium infected mice, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . Nat Immunol (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig s6a
In order to generate and characterize Hoxb8-FL cells, Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig s6a). Nat Methods (2013) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 6a
In order to generate and characterize Hoxb8-FL cells, Invitrogen Ly6a2 antibody (eBiosciences, D7) was used in flow cytometry on mouse samples (fig 6a). Nat Methods (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2
In order to determine if Bok and Bax have any functional redundancy controlling apoptosis using knock out mice, Invitrogen Ly6a2 antibody (Caltag, clone RB6-8C5) was used in flow cytometry on mouse samples (fig 2). Cell Death Dis (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to investigate the role of short-chain fatty acids and their receptor on intestinal immune responses, Invitrogen Ly6a2 antibody (Invitrogen, RB6-8C5) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Gastroenterology (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • immunocytochemistry; mouse; 0.5 ug/ml
  • immunohistochemistry; mouse; 0.5 ug/ml
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in immunocytochemistry on mouse samples at 0.5 ug/ml and in immunohistochemistry on mouse samples at 0.5 ug/ml. Proc Natl Acad Sci U S A (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to report that interferon gamma is essential for effective ionizing radiation therapy, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Am J Pathol (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; tbl 1
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (tbl 1). PLoS ONE (2013) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 7
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 7). PLoS ONE (2013) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; 1:250
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples at 1:250. Biomed Res Int (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study the impact of mesenchymal stem cells to experimental allergic encephalomyelitis, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Front Immunol (2013) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to study the impact of mesenchymal stem cells to experimental allergic encephalomyelitis, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . Front Immunol (2013) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; fig 7j
In order to report the effects of aging on maturation of M cells, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples (fig 7j). Mucosal Immunol (2013) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to examine IL-7R signaling in Tbx21 and Rag2 knockout mice, Invitrogen Ly6a2 antibody (Invitrogen, D7) was used in flow cytometry on mouse samples . Immunity (2012) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to examine IL-7R signaling in Tbx21 and Rag2 knockout mice, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Immunity (2012) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, 13-5931) was used in flow cytometry on mouse samples . Exp Hematol (2012) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; human
In order to review cellular and molecular mechanisms that contribute to chronic obstructive pulmonary disease pathogenesis, Invitrogen Ly6a2 antibody (Invitrogen, RB6-8C5) was used in flow cytometry on human samples . PLoS ONE (2011) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3
In order to determine the contributions of individual MHC class I family members to autoimmunity in two mouse models, Invitrogen Ly6a2 antibody (Invitrogen, RM3030) was used in flow cytometry on mouse samples (fig 3). J Immunol (2011) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Haematologica (2011) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, ebio 25-5931) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to determine the origin of tumor macrophages, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Nature (2011) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBiosciences, D7) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2
In order to investigate the role of flotillin 1 in neutrophil chemotaxis., Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 2). J Cell Biol (2010) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; tbl 1
In order to develop and characterize a novel model of heterologous pulmonary infection using Bordetella parapertussis and influenza virus, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2010) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 9
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 9). J Immunol (2009) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2009) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
In order to study committed transformed progenitors in a murine model of acute promyelocytic leukemia, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 1). Blood (2009) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
In order to study committed transformed progenitors in a murine model of acute promyelocytic leukemia, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 1). Blood (2009) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study the role of bone marrow-derived cells in lymphangiogenesis, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . PLoS ONE (2009) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 7
In order to investigate how lymphocytes traffic between the peritoneal cavity and omentum, Invitrogen Ly6a2 antibody (eBioscience, 17-5931-82) was used in flow cytometry on mouse samples (fig 7). J Immunol (2009) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to report that Gfi1 suppresses the HoxA9-Pbx1-Meis1 progenitor program and induces a granulopoietic transcription program, Invitrogen Ly6a2 antibody (Invitrogen, RB6-8C5) was used in flow cytometry on mouse samples . Blood (2009) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
In order to investigate the immunological mechanism leading to rejection of allogeneic bone marrow-derived stromal cells after implantation in murine central nervous system, Invitrogen Ly6a2 antibody (eBioscience, 11-5981) was used in flow cytometry on mouse samples (fig 1). Immunol Cell Biol (2009) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to elucidate the role of VAMP8 in the thymus, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . Cell Tissue Res (2008) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . Cell Res (2008) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
In order to assess the effects of Flt3 signaling on macrophage dendritic cell progenitors and on peripheral dendritic cells, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2008) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
In order to assess the effects of Flt3 signaling on macrophage dendritic cell progenitors and on peripheral dendritic cells, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2008) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
In order to study neutrophil-T cell interactions, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples (fig 1). Immunol Lett (2008) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse
In order to assess whether B cells and antibodies are involved in Leishmania amazonensis disease and pathogenesis in mice, Invitrogen Ly6a2 antibody (Invitrogen, RB6-8C5) was used in immunohistochemistry on mouse samples . Int J Parasitol (2008) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to investigate whether hematopoietic cells transduce canonical Wnt signals in the absence of beta- and gamma-catenin, Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Blood (2008) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3
Invitrogen Ly6a2 antibody (eBiosciences, RB6-8C5) was used in flow cytometry on mouse samples (fig 3). Gene Ther (2007) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to suggest that the enzyme IDO is more highly expressed in nonplasmacytoid dendritic cells of the nose draining lymph nodes, Invitrogen Ly6a2 antibody (eBioscience, Rb6-8C5) was used in flow cytometry on mouse samples . J Immunol (2007) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2007) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
In order to identify the cells that are producing gamma interferon during infection with Listeria monocytogenes, Invitrogen Ly6a2 antibody (Caltag, RB68C5) was used in flow cytometry on mouse samples (fig 1). Infect Immun (2007) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; fig 2
In order to explore the role of mammalian chitinase-like proteins in dermatitis, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples (fig 2). Exp Dermatol (2006) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to demonstrate that AChE-R and ARP facilitate granulocytosis, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . J Immunol (2006) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; 1:20
In order to examine the effect of age on the movement of leukocytes into skeletal muscle after a sports-related injury, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples at 1:20. Orthop Nurs (2005) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to investigate how peroxide affects hematopoiesis, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . Blood (2006) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 8
In order to investigate how peroxide affects hematopoiesis, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 8). Blood (2006) ncbi
brown rat monoclonal (RB6-8C5)
  • blocking or activating experiments; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in blocking or activating experiments on mouse samples . Am J Physiol Lung Cell Mol Physiol (2006) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study T cell progenitors in the adult thymus, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . J Immunol (2005) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
In order to report that granulocyte colony-stimulating factor modulates angiogenesis by increasing myelomonocytic cells and vascular endothelial growth factor release, Invitrogen Ly6a2 antibody (noco, A14748) was used in flow cytometry on mouse samples (fig 1). FASEB J (2005) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse
In order to elucidate the cellular mechanisms by which granulocyte/monocyte progenitors give rise to eosinophils, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples . J Exp Med (2005) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
Invitrogen Ly6a2 antibody (eBioscience, RB6-8C5) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2005) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3
In order to elucidate the role of neutrophils in tuberculosis resistance and pathology, Invitrogen Ly6a2 antibody (Caltag Laboratories, RB6-8C5) was used in flow cytometry on mouse samples (fig 3). Infect Immun (2005) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3
In order to measure the number of splenic myeloid progenitors and their progeny after burn injury, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples (fig 3). Shock (2005) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to study mycobacterial dissemination and immune-cell trafficking in tuberculosis, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . J Infect Dis (2004) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to identify a role for TRAIL in apoptosis during listeriosis, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . J Immunol (2004) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to investigate mechanisms that regulate thymus size, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . J Immunol (2004) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to elucidate how Schistosoma mansoni suppresses T cell activation, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . J Immunol (2004) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 2
In order to investigate the contribution of GRAIL and GRAIL-interacting proteins to CD4 T cell anergy, Invitrogen Ly6a2 antibody (eBioscience, D7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2004) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 4
In order to demonstrate that deletion p18(INK4C) results in improved long-term engraftment, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples (fig 4). Nat Cell Biol (2004) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; human; fig 6
  • flow cytometry; mouse; fig 6
In order to identify and characterize the chemotaxis inhibitory protein of Staphylococcus aureus, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on human samples (fig 6) and in flow cytometry on mouse samples (fig 6). J Exp Med (2004) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to assess the contribution of DC function in non-obese diabetic mice, Invitrogen Ly6a2 antibody (Caltag, RB6?C8C5) was used in flow cytometry on mouse samples . Clin Exp Immunol (2003) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to discuss DC generation from monocytes, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . Blood (2004) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 2
In order to determine the safety of using BBG2Na in animals challenged with RSV-B, Invitrogen Ly6a2 antibody (Caltag, clone RB6-8C5) was used in flow cytometry on mouse samples (fig 2). Vaccine (2003) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 3
In order to investigate DCs in non-obese diabetic mice, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples (fig 3). Cell Immunol (2003) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 5D
In order to report the temporal expression of chemokines and cytokines from the tibiotarsal joint in arthritis-resistant and -susceptible mice, Invitrogen Ly6a2 antibody (noco, RB6-8C5) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 5D). J Immunol (2003) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 4
In order to test if a total lymphoid irradiation and anti-thymocyte serum regimen can prevent graft verses host disease, Invitrogen Ly6a2 antibody (Caltag, clone RB6-8C5) was used in flow cytometry on mouse samples (fig 4). Biol Blood Marrow Transplant (2003) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to use the BALB-neuT model to study carcinogenesis, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . Blood (2003) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1
In order to study the effect of neonatal priming on the Th2 response using respiratory syncytial virus, Invitrogen Ly6a2 antibody (Caltag, clone RB6-8C5) was used in flow cytometry on mouse samples (fig 1). Vaccine (2003) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 8
In order to examine the ability of different tumor cells to induce apoptosis of activated CD8(+) T cells in vitro, Invitrogen Ly6a2 antibody (Caltag Laboratories, RB6-8C5) was used in flow cytometry on mouse samples (fig 8). J Immunol (2001) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; fig 1, 2
In order to develop a nonmyeloablative host conditioning regimen for transplantation, Invitrogen Ly6a2 antibody (Caltag Laboratories, RB6-8C5) was used in flow cytometry on mouse samples (fig 1, 2). J Immunol (2001) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; fig 4
In order to characterize a new nasal adjuvant, dimethyldioctadecylammonium bromide, Invitrogen Ly6a2 antibody (Caltag, clone RB6-8C5) was used in immunohistochemistry on mouse samples (fig 4). Vaccine (2001) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; fig 4
In order to discuss vaccination with BBG2Na, Invitrogen Ly6a2 antibody (Caltag, clone RB6-8C5) was used in immunohistochemistry on mouse samples (fig 4). Vaccine (2001) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to determine the role of polymorphonuclear neutrophils in Chlamydophila abortus-infected mice, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples . Infect Immun (2000) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; fig 2
In order to study the contributions of P-selectin and ICAM-1 to traumatic brain injury, Invitrogen Ly6a2 antibody (Caltag Laboratories, clone RB6-8C5) was used in immunohistochemistry - frozen section on mouse samples (fig 2). J Leukoc Biol (2000) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; tbl 4
In order to test if the functional capacity of hemopoietic progenitor cells and the micro-environment of aged and young mice are identical, Invitrogen Ly6a2 antibody (Caltag, RB6-8C5) was used in flow cytometry on mouse samples (tbl 4). Mech Ageing Dev (1999) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to examine the effect of NGFI-A deficiency on macrophage differentiation and function in vivo, Invitrogen Ly6a2 antibody (CalTag, RB6.8C5) was used in flow cytometry on mouse samples . Mol Cell Biol (1996) ncbi
brown rat monoclonal (D7)
  • western blot; mouse; fig 3
In order to discuss detection of Ly-6 locus-controlled antigen, Invitrogen Ly6a2 antibody (noco, D7) was used in western blot on mouse samples (fig 3). Immunogenetics (1986) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to show the involvement of the MEL-14 antigen in neutrophil-endothelial cell interactions, Invitrogen Ly6a2 antibody (noco, RB6-8C5) was used in flow cytometry on mouse samples . J Immunol (1987) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse
In order to use a new Ly-6C-specific antibody to study monocytes, macrophages, and endothelial cells, Invitrogen Ly6a2 antibody (noco, RB6-8C5) was used in flow cytometry on mouse samples . Eur J Immunol (1988) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
In order to elucidate the cellular basis for differential expression of the Ly-6A/E alloantigen on T cells, Invitrogen Ly6a2 antibody (noco, D7) was used in flow cytometry on mouse samples (fig 1). Immunogenetics (1989) ncbi
Abcam
brown rat monoclonal (ER-MP20)
  • flow cytometry; mouse; loading ...; fig 2d
Abcam Ly6a2 antibody (Abcam, ER-MP20) was used in flow cytometry on mouse samples (fig 2d). Front Immunol (2018) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse; loading ...; fig s4a
Abcam Ly6a2 antibody (Abcam, HK1.4) was used in flow cytometry on mouse samples (fig s4a). Leukemia (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 4i, 5h
Abcam Ly6a2 antibody (Abcam, ab25377) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 4i, 5h). J Neurovirol (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5c
Abcam Ly6a2 antibody (Abcam, ab25024) was used in immunohistochemistry - frozen section on mouse samples (fig 5c). J Am Heart Assoc (2018) ncbi
brown rat monoclonal
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2
Abcam Ly6a2 antibody (Abcam, ab210204) was used in immunohistochemistry - frozen section on mouse samples (fig 2). J Am Heart Assoc (2018) ncbi
brown rat monoclonal (ER-MP20)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3f
Abcam Ly6a2 antibody (Abcam, ab15627) was used in immunohistochemistry on mouse samples at 1:500 (fig 3f). J Neurosci (2018) ncbi
brown rat monoclonal (ER-MP20)
  • immunohistochemistry - paraffin section; mouse; 1:1500; fig 5e
Abcam Ly6a2 antibody (Abcam, ab15627) was used in immunohistochemistry - paraffin section on mouse samples at 1:1500 (fig 5e). JCI Insight (2017) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
Abcam Ly6a2 antibody (Abcam, ab25031) was used in flow cytometry on mouse samples (fig 1). Mol Med Rep (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 5e
Abcam Ly6a2 antibody (Abcam, ab25377) was used in immunohistochemistry on mouse samples at 1:250 (fig 5e). Mol Vis (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry; mouse; loading ...; fig 4b
In order to study the expression and functional role of stabilin-1 in breast cancer, Abcam Ly6a2 antibody (Abcam, RB6-8C5) was used in immunohistochemistry on mouse samples (fig 4b). Oncotarget (2016) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; 1:2000; loading ...; fig 2a
Abcam Ly6a2 antibody (Abcam, ab25377) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 2a). Nat Commun (2016) ncbi
brown rat monoclonal (E13 161-7)
  • western blot; mouse; fig 3b
Abcam Ly6a2 antibody (Abcam, 51317) was used in western blot on mouse samples (fig 3b). EMBO Mol Med (2016) ncbi
brown rat monoclonal (E13 161-7)
  • immunohistochemistry - paraffin section; mouse; fig 1
Abcam Ly6a2 antibody (Abcam, ab51317) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Nat Med (2015) ncbi
brown rat monoclonal (D7)
  • flow cytometry; mouse; fig 1
Abcam Ly6a2 antibody (Abcam, ab25031) was used in flow cytometry on mouse samples (fig 1). Mol Med Rep (2015) ncbi
brown rat monoclonal (HK1.4)
  • flow cytometry; mouse
Abcam Ly6a2 antibody (Abcam, HK1.4) was used in flow cytometry on mouse samples . J Biol Chem (2014) ncbi
R&D Systems
brown rat monoclonal (177228)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1d
R&D Systems Ly6a2 antibody (R&D systems, BAM1226) was used in immunohistochemistry - frozen section on mouse samples (fig 1d). Cell Stem Cell (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 3a
R&D Systems Ly6a2 antibody (R&D, MAB1037) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3a). Oncol Rep (2018) ncbi
brown rat monoclonal (RB6-8C5)
  • flow cytometry; mouse; loading ...; fig 2
R&D Systems Ly6a2 antibody (R&D Systems, RB6-8C5) was used in flow cytometry on mouse samples (fig 2). Front Microbiol (2017) ncbi
brown rat monoclonal (177228)
  • flow cytometry; mouse; loading ...; fig st2
In order to demonstrate that plasmalemma vesicle-associated protein governs the seeding of fetal monocyte-derived macrophages in the tissues of mice, R&D Systems Ly6a2 antibody (R&D Systems, FAB1226P) was used in flow cytometry on mouse samples (fig st2). Nature (2016) ncbi
brown rat monoclonal (177228)
  • flow cytometry; mouse; 0.1 ug/ul; tbl 1
In order to examine the contribution of orbital fibroblasts in a mouse model of Graves' orbitopathy, R&D Systems Ly6a2 antibody (R&D Systems, MAB1226) was used in flow cytometry on mouse samples at 0.1 ug/ul (tbl 1). Endocrinology (2016) ncbi
brown rat monoclonal (177228)
  • flow cytometry; mouse; 1:100
R&D Systems Ly6a2 antibody (R&D Systems, FAB1226P) was used in flow cytometry on mouse samples at 1:100. Cell Transplant (2015) ncbi
EMD Millipore
brown rat monoclonal (E13 161-7)
  • flow cytometry; mouse
EMD Millipore Ly6a2 antibody (Millipore, FCMAB224F) was used in flow cytometry on mouse samples . Springerplus (2014) ncbi
Articles Reviewed
  1. Grüneboom A, Hawwari I, Weidner D, Culemann S, Müller S, Henneberg S, et al. A network of trans-cortical capillaries as mainstay for blood circulation in long bones. Nat Metab. 2019;1:236-250 pubmed publisher
  2. Nagai M, Noguchi R, Takahashi D, Morikawa T, Koshida K, Komiyama S, et al. Fasting-Refeeding Impacts Immune Cell Dynamics and Mucosal Immune Responses. Cell. 2019;178:1072-1087.e14 pubmed publisher
  3. Irons E, Lee Sundlov M, Zhu Y, Neelamegham S, Hoffmeister K, LAU J. B cells suppress medullary granulopoiesis by an extracellular glycosylation-dependent mechanism. elife. 2019;8: pubmed publisher
  4. Cohen J, Edwards T, Liu A, Hirai T, Jones M, Wu J, et al. Cutaneous TRPV1+ Neurons Trigger Protective Innate Type 17 Anticipatory Immunity. Cell. 2019;178:919-932.e14 pubmed publisher
  5. Jaitin D, Adlung L, Thaiss C, Weiner A, Li B, Descamps H, et al. Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner. Cell. 2019;178:686-698.e14 pubmed publisher
  6. Minuesa G, Albanese S, Xie W, Kazansky Y, Worroll D, Chow A, et al. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia. Nat Commun. 2019;10:2691 pubmed publisher
  7. Pascual García M, Bonfill Teixidor E, Planas Rigol E, Rubio Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10:2416 pubmed publisher
  8. Loh J, Xu S, Huo J, Kim S, Wang Y, Lam K. Dok3-protein phosphatase 1 interaction attenuates Card9 signaling and neutrophil-dependent antifungal immunity. J Clin Invest. 2019;129:2717-2729 pubmed publisher
  9. Baryawno N, Przybylski D, Kowalczyk M, Kfoury Y, Severe N, Gustafsson K, et al. A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia. Cell. 2019;177:1915-1932.e16 pubmed publisher
  10. Peng L, Guo H, Ma P, Sun Y, Dennison L, Aplan P, et al. HoxA9 binds and represses the Cebpa +8 kb enhancer. PLoS ONE. 2019;14:e0217604 pubmed publisher
  11. Cunin P, Bouslama R, Machlus K, Martínez Bonet M, Lee P, Wactor A, et al. Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets. elife. 2019;8: pubmed publisher
  12. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed publisher
  13. Kuriakose J, Redecke V, Guy C, Zhou J, Wu R, Ippagunta S, et al. Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis. J Clin Invest. 2019;129:2251-2265 pubmed publisher
  14. Mogilenko D, Haas J, L homme L, Fleury S, Quemener S, Levavasseur M, et al. Metabolic and Innate Immune Cues Merge into a Specific Inflammatory Response via the UPR. Cell. 2019;177:1201-1216.e19 pubmed publisher
  15. Lemarchand E, Barrington J, Chenery A, Haley M, Coutts G, Allen J, et al. Extent of Ischemic Brain Injury After Thrombotic Stroke Is Independent of the NLRP3 (NACHT, LRR and PYD Domains-Containing Protein 3) Inflammasome. Stroke. 2019;50:1232-1239 pubmed publisher
  16. Lesch B, Tothova Z, Morgan E, Liao Z, Bronson R, Ebert B, et al. Intergenerational epigenetic inheritance of cancer susceptibility in mammals. elife. 2019;8: pubmed publisher
  17. Uderhardt S, Martins A, Tsang J, Lämmermann T, Germain R. Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage. Cell. 2019;177:541-555.e17 pubmed publisher
  18. Lytle N, Ferguson L, Rajbhandari N, Gilroy K, Fox R, Deshpande A, et al. A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Cell. 2019;177:572-586.e22 pubmed publisher
  19. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  20. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  21. Liao W, Overman M, Boutin A, Shang X, Zhao D, Dey P, et al. KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. Cancer Cell. 2019;35:559-572.e7 pubmed publisher
  22. Frank A, Ebersberger S, Fink A, Lampe S, Weigert A, Schmid T, et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype. Nat Commun. 2019;10:1135 pubmed publisher
  23. Dey A, Yang W, Gegonne A, Nishiyama A, Pan R, Yagi R, et al. BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses. EMBO J. 2019;38: pubmed publisher
  24. Joy M, Ben Assayag E, Shabashov Stone D, Liraz Zaltsman S, Mazzitelli J, Arenas M, et al. CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury. Cell. 2019;176:1143-1157.e13 pubmed publisher
  25. Anderson R, Lagnado A, Maggiorani D, Walaszczyk A, Dookun E, Chapman J, et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. EMBO J. 2019;38: pubmed publisher
  26. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  27. Rowe R, Lummertz da Rocha E, Sousa P, Missios P, Morse M, Marion W, et al. The developmental stage of the hematopoietic niche regulates lineage in MLL-rearranged leukemia. J Exp Med. 2019;216:527-538 pubmed publisher
  28. Paudel S, Baral P, Ghimire L, Bergeron S, Jin L, De Corte J, et al. CXCL1 regulates neutrophil homeostasis in pneumonia-derived sepsis caused by Streptococcus pneumoniae serotype 3. Blood. 2019;: pubmed publisher
  29. Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019;176:998-1013.e16 pubmed publisher
  30. Kobayashi T, Voisin B, Kim D, Kennedy E, Jo J, Shih H, et al. Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium. Cell. 2019;176:982-997.e16 pubmed publisher
  31. Lavoie S, Conway K, Lassen K, Jijon H, Pan H, Chun E, et al. The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response. elife. 2019;8: pubmed publisher
  32. Wheeler M, Jaronen M, Covacu R, Zandee S, Scalisi G, Rothhammer V, et al. Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation. Cell. 2019;176:581-596.e18 pubmed publisher
  33. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  34. Lee Y, Ju J, Shon W, Oh S, Min C, Kang M, et al. Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD. Immune Netw. 2018;18:e44 pubmed publisher
  35. Keklikoglou I, Cianciaruso C, Güç E, Squadrito M, Spring L, Tazzyman S, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol. 2019;21:190-202 pubmed publisher
  36. Düsedau H, Kleveman J, Figueiredo C, Biswas A, Steffen J, Kliche S, et al. p75NTR regulates brain mononuclear cell function and neuronal structure in Toxoplasma infection-induced neuroinflammation. Glia. 2019;67:193-211 pubmed publisher
  37. Al Mamun A, Yu H, Mirza M, Romana S, McCullough L, Liu F. Myeloid cell IRF4 signaling protects neonatal brains from hypoxic ischemic encephalopathy. Neurochem Int. 2019;127:148-157 pubmed publisher
  38. Ruscetti M, Leibold J, Bott M, Fennell M, Kulick A, Salgado N, et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 2018;362:1416-1422 pubmed publisher
  39. Karmaus P, Chen X, Lim S, Herrada A, Nguyen T, Xu B, et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature. 2019;565:101-105 pubmed publisher
  40. Barros Silva J, Linn D, Steiner I, Guo G, Ali A, Pakula H, et al. Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Rep. 2018;25:3504-3518.e6 pubmed publisher
  41. Normand S, Waldschmitt N, Neerincx A, Martinez Torres R, Chauvin C, Couturier Maillard A, et al. Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens. Nat Commun. 2018;9:5338 pubmed publisher
  42. Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin G, Shurin M, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A. 2019;116:1361-1369 pubmed publisher
  43. Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed publisher
  44. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  45. Gubernatorova E, Gorshkova E, Namakanova O, Zvartsev R, Hidalgo J, Drutskaya M, et al. Non-redundant Functions of IL-6 Produced by Macrophages and Dendritic Cells in Allergic Airway Inflammation. Front Immunol. 2018;9:2718 pubmed publisher
  46. Cai Z, Kotzin J, Ramdas B, Chen S, Nelanuthala S, Palam L, et al. Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis. Cell Stem Cell. 2018;23:833-849.e5 pubmed publisher
  47. Benmerzoug S, Rose S, Bounab B, Gosset D, Duneau L, Chenuet P, et al. STING-dependent sensing of self-DNA drives silica-induced lung inflammation. Nat Commun. 2018;9:5226 pubmed publisher
  48. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  49. Aarts S, Seijkens T, Kusters P, Van Tiel C, Reiche M, den Toom M, et al. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis. J Pathol. 2019;247:471-480 pubmed publisher
  50. Inoue T, Ito Y, Nishizawa N, Eshima K, Kojo K, Otaka F, et al. RAMP1 in Kupffer cells is a critical regulator in immune-mediated hepatitis. PLoS ONE. 2018;13:e0200432 pubmed publisher
  51. Sharma D, Malik A, Guy C, Vogel P, Kanneganti T. TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy. J Clin Invest. 2019;129:150-162 pubmed publisher
  52. Glal D, Sudhakar J, Lu H, Liu M, Chiang H, Liu Y, et al. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol. 2018;9:2522 pubmed publisher
  53. Safronova A, Araujo A, Camanzo E, Moon T, Elliott M, Beiting D, et al. Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii. Nat Immunol. 2019;20:64-72 pubmed publisher
  54. Lund H, Pieber M, Parsa R, Han J, Grommisch D, Ewing E, et al. Competitive repopulation of an empty microglial niche yields functionally distinct subsets of microglia-like cells. Nat Commun. 2018;9:4845 pubmed publisher
  55. Rao T, Gupta M, Softic S, Wang L, Jang Y, Thomou T, et al. Attenuation of PKCδ enhances metabolic activity and promotes expansion of blood progenitors. EMBO J. 2018;37: pubmed publisher
  56. Chinta K, Rahman M, Saini V, Glasgow J, Reddy V, Lever J, et al. Microanatomic Distribution of Myeloid Heme Oxygenase-1 Protects against Free Radical-Mediated Immunopathology in Human Tuberculosis. Cell Rep. 2018;25:1938-1952.e5 pubmed publisher
  57. Hakuno D, Kimura M, Ito S, Satoh J, Nakashima Y, Horie T, et al. Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction. Sci Rep. 2018;8:16749 pubmed publisher
  58. Grigoryan A, Guidi N, Senger K, Liehr T, Soller K, Marka G, et al. LaminA/C regulates epigenetic and chromatin architecture changes upon aging of hematopoietic stem cells. Genome Biol. 2018;19:189 pubmed publisher
  59. Hsu J, Dayaram T, Tovy A, De Braekeleer E, Jeong M, Wang F, et al. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. Cell Stem Cell. 2018;23:700-713.e6 pubmed publisher
  60. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  61. Meyer I, Goetzke C, Kespohl M, Sauter M, Heuser A, Eckstein V, et al. Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis. Front Immunol. 2018;9:2303 pubmed publisher
  62. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  63. Mollaoglu G, Jones A, Wait S, Mukhopadhyay A, Jeong S, Arya R, et al. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity. 2018;49:764-779.e9 pubmed publisher
  64. Er J, Koean R, Ding J. Loss of T-bet confers survival advantage to influenza-bacterial superinfection. EMBO J. 2019;38: pubmed publisher
  65. Chang S, Kim Y, Kim Y, Kim Y, Moon S, Lee Y, et al. Taurodeoxycholate Increases the Number of Myeloid-Derived Suppressor Cells That Ameliorate Sepsis in Mice. Front Immunol. 2018;9:1984 pubmed publisher
  66. Masuda J, Umemura C, Yokozawa M, Yamauchi K, Seko T, Yamashita M, et al. Dietary Supplementation of Selenoneine-Containing Tuna Dark Muscle Extract Effectively Reduces Pathology of Experimental Colorectal Cancers in Mice. Nutrients. 2018;10: pubmed publisher
  67. Stephens J, Bailey J, Hang H, Rittell V, Dietrich M, Mynatt R, et al. Adipose Tissue Dysfunction Occurs Independently of Obesity in Adipocyte-Specific Oncostatin Receptor Knockout Mice. Obesity (Silver Spring). 2018;26:1439-1447 pubmed publisher
  68. Williams G, Schonhoff A, Jurkuvenaite A, Thome A, Standaert D, Harms A. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. J Neuroinflammation. 2018;15:244 pubmed publisher
  69. Schrand B, Clark E, Levay A, Capote A, Martínez O, Brenneman R, et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun. 2018;9:3348 pubmed publisher
  70. Lee S, North K, Kim E, Jang E, Obeng E, Lu S, et al. Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations. Cancer Cell. 2018;34:225-241.e8 pubmed publisher
  71. Kiang L, Ross B, Yao J, Shanmugam S, Andrews C, Hansen S, et al. Vitreous Cytokine Expression and a Murine Model Suggest a Key Role of Microglia in the Inflammatory Response to Retinal Detachment. Invest Ophthalmol Vis Sci. 2018;59:3767-3778 pubmed publisher
  72. Heshmati Y, Kharazi S, Türköz G, Chang D, Kamali Dolatabadi E, Boström J, et al. The histone chaperone NAP1L3 is required for haematopoietic stem cell maintenance and differentiation. Sci Rep. 2018;8:11202 pubmed publisher
  73. Gallot Y, Straughn A, Bohnert K, Xiong G, Hindi S, Kumar A. MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice. Hum Mol Genet. 2018;27:3449-3463 pubmed publisher
  74. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  75. Kim Y, Lee M, Gu H, Kim J, Jeong S, Yeo S, et al. HIF-1α activation in myeloid cells accelerates dextran sodium sulfate-induced colitis progression in mice. Dis Model Mech. 2018;11: pubmed publisher
  76. Li J, Byrne K, Yan F, Yamazoe T, Chen Z, Baslan T, et al. Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity. 2018;49:178-193.e7 pubmed publisher
  77. Nusse Y, Savage A, Marangoni P, Rosendahl Huber A, Landman T, De Sauvage F, et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature. 2018;559:109-113 pubmed publisher
  78. Quenum Zangbede F, Chauhan A, Sharma J, Mishra B. Galectin-3 in M2 Macrophages Plays a Protective Role in Resolution of Neuropathology in Brain Parasitic Infection by Regulating Neutrophil Turnover. J Neurosci. 2018;38:6737-6750 pubmed publisher
  79. Umemoto T, Hashimoto M, Matsumura T, Nakamura Ishizu A, Suda T. Ca2+-mitochondria axis drives cell division in hematopoietic stem cells. J Exp Med. 2018;215:2097-2113 pubmed publisher
  80. Wang X, Dong F, Zhang S, Yang W, Yu W, Wang Z, et al. TGF-?1 Negatively Regulates the Number and Function of Hematopoietic Stem Cells. Stem Cell Reports. 2018;11:274-287 pubmed publisher
  81. Casey A, Sinha A, Singhania R, Livingstone J, Waterhouse P, Tharmapalan P, et al. Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities. J Cell Biol. 2018;217:2951-2974 pubmed publisher
  82. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  83. Greenblatt S, Man N, Hamard P, Asai T, Karl D, Martínez C, et al. CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis. Cancer Cell. 2018;33:1111-1127.e5 pubmed publisher
  84. Napolitano A, van der Veen A, Bunyan M, Borg A, Frith D, Howell S, et al. Cysteine-Reactive Free ISG15 Generates IL-1β-Producing CD8α+ Dendritic Cells at the Site of Infection. J Immunol. 2018;201:604-614 pubmed publisher
  85. Gu C, Borjabad A, Hadas E, Kelschenbach J, Kim B, Chao W, et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathog. 2018;14:e1007061 pubmed publisher
  86. Ghanem L, Kromer A, Silverman I, Ji X, Gazzara M, Nguyen N, et al. Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 Transcript. Mol Cell Biol. 2018;38: pubmed publisher
  87. Lau A, Chung H, Komada T, Platnich J, Sandall C, Choudhury S, et al. Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury. J Clin Invest. 2018;128:2894-2913 pubmed publisher
  88. Tsiantoulas D, Sage A, Göderle L, Ozsvar Kozma M, Murphy D, Porsch F, et al. BAFF Neutralization Aggravates Atherosclerosis. Circulation. 2018;: pubmed publisher
  89. Chen Y, Qin X, An Q, Yi J, Feng F, Yin D, et al. Mesenchymal Stromal Cells Directly Promote Inflammation by Canonical NLRP3 and Non-canonical Caspase-11 Inflammasomes. EBioMedicine. 2018;32:31-42 pubmed publisher
  90. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion. Cell Stem Cell. 2018;22:879-892.e6 pubmed publisher
  91. Kanneganti A, Malireddi R, Saavedra P, Vande Walle L, Van Gorp H, Kambara H, et al. GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever. J Exp Med. 2018;215:1519-1529 pubmed publisher
  92. Shaw T, Houston S, Wemyss K, Bridgeman H, Barbera T, Zangerle Murray T, et al. Tissue-resident macrophages in the intestine are long lived and defined by Tim-4 and CD4 expression. J Exp Med. 2018;215:1507-1518 pubmed publisher
  93. Hsiao H, Fernandez R, Tanaka S, Li W, Spahn J, Chiu S, et al. Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1β. J Clin Invest. 2018;128:2833-2847 pubmed publisher
  94. Huynh J, Lin C, Kimmey J, Jarjour N, Schwarzkopf E, Bradstreet T, et al. Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection. J Exp Med. 2018;215:1823-1838 pubmed publisher
  95. Mitchell K, Barreyro L, Todorova T, Taylor S, Antony Debré I, Narayanagari S, et al. IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med. 2018;215:1709-1727 pubmed publisher
  96. Thomson C, van de Pavert S, Stakenborg M, Labeeuw E, Matteoli G, Mowat A, et al. Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators. J Immunol. 2018;201:215-229 pubmed publisher
  97. Thompson T, Jackson B, Li P, Wang J, Kim A, Huang K, et al. Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages. elife. 2018;7: pubmed publisher
  98. Gozdecka M, Meduri E, Mazan M, Tzelepis K, Dudek M, Knights A, et al. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. Nat Genet. 2018;50:883-894 pubmed publisher
  99. Crosby E, Wei J, Yang X, Lei G, Wang T, Liu C, et al. Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors. Oncoimmunology. 2018;7:e1421891 pubmed publisher
  100. Baba O, Horie T, Nakao T, Hakuno D, Nakashima Y, Nishi H, et al. MicroRNA 33 Regulates the Population of Peripheral Inflammatory Ly6Chigh Monocytes through Dual Pathways. Mol Cell Biol. 2018;38: pubmed publisher
  101. Takamori A, Nambu A, Sato K, Yamaguchi S, Matsuda K, Numata T, et al. IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity. Sci Rep. 2018;8:6639 pubmed publisher
  102. Ge J, Burnier L, Adamopoulou M, Kwa M, Schaks M, Rottner K, et al. RhoA, Rac1, and Cdc42 differentially regulate αSMA and collagen I expression in mesenchymal stem cells. J Biol Chem. 2018;293:9358-9369 pubmed publisher
  103. Gounder A, Yokoyama C, Jarjour N, Bricker T, Edelson B, Boon A. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer. PLoS Pathog. 2018;14:e1007001 pubmed publisher
  104. Grist J, Marro B, Skinner D, Syage A, Worne C, Doty D, et al. Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment. Eur J Immunol. 2018;48:1199-1210 pubmed publisher
  105. Chen W, Yang J, Wu Y, Li L, Li R, Chang Y, et al. IL-33/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury. Exp Mol Med. 2018;50:36 pubmed publisher
  106. Salomè M, Magee A, Yalla K, Chaudhury S, Sarrou E, Carmody R, et al. A Trib2-p38 axis controls myeloid leukaemia cell cycle and stress response signalling. Cell Death Dis. 2018;9:443 pubmed publisher
  107. Foerster F, Boegel S, Heck R, Pickert G, R ssel N, Rosigkeit S, et al. Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells. Oncoimmunology. 2018;7:e1409929 pubmed publisher
  108. Xia P, Wang S, Ye B, Du Y, Li C, Xiong Z, et al. A Circular RNA Protects Dormant Hematopoietic Stem Cells from DNA Sensor cGAS-Mediated Exhaustion. Immunity. 2018;48:688-701.e7 pubmed publisher
  109. Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 2018;173:634-648.e12 pubmed publisher
  110. Lyons J, Ghazi P, Starchenko A, Tovaglieri A, Baldwin K, Poulin E, et al. The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile. PLoS Biol. 2018;16:e2002417 pubmed publisher
  111. Kobayashi Y, Inagawa H, Kohchi C, Kazumura K, Tsuchiya H, Miwa T, et al. Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents development of atherosclerosis in high-fat diet-fed apoE-deficient mice via ameliorating hyperlipidemia, pro-inflammatory mediators and oxidative responses. PLoS ONE. 2018;13:e0195008 pubmed publisher
  112. Zhang Y, Xia F, Liu X, Yu Z, Xie L, Liu L, et al. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/?-catenin/CCND1 signaling. J Clin Invest. 2018;128:1737-1751 pubmed publisher
  113. Shevchenko M, Bogorodskiy A, Troyanova N, Servuli E, Bolkhovitina E, Büldt G, et al. Aspergillus fumigatus Infection-Induced Neutrophil Recruitment and Location in the Conducting Airway of Immunocompetent, Neutropenic, and Immunosuppressed Mice. J Immunol Res. 2018;2018:5379085 pubmed publisher
  114. Hill R, Hoffman B, Morita T, Campos S, Lumpkin E, Brem R, et al. The signaling lipid sphingosine 1-phosphate regulates mechanical pain. elife. 2018;7: pubmed publisher
  115. Verbiest T, Finnon R, Brown N, Cruz Garcia L, Finnon P, O Brien G, et al. Tracking preleukemic cells in vivo to reveal the sequence of molecular events in radiation leukemogenesis. Leukemia. 2018;32:1435-1444 pubmed publisher
  116. Tsubaki T, Kadonosono T, Sakurai S, Shiozawa T, Goto T, Sakai S, et al. Novel adherent CD11b+ Gr-1+ tumor-infiltrating cells initiate an immunosuppressive tumor microenvironment. Oncotarget. 2018;9:11209-11226 pubmed publisher
  117. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed publisher
  118. Zhang B, Nguyen L, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450-462 pubmed publisher
  119. Zukor K, Wang H, Siddharthan V, Julander J, Morrey J. Zika virus-induced acute myelitis and motor deficits in adult interferon ??/? receptor knockout mice. J Neurovirol. 2018;24:273-290 pubmed publisher
  120. Panduro M, Benoist C, Mathis D. Treg cells limit IFN-? production to control macrophage accrual and phenotype during skeletal muscle regeneration. Proc Natl Acad Sci U S A. 2018;115:E2585-E2593 pubmed publisher
  121. Westhorpe C, Norman M, Hall P, Snelgrove S, Finsterbusch M, Li A, et al. Effector CD4+ T cells recognize intravascular antigen presented by patrolling monocytes. Nat Commun. 2018;9:747 pubmed publisher
  122. Trapecar M, Khan S, Cohn B, Wu F, Sanjabi S. B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection. Mucosal Immunol. 2018;11:1158-1167 pubmed publisher
  123. Lee Y, Lee J, Jang Y, Seo S, Chang J, Seong B. Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine. Front Microbiol. 2018;9:83 pubmed publisher
  124. Qu S, Xue H, Dong X, Lin D, Wu R, Nabavi N, et al. Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model. Int J Cancer. 2018;143:419-429 pubmed publisher
  125. Zhu Y, Zhou J, Feng Y, Chen L, Zhang L, Yang F, et al. Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2. Front Immunol. 2018;9:87 pubmed publisher
  126. Sokhi U, Liber M, Frye L, Park S, Kang K, Pannellini T, et al. Dissection and function of autoimmunity-associated TNFAIP3 (A20) gene enhancers in humanized mouse models. Nat Commun. 2018;9:658 pubmed publisher
  127. Supramaniam A, Liu X, Ferro V, Herrero L. Prophylactic Antiheparanase Activity by PG545 Is Antiviral In Vitro and Protects against Ross River Virus Disease in Mice. Antimicrob Agents Chemother. 2018;62: pubmed publisher
  128. Wen G, An W, Chen J, Maguire E, Chen Q, Yang F, et al. Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis. J Am Heart Assoc. 2018;7: pubmed publisher
  129. Perry C, Muñoz Rojas A, Meeth K, Kellman L, Amezquita R, Thakral D, et al. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med. 2018;215:877-893 pubmed publisher
  130. King E, Mazor R, Cuburu N, Pastan I. Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin. J Immunol. 2018;200:2038-2045 pubmed publisher
  131. Pitts M, Combs T, D Orazio S. Neutrophils from Both Susceptible and Resistant Mice Efficiently Kill Opsonized Listeria monocytogenes. Infect Immun. 2018;86: pubmed publisher
  132. Soncin I, Sheng J, Chen Q, Foo S, Duan K, Lum J, et al. The tumour microenvironment creates a niche for the self-renewal of tumour-promoting macrophages in colon adenoma. Nat Commun. 2018;9:582 pubmed publisher
  133. Niraula A, Wang Y, Godbout J, Sheridan J. Corticosterone Production during Repeated Social Defeat Causes Monocyte Mobilization from the Bone Marrow, Glucocorticoid Resistance, and Neurovascular Adhesion Molecule Expression. J Neurosci. 2018;38:2328-2340 pubmed publisher
  134. Bogoslowski A, Butcher E, Kubes P. Neutrophils recruited through high endothelial venules of the lymph nodes via PNAd intercept disseminating Staphylococcus aureus. Proc Natl Acad Sci U S A. 2018;115:2449-2454 pubmed publisher
  135. Shen Q, Zhang Q, Shi Y, Shi Q, Jiang Y, Gu Y, et al. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation. Nature. 2018;554:123-127 pubmed publisher
  136. Delong J, Hall A, Konradt C, Coppock G, Park J, Harms Pritchard G, et al. Cytokine- and TCR-Mediated Regulation of T Cell Expression of Ly6C and Sca-1. J Immunol. 2018;200:1761-1770 pubmed publisher
  137. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed publisher
  138. Yoshida S, Hagiwara Y, Tsuchiya M, Shinoda M, Koide M, Hatakeyama H, et al. Involvement of neutrophils and interleukin-18 in nociception in a mouse model of muscle pain. Mol Pain. 2018;14:1744806918757286 pubmed publisher
  139. Capucha T, Koren N, Nassar M, Heyman O, Nir T, Levy M, et al. Sequential BMP7/TGF-β1 signaling and microbiota instruct mucosal Langerhans cell differentiation. J Exp Med. 2018;215:481-500 pubmed publisher
  140. Tang H, Liang Y, Anders R, Taube J, Qiu X, Mulgaonkar A, et al. PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression. J Clin Invest. 2018;128:580-588 pubmed publisher
  141. Tavazoie M, Pollack I, Tanqueco R, Ostendorf B, Reis B, Gonsalves F, et al. LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer. Cell. 2018;172:825-840.e18 pubmed publisher
  142. Teater M, Domínguez P, Redmond D, Chen Z, Ennishi D, Scott D, et al. AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis. Nat Commun. 2018;9:222 pubmed publisher
  143. Christ A, Günther P, Lauterbach M, Duewell P, Biswas D, Pelka K, et al. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell. 2018;172:162-175.e14 pubmed publisher
  144. Mitroulis I, Ruppova K, Wang B, Chen L, Grzybek M, Grinenko T, et al. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Cell. 2018;172:147-161.e12 pubmed publisher
  145. Zhang C, Yi W, Li F, Du X, Wang H, Wu P, et al. Eosinophil-derived CCL-6 impairs hematopoietic stem cell homeostasis. Cell Res. 2018;28:323-335 pubmed publisher
  146. Garaycoechea J, Crossan G, Langevin F, Mulderrig L, Louzada S, Yang F, et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature. 2018;553:171-177 pubmed publisher
  147. Stremmel C, Schuchert R, Wagner F, Thaler R, Weinberger T, Pick R, et al. Yolk sac macrophage progenitors traffic to the embryo during defined stages of development. Nat Commun. 2018;9:75 pubmed publisher
  148. Guarnerio J, Mendez L, Asada N, Menon A, Fung J, Berry K, et al. A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche. Nat Commun. 2018;9:66 pubmed publisher
  149. Kurkewich J, Boucher A, Klopfenstein N, Baskar R, Kapur R, Dahl R. The mirn23a and mirn23b microrna clusters are necessary for proper hematopoietic progenitor cell production and differentiation. Exp Hematol. 2018;59:14-29 pubmed publisher
  150. Mumau M, Vanderbeck A, Lynch E, Golec S, Emerson S, Punt J. Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1. J Immunol. 2018;200:1078-1087 pubmed publisher
  151. Kunimoto H, Meydan C, Nazir A, Whitfield J, Shank K, Rapaport F, et al. Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity. Cancer Cell. 2018;33:44-59.e8 pubmed publisher
  152. Thion M, Low D, Silvin A, Chen J, Grisel P, Schulte Schrepping J, et al. Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner. Cell. 2018;172:500-516.e16 pubmed publisher
  153. Campana L, Starkey Lewis P, Pellicoro A, Aucott R, Man J, O Duibhir E, et al. The STAT3-IL-10-IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver Injury. J Immunol. 2018;200:1169-1187 pubmed publisher
  154. Zhang Y, Khairallah C, Sheridan B, van der Velden A, Bliska J. CCR2+ Inflammatory Monocytes Are Recruited to Yersinia pseudotuberculosis Pyogranulomas and Dictate Adaptive Responses at the Expense of Innate Immunity during Oral Infection. Infect Immun. 2018;86: pubmed publisher
  155. Yui S, Azzolin L, Maimets M, Pedersen M, Fordham R, Hansen S, et al. YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration. Cell Stem Cell. 2018;22:35-49.e7 pubmed publisher
  156. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed publisher
  157. Gaya M, Barral P, Burbage M, Aggarwal S, Montaner B, Warren Navia A, et al. Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells. Cell. 2018;172:517-533.e20 pubmed publisher
  158. Montford J, Lehman A, Bauer C, Klawitter J, Klawitter J, Poczobutt J, et al. Bone marrow-derived cPLA2α contributes to renal fibrosis progression. J Lipid Res. 2018;59:380-390 pubmed publisher
  159. Hoggatt J, Singh P, Tate T, Chou B, Datari S, Fukuda S, et al. Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. Cell. 2018;172:191-204.e10 pubmed publisher
  160. Medaglia C, Giladi A, Stoler Barak L, De Giovanni M, Salame T, Biram A, et al. Spatial reconstruction of immune niches by combining photoactivatable reporters and scRNA-seq. Science. 2017;358:1622-1626 pubmed publisher
  161. Zhao B, Mei Y, Cao L, Zhang J, Sumagin R, Yang J, et al. Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms. J Clin Invest. 2018;128:125-140 pubmed publisher
  162. Ring N, Herndler Brandstetter D, Weiskopf K, Shan L, Volkmer J, George B, et al. Anti-SIRP? antibody immunotherapy enhances neutrophil and macrophage antitumor activity. Proc Natl Acad Sci U S A. 2017;114:E10578-E10585 pubmed publisher
  163. Harms A, Thome A, Yan Z, Schonhoff A, Williams G, Li X, et al. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol. 2018;300:179-187 pubmed publisher
  164. Zhang H, Li X, Liao S, Wang H, Chen P, Zhu G, et al. SPLUNC1 knockout enhances LPS-induced lung injury by increasing recruitment of CD11b+Gr-1+ cells to the spleen of mice. Oncol Rep. 2018;39:358-366 pubmed publisher
  165. Gopalakrishnan V, Spencer C, Nezi L, Reuben A, Andrews M, Karpinets T, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359:97-103 pubmed publisher
  166. Kovtun A, Bergdolt S, Hägele Y, Matthes R, Lambris J, Huber Lang M, et al. Complement receptors C5aR1 and C5aR2 act differentially during the early immune response after bone fracture but are similarly involved in bone repair. Sci Rep. 2017;7:14061 pubmed publisher
  167. Mao A, Ishizuka I, Kasal D, Mandal M, Bendelac A. A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage development. Nat Commun. 2017;8:863 pubmed publisher
  168. Wang J, Hossain M, Thanabalasuriar A, Gunzer M, Meininger C, Kubes P. Visualizing the function and fate of neutrophils in sterile injury and repair. Science. 2017;358:111-116 pubmed publisher
  169. Nishi H, Furuhashi K, Cullere X, Saggu G, Miller M, Chen Y, et al. Neutrophil Fc?RIIA promotes IgG-mediated glomerular neutrophil capture via Abl/Src kinases. J Clin Invest. 2017;127:3810-3826 pubmed publisher
  170. Cole C, Russler Germain D, Ketkar S, Verdoni A, Smith A, Bangert C, et al. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies. J Clin Invest. 2017;127:3657-3674 pubmed publisher
  171. Kumar B, Garcia M, Weng L, Jung X, Murakami J, Hu X, et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 2018;32:575-587 pubmed publisher
  172. Chang S, Kohlgruber A, Mizoguchi F, Michelet X, Wolf B, Wei K, et al. Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes. J Clin Invest. 2017;127:3300-3312 pubmed publisher
  173. Tejada M, Montilla García Á, Cronin S, Cikes D, Sánchez Fernández C, González Cano R, et al. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice. Proc Natl Acad Sci U S A. 2017;114:8396-8401 pubmed publisher
  174. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  175. Hannibal T, Schmidt Christensen A, Nilsson J, Fransén Pettersson N, Hansen L, Holmberg D. Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice. Diabetologia. 2017;60:2033-2041 pubmed publisher
  176. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  177. Mylonas K, Turner N, Bageghni S, Kenyon C, White C, McGregor K, et al. 11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI. J Endocrinol. 2017;233:315-327 pubmed publisher
  178. Mildner A, Schönheit J, Giladi A, David E, Lara Astiaso D, Lorenzo Vivas E, et al. Genomic Characterization of Murine Monocytes Reveals C/EBP? Transcription Factor Dependence of Ly6C- Cells. Immunity. 2017;46:849-862.e7 pubmed publisher
  179. Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545:500-504 pubmed publisher
  180. Gordon S, Maute R, Dulken B, Hutter G, George B, McCracken M, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495-499 pubmed publisher
  181. Lis R, Karrasch C, Poulos M, Kunar B, Redmond D, Duran J, et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. 2017;545:439-445 pubmed publisher
  182. Hara T, Nakaoka H, Hayashi T, Mimura K, Hoshino D, Inoue M, et al. Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes. Proc Natl Acad Sci U S A. 2017;114:E4416-E4424 pubmed publisher
  183. Kraakman M, Lee M, Al Sharea A, Dragoljevic D, Barrett T, Montenont E, et al. Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest. 2017;127:2133-2147 pubmed publisher
  184. Ebner F, Sedlyarov V, Tasciyan S, Ivin M, Kratochvill F, Gratz N, et al. The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection. J Clin Invest. 2017;127:2051-2065 pubmed publisher
  185. Zhang C, Feng J, Du J, Zhuo Z, Yang S, Zhang W, et al. Macrophage-derived IL-1α promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity. Cell Mol Immunol. 2018;15:973-982 pubmed publisher
  186. Minutti C, Jackson Jones L, Garcia Fojeda B, Knipper J, Sutherland T, Logan N, et al. Local amplifiers of IL-4R?-mediated macrophage activation promote repair in lung and liver. Science. 2017;356:1076-1080 pubmed publisher
  187. Bosurgi L, Cao Y, Cabeza Cabrerizo M, Tucci A, Hughes L, Kong Y, et al. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science. 2017;356:1072-1076 pubmed publisher
  188. Taylor S, Huang Y, Mallett G, Stathopoulou C, Felizardo T, Sun M, et al. PD-1 regulates KLRG1+ group 2 innate lymphoid cells. J Exp Med. 2017;214:1663-1678 pubmed publisher
  189. Tang A, Choi J, Kotzin J, Yang Y, Hong C, Hobson N, et al. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017;545:305-310 pubmed publisher
  190. Kwan B, Zhu E, Tzeng A, Sugito H, Eltahir A, Ma B, et al. Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. J Exp Med. 2017;214:1679-1690 pubmed publisher
  191. Thanabalasuriar A, Surewaard B, Willson M, Neupane A, Stover C, Warrener P, et al. Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature. J Clin Invest. 2017;127:2249-2261 pubmed publisher
  192. Bagchi S, He Y, Zhang H, Cao L, Van Rhijn I, Moody D, et al. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017;127:2339-2352 pubmed publisher
  193. Carrieri C, Comazzetto S, Grover A, Morgan M, Buness A, Nerlov C, et al. A transit-amplifying population underpins the efficient regenerative capacity of the testis. J Exp Med. 2017;214:1631-1641 pubmed publisher
  194. Audzevich T, Bashford Rogers R, Mabbott N, Frampton D, Freeman T, Potocnik A, et al. Pre/pro-B cells generate macrophage populations during homeostasis and inflammation. Proc Natl Acad Sci U S A. 2017;114:E3954-E3963 pubmed publisher
  195. Kammertoens T, Friese C, Arina A, Idel C, Briesemeister D, Rothe M, et al. Tumour ischaemia by interferon-? resembles physiological blood vessel regression. Nature. 2017;545:98-102 pubmed publisher
  196. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  197. Ge Y, Gomez N, Adam R, Nikolova M, Yang H, Verma A, et al. Stem Cell Lineage Infidelity Drives Wound Repair and Cancer. Cell. 2017;169:636-650.e14 pubmed publisher
  198. Deniset J, Surewaard B, Lee W, Kubes P. Splenic Ly6Ghigh mature and Ly6Gint immature neutrophils contribute to eradication of S. pneumoniae. J Exp Med. 2017;214:1333-1350 pubmed publisher
  199. Lee H, Tian L, Bouladoux N, Davis J, Quinones M, Belkaid Y, et al. Dendritic cells expressing immunoreceptor CD300f are critical for controlling chronic gut inflammation. J Clin Invest. 2017;127:1905-1917 pubmed publisher
  200. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  201. Huang Y, Rajappa P, Hu W, Hoffman C, CISSE B, Kim J, et al. A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma. J Clin Invest. 2017;127:1826-1838 pubmed publisher
  202. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  203. Lino C, Barros Martins J, Oberdörfer L, Walzer T, Prinz I. Eomes expression reports the progressive differentiation of IFN-?-producing Th1-like ?? T cells. Eur J Immunol. 2017;47:970-981 pubmed publisher
  204. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  205. Katerndahl C, Heltemes Harris L, Willette M, Henzler C, Frietze S, Yang R, et al. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. Nat Immunol. 2017;18:694-704 pubmed publisher
  206. Hérault A, Binnewies M, Leong S, Calero Nieto F, Zhang S, Kang Y, et al. Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis. Nature. 2017;544:53-58 pubmed publisher
  207. Guo Q, Minnier J, Burchard J, Chiotti K, Spellman P, Schedin P. Physiologically activated mammary fibroblasts promote postpartum mammary cancer. JCI Insight. 2017;2:e89206 pubmed publisher
  208. Thomas D, Clare S, Sowerby J, Pardo M, Juss J, Goulding D, et al. Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity. J Exp Med. 2017;214:1111-1128 pubmed publisher
  209. Briseño C, Gargaro M, Durai V, Davidson J, Theisen D, Anderson D, et al. Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. Proc Natl Acad Sci U S A. 2017;114:3957-3962 pubmed publisher
  210. He W, Wang C, Mu R, Liang P, Huang Z, Zhang J, et al. MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles. Oncogene. 2017;36:4212-4223 pubmed publisher
  211. Sindhava V, Oropallo M, Moody K, Naradikian M, Higdon L, Zhou L, et al. A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens. J Clin Invest. 2017;127:1651-1663 pubmed publisher
  212. Liu Z, Ravindranathan R, Kalinski P, Guo Z, Bartlett D. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nat Commun. 2017;8:14754 pubmed publisher
  213. Wang X, Chen H, Tian R, Zhang Y, Drutskaya M, Wang C, et al. Macrophages induce AKT/β-catenin-dependent Lgr5+ stem cell activation and hair follicle regeneration through TNF. Nat Commun. 2017;8:14091 pubmed publisher
  214. Xiong G, Hindi S, Mann A, Gallot Y, Bohnert K, Cavener D, et al. The PERK arm of the unfolded protein response regulates satellite cell-mediated skeletal muscle regeneration. elife. 2017;6: pubmed publisher
  215. Wolf Y, Shemer A, Polonsky M, Gross M, Mildner A, Yona S, et al. Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation. J Exp Med. 2017;214:905-917 pubmed publisher
  216. Lefrançais E, Ortiz Muñoz G, Caudrillier A, Mallavia B, Liu F, Sayah D, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544:105-109 pubmed publisher
  217. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  218. Klein J, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, et al. Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun. 2017;8:14600 pubmed publisher
  219. Wagner J, Jaurich H, Wallner C, Abraham S, Becerikli M, Dadras M, et al. Diminished bone regeneration after debridement of posttraumatic osteomyelitis is accompanied by altered cytokine levels, elevated B cell activity, and increased osteoclast activity. J Orthop Res. 2017;35:2425-2434 pubmed publisher
  220. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  221. Guidi N, Sacma M, Ständker L, Soller K, Marka G, Eiwen K, et al. Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells. EMBO J. 2017;36:840-853 pubmed publisher
  222. Ho T, Warr M, Adelman E, Lansinger O, Flach J, Verovskaya E, et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature. 2017;543:205-210 pubmed publisher
  223. Wan L, Wen H, Li Y, Lyu J, Xi Y, Hoshii T, et al. ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia. Nature. 2017;543:265-269 pubmed publisher
  224. Li H, Liu P, Xu S, Li Y, Dekker J, Li B, et al. FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging. J Clin Invest. 2017;127:1241-1253 pubmed publisher
  225. Stanley R, Piszczatowski R, Bartholdy B, Mitchell K, McKimpson W, Narayanagari S, et al. A myeloid tumor suppressor role for NOL3. J Exp Med. 2017;214:753-771 pubmed publisher
  226. Moestrup K, Andersen M, Jensen K. Isolation and In Vitro Characterization of Epidermal Stem Cells. Methods Mol Biol. 2017;1553:67-83 pubmed publisher
  227. Huang A, Peng D, Guo H, Ben Y, Zuo X, Wu F, et al. A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies. Sci Rep. 2017;7:42687 pubmed publisher
  228. Ellenbroek G, van Puijvelde G, Anas A, Bot M, Asbach M, Schoneveld A, et al. Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness. Sci Rep. 2017;7:42688 pubmed publisher
  229. Lang S, Harre U, Purohit P, Dietel K, Kienhöfer D, Hahn J, et al. Neurodegeneration Enhances the Development of Arthritis. J Immunol. 2017;198:2394-2402 pubmed publisher
  230. Xu W, Li B, Guan X, Chung S, Wang Y, Yip Y, et al. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nat Commun. 2017;8:14399 pubmed publisher
  231. Cuccarese M, Dubach J, Pfirschke C, Engblom C, Garris C, Miller M, et al. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat Commun. 2017;8:14293 pubmed publisher
  232. Fleming S, McCaughan C, Lateef Z, Dunn A, Wise L, Real N, et al. Deletion of the Chemokine Binding Protein Gene from the Parapoxvirus Orf Virus Reduces Virulence and Pathogenesis in Sheep. Front Microbiol. 2017;8:46 pubmed publisher
  233. Berlato C, Khan M, Schioppa T, Thompson R, Maniati E, Montfort A, et al. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. J Clin Invest. 2017;127:801-813 pubmed publisher
  234. Zhu Y, Lyapichev K, Lee D, Motti D, Ferraro N, Zhang Y, et al. Macrophage Transcriptional Profile Identifies Lipid Catabolic Pathways That Can Be Therapeutically Targeted after Spinal Cord Injury. J Neurosci. 2017;37:2362-2376 pubmed publisher
  235. Ishiguro T, Fukawa T, Akaki K, Nagaoka K, Takeda T, Iwakura Y, et al. Absence of DCIR1 reduces the mortality rate of endotoxemic hepatitis in mice. Eur J Immunol. 2017;47:704-712 pubmed publisher
  236. Gopinath S. Inhibition of Stat3 signaling ameliorates atrophy of the soleus muscles in mice lacking the vitamin D receptor. Skelet Muscle. 2017;7:2 pubmed publisher
  237. Edwards R, Kopp S, Ifergan I, Shui J, Kronenberg M, Miller S, et al. Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy. Invest Ophthalmol Vis Sci. 2017;58:282-291 pubmed publisher
  238. Gardner P, Liyanage S, Cristante E, Sampson R, Dick A, Ali R, et al. Hypoxia inducible factors are dispensable for myeloid cell migration into the inflamed mouse eye. Sci Rep. 2017;7:40830 pubmed publisher
  239. Hattori A, McSkimming D, Kannan N, Ito T. RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia. Leuk Res. 2017;54:47-54 pubmed publisher
  240. Yanagita T, Murata Y, Tanaka D, Motegi S, Arai E, Daniwijaya E, et al. Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy. JCI Insight. 2017;2:e89140 pubmed publisher
  241. Oben K, Gachuki B, Alhakeem S, McKenna M, Liang Y, St Clair D, et al. Radiation Induced Apoptosis of Murine Bone Marrow Cells Is Independent of Early Growth Response 1 (EGR1). PLoS ONE. 2017;12:e0169767 pubmed publisher
  242. Ellman D, Degn M, Lund M, Clausen B, Novrup H, Flæng S, et al. Genetic Ablation of Soluble TNF Does Not Affect Lesion Size and Functional Recovery after Moderate Spinal Cord Injury in Mice. Mediators Inflamm. 2016;2016:2684098 pubmed publisher
  243. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  244. Scott C, Bain C, Mowat A. Isolation and Identification of Intestinal Myeloid Cells. Methods Mol Biol. 2017;1559:223-239 pubmed publisher
  245. de Jong R, Paulin N, Lemnitzer P, Viola J, Winter C, Ferraro B, et al. Protective Aptitude of Annexin A1 in Arterial Neointima Formation in Atherosclerosis-Prone Mice-Brief Report. Arterioscler Thromb Vasc Biol. 2017;37:312-315 pubmed publisher
  246. Rombouts M, Cools N, Grootaert M, de Bakker F, Van Brussel I, Wouters A, et al. Long-Term Depletion of Conventional Dendritic Cells Cannot Be Maintained in an Atherosclerotic Zbtb46-DTR Mouse Model. PLoS ONE. 2017;12:e0169608 pubmed publisher
  247. Cañete A, Carmona R, Ariza L, Sanchez M, Rojas A, Muñoz Chápuli R. A population of hematopoietic stem cells derives from GATA4-expressing progenitors located in the placenta and lateral mesoderm of mice. Haematologica. 2017;102:647-655 pubmed publisher
  248. Larabee C, Desai S, Agasing A, Georgescu C, Wren J, Axtell R, et al. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Mol Vis. 2016;22:1503-1513 pubmed
  249. Fujikura D, Ikesue M, Endo T, Chiba S, Higashi H, Uede T. Death receptor 6 contributes to autoimmunity in lupus-prone mice. Nat Commun. 2017;8:13957 pubmed publisher
  250. Astuti Y, Kramer A, Blake A, Blazar B, Tolar J, Taisto M, et al. A Functional Bioluminescent Zebrafish Screen for Enhancing Hematopoietic Cell Homing. Stem Cell Reports. 2017;8:177-190 pubmed publisher
  251. Guan X, Lapak K, Hennessey R, Yu C, Shakya R, Zhang J, et al. Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth. Mol Cancer Res. 2017;15:237-249 pubmed publisher
  252. Rychtarčíková Z, Lettlova S, Tomkova V, Korenkova V, Langerova L, Simonova E, et al. Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism. Oncotarget. 2017;8:6376-6398 pubmed publisher
  253. Weindel C, Richey L, Mehta A, Shah M, Huber B. Autophagy in Dendritic Cells and B Cells Is Critical for the Inflammatory State of TLR7-Mediated Autoimmunity. J Immunol. 2017;198:1081-1092 pubmed publisher
  254. Aguilera T, Rafat M, Castellini L, Shehade H, Kariolis M, Hui A, et al. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nat Commun. 2016;7:13898 pubmed publisher
  255. Yang J, Tanaka Y, Seay M, Li Z, Jin J, Garmire L, et al. Single cell transcriptomics reveals unanticipated features of early hematopoietic precursors. Nucleic Acids Res. 2017;45:1281-1296 pubmed publisher
  256. Schneider C, Oellerich T, Baldauf H, Schwarz S, Thomas D, Flick R, et al. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nat Med. 2017;23:250-255 pubmed publisher
  257. Kamioka Y, Takakura K, Sumiyama K, Matsuda M. Intravital Förster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli. Cancer Sci. 2017;108:226-235 pubmed publisher
  258. Karki R, Man S, Malireddi R, Kesavardhana S, Zhu Q, Burton A, et al. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature. 2016;540:583-587 pubmed publisher
  259. Hahm E, Wei C, Fernandez I, Li J, Tardi N, Tracy M, et al. Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease. Nat Med. 2017;23:100-106 pubmed publisher
  260. Sharif S, Nakatani Y, Wise L, Corbett M, Real N, Stuart G, et al. A Broad-Spectrum Chemokine-Binding Protein of Bovine Papular Stomatitis Virus Inhibits Neutrophil and Monocyte Infiltration in Inflammatory and Wound Models of Mouse Skin. PLoS ONE. 2016;11:e0168007 pubmed publisher
  261. Nakaya M, Watari K, Tajima M, Nakaya T, Matsuda S, Ohara H, et al. Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction. J Clin Invest. 2017;127:383-401 pubmed publisher
  262. Bieber K, Witte M, Sun S, Hundt J, Kalies K, Dräger S, et al. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. Sci Rep. 2016;6:38357 pubmed publisher
  263. Connor L, Tang S, Cognard E, Ochiai S, Hilligan K, Old S, et al. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. J Exp Med. 2017;214:125-142 pubmed publisher
  264. Yanagisawa H, Hashimoto M, Minagawa S, Takasaka N, Ma R, Moermans C, et al. Role of IL-17A in murine models of COPD airway disease. Am J Physiol Lung Cell Mol Physiol. 2017;312:L122-L130 pubmed publisher
  265. Swanson P, Hart G, Russo M, Nayak D, Yazew T, Pena M, et al. CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature. PLoS Pathog. 2016;12:e1006022 pubmed publisher
  266. Forster M, Farrington K, Petrov J, Belle J, Mindt B, Witalis M, et al. MYSM1-dependent checkpoints in B cell lineage differentiation and B cell-mediated immune response. J Leukoc Biol. 2017;101:643-654 pubmed publisher
  267. Le Q, Yao W, Chen Y, Yan B, Liu C, Yuan M, et al. GRK6 regulates ROS response and maintains hematopoietic stem cell self-renewal. Cell Death Dis. 2016;7:e2478 pubmed publisher
  268. Monnerat G, Alarcón M, Vasconcellos L, Hochman Mendez C, Brasil G, Bassani R, et al. Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice. Nat Commun. 2016;7:13344 pubmed publisher
  269. Kuchmiy A, D Hont J, Hochepied T, Lamkanfi M. NLRP2 controls age-associated maternal fertility. J Exp Med. 2016;213:2851-2860 pubmed
  270. Sektioglu I, Carretero R, Bulbuc N, Bald T, Tüting T, Rudensky A, et al. Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. Cancer Res. 2017;77:291-302 pubmed publisher
  271. Kimura Y, Inoue A, Hangai S, Saijo S, Negishi H, Nishio J, et al. The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis. Proc Natl Acad Sci U S A. 2016;113:14097-14102 pubmed
  272. Hidaka T, Ogawa E, Kobayashi E, Suzuki T, Funayama R, Nagashima T, et al. The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin. Nat Immunol. 2017;18:64-73 pubmed publisher
  273. Yu V, Yusuf R, Oki T, Wu J, Saez B, Wang X, et al. Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells. Cell. 2016;167:1310-1322.e17 pubmed publisher
  274. Khan S, Woodruff E, Trapecar M, Fontaine K, Ezaki A, Borbet T, et al. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016;213:2913-2929 pubmed
  275. Cummings R, Barbet G, Bongers G, Hartmann B, Gettler K, Muniz L, et al. Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs. Nature. 2016;539:565-569 pubmed publisher
  276. Cousins F, Kirkwood P, Saunders P, Gibson D. Evidence for a dynamic role for mononuclear phagocytes during endometrial repair and remodelling. Sci Rep. 2016;6:36748 pubmed publisher
  277. Geng S, Chen K, Yuan R, Peng L, Maitra U, Diao N, et al. The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis. Nat Commun. 2016;7:13436 pubmed publisher
  278. Kirschbaum K, Sonner J, Zeller M, Deumelandt K, Bode J, Sharma R, et al. In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proc Natl Acad Sci U S A. 2016;113:13227-13232 pubmed
  279. Coleman C, Sisk J, Halasz G, Zhong J, Beck S, Matthews K, et al. CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. J Virol. 2017;91: pubmed publisher
  280. Teng O, Chen S, Hsu T, Sia S, Cole S, Valkenburg S, et al. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo. J Virol. 2017;91: pubmed publisher
  281. Theeß W, Sellau J, Steeg C, Klinke A, Baldus S, Cramer J, et al. Myeloperoxidase Attenuates Pathogen Clearance during Plasmodium yoelii Nonlethal Infection. Infect Immun. 2017;85: pubmed publisher
  282. Smirnova T, Bonapace L, MacDonald G, Kondo S, Wyckoff J, Ebersbach H, et al. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages. Oncotarget. 2016;7:82289-82304 pubmed publisher
  283. Dong L, Yu W, Zheng H, Loh M, Bunting S, Pauly M, et al. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment. Nature. 2016;539:304-308 pubmed publisher
  284. Ulland T, Jain N, Hornick E, Elliott E, Clay G, Sadler J, et al. Nlrp12 mutation causes C57BL/6J strain-specific defect in neutrophil recruitment. Nat Commun. 2016;7:13180 pubmed publisher
  285. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed publisher
  286. Jiang J, Gao Q, Wang T, Lin H, Zhan Q, Chu Z, et al. MicroRNA expression profiles of granulocytic myeloid?derived suppressor cells from mice bearing Lewis lung carcinoma. Mol Med Rep. 2016;14:4567-4574 pubmed publisher
  287. Nowacka J, Baumgartner C, Pelorosso C, Roth M, Zuber J, Baccarini M. MEK1 is required for the development of NRAS-driven leukemia. Oncotarget. 2016;7:80113-80130 pubmed publisher
  288. Saha S, Aranda E, Hayakawa Y, Bhanja P, Atay S, Brodin N, et al. Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injury. Nat Commun. 2016;7:13096 pubmed publisher
  289. Wright R, Souza P, Flak M, Thedchanamoorthy P, Norling L, Cooper D. Galectin-3-null mice display defective neutrophil clearance during acute inflammation. J Leukoc Biol. 2017;101:717-726 pubmed publisher
  290. Rantakari P, Jäppinen N, Lokka E, Mokkala E, Gerke H, Peuhu E, et al. Fetal liver endothelium regulates the seeding of tissue-resident macrophages. Nature. 2016;538:392-396 pubmed publisher
  291. Kimura T, Nada S, Takegahara N, Okuno T, Nojima S, Kang S, et al. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals. Nat Commun. 2016;7:13130 pubmed publisher
  292. Vannini N, Girotra M, Naveiras O, Nikitin G, Campos V, Giger S, et al. Specification of haematopoietic stem cell fate via modulation of mitochondrial activity. Nat Commun. 2016;7:13125 pubmed publisher
  293. Yu S, Pearson A, Lim R, Rodgers D, Li S, Parker H, et al. Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate. Mol Ther. 2016;24:2078-2089 pubmed publisher
  294. Nalbandian A, Khan A, Srivastava R, Llewellyn K, Tan B, Shukr N, et al. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy. Inflammation. 2017;40:21-41 pubmed publisher
  295. Chu V, Graf R, Wirtz T, Weber T, Favret J, Li X, et al. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc Natl Acad Sci U S A. 2016;113:12514-12519 pubmed
  296. Georgiev H, Ravens I, Benarafa C, Forster R, Bernhardt G. Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets. Nat Commun. 2016;7:13116 pubmed publisher
  297. Lopez Guadamillas E, Fernandez Marcos P, Pantoja C, Muñoz Martin M, Martinez D, Gomez Lopez G, et al. p21Cip1 plays a critical role in the physiological adaptation to fasting through activation of PPAR?. Sci Rep. 2016;6:34542 pubmed publisher
  298. Hu X, García M, Weng L, Jung X, Murakami J, Kumar B, et al. Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche. Nat Commun. 2016;7:13095 pubmed publisher
  299. Yoon Y, Storm K, Kamimae Lanning A, Goloviznina N, Kurre P. Endogenous DNA Damage Leads to p53-Independent Deficits in Replicative Fitness in Fetal Murine Fancd2-/- Hematopoietic Stem and Progenitor Cells. Stem Cell Reports. 2016;7:840-853 pubmed publisher
  300. Ramirez Carrozzi V, Sambandam A, Zhou M, Yan D, Kang J, Wu X, et al. Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone. J Allergy Clin Immunol. 2017;139:705-708.e6 pubmed publisher
  301. Mittal S, Omoto M, Amouzegar A, Sahu A, Rezazadeh A, Katikireddy K, et al. Restoration of Corneal Transparency by Mesenchymal Stem Cells. Stem Cell Reports. 2016;7:583-590 pubmed publisher
  302. Johnston L, Hsu C, Krier Burris R, Chhiba K, Chien K, McKenzie A, et al. IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis. J Immunol. 2016;197:3445-3453 pubmed
  303. Ippagunta S, Gangwar R, Finkelstein D, Vogel P, Pelletier S, Gingras S, et al. Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function. Proc Natl Acad Sci U S A. 2016;113:E6162-E6171 pubmed
  304. Thanabalasuriar A, Neupane A, Wang J, Krummel M, Kubes P. iNKT Cell Emigration out of the Lung Vasculature Requires Neutrophils and Monocyte-Derived Dendritic Cells in Inflammation. Cell Rep. 2016;16:3260-3272 pubmed publisher
  305. Takeshima T, Pop L, Laine A, Iyengar P, Vitetta E, Hannan R. Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF. Proc Natl Acad Sci U S A. 2016;113:11300-11305 pubmed
  306. Kaneda M, Messer K, Ralainirina N, Li H, Leem C, Gorjestani S, et al. PI3Kγ is a molecular switch that controls immune suppression. Nature. 2016;539:437-442 pubmed publisher
  307. Lopes C, Daifalla N, Das B, Dias da Silva V, Campos Neto A. CD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum. PLoS ONE. 2016;11:e0162927 pubmed publisher
  308. Hay C, Sult E, Huang Q, Mulgrew K, Fuhrmann S, McGlinchey K, et al. Targeting CD73 in the tumor microenvironment with MEDI9447. Oncoimmunology. 2016;5:e1208875 pubmed publisher
  309. Vila Leahey A, Oldford S, Marignani P, Wang J, Haidl I, Marshall J. Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice. Oncoimmunology. 2016;5:e1151591 pubmed publisher
  310. Nam S, Kang K, Cha J, Kim J, Lee H, Kim Y, et al. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. J Leukoc Biol. 2016;100:1273-1284 pubmed
  311. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  312. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed publisher
  313. Chew W, Tabebordbar M, Cheng J, Mali P, Wu E, Ng A, et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat Methods. 2016;13:868-74 pubmed publisher
  314. Jackson Jones L, Duncan S, Magalhaes M, Campbell S, Maizels R, McSorley H, et al. Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation. Nat Commun. 2016;7:12651 pubmed publisher
  315. Xu H, Gelyana E, Rajsombath M, Yang T, Li S, Selkoe D. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid ?-Protein Oligomers. J Neurosci. 2016;36:9041-56 pubmed publisher
  316. Olsson A, Venkatasubramanian M, Chaudhri V, Aronow B, Salomonis N, Singh H, et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature. 2016;537:698-702 pubmed publisher
  317. Uckelmann H, Blaszkiewicz S, Nicolae C, Haas S, Schnell A, Wurzer S, et al. Extracellular matrix protein Matrilin-4 regulates stress-induced HSC proliferation via CXCR4. J Exp Med. 2016;213:1961-71 pubmed publisher
  318. Vogel K, Bell L, Galloway A, Ahlfors H, Turner M. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016;197:2673-2685 pubmed publisher
  319. Greco S, Torres Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, et al. Mincle Signaling Promotes Con A Hepatitis. J Immunol. 2016;197:2816-27 pubmed publisher
  320. Görtz G, Moshkelgosha S, Jesenek C, Edelmann B, Horstmann M, Banga J, et al. Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model. Endocrinology. 2016;157:3771-3778 pubmed
  321. Yoon J, Leyva Castillo J, Wang G, Galand C, Oyoshi M, Kumar L, et al. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med. 2016;213:2147-66 pubmed publisher
  322. Kim K, Williams J, Wang Y, Ivanov S, Gilfillan S, Colonna M, et al. MHC II+ resident peritoneal and pleural macrophages rely on IRF4 for development from circulating monocytes. J Exp Med. 2016;213:1951-9 pubmed publisher
  323. Dave M, Silva J, Eliçabe R, Jeréz M, Filippa V, Gorlino C, et al. Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain. Infect Immun. 2016;84:3172-3181 pubmed publisher
  324. Papp S, Moderzynski K, Rauch J, Heine L, Kuehl S, Richardt U, et al. Liver Necrosis and Lethal Systemic Inflammation in a Murine Model of Rickettsia typhi Infection: Role of Neutrophils, Macrophages and NK Cells. PLoS Negl Trop Dis. 2016;10:e0004935 pubmed publisher
  325. Murakami S, Shahbazian D, Surana R, Zhang W, Chen H, Graham G, et al. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. Oncogene. 2017;36:1232-1244 pubmed publisher
  326. Kim G, Das R, Goduni L, McClellan S, Hazlett L, Mahabeleshwar G. Kruppel-like Factor 6 Promotes Macrophage-mediated Inflammation by Suppressing B Cell Leukemia/Lymphoma 6 Expression. J Biol Chem. 2016;291:21271-21282 pubmed
  327. Finsterbusch M, Hall P, Li A, Devi S, Westhorpe C, Kitching A, et al. Patrolling monocytes promote intravascular neutrophil activation and glomerular injury in the acutely inflamed glomerulus. Proc Natl Acad Sci U S A. 2016;113:E5172-81 pubmed publisher
  328. Cordova Z, Grönholm A, Kytölä V, Taverniti V, Hämäläinen S, Aittomäki S, et al. Myeloid cell expressed proprotein convertase FURIN attenuates inflammation. Oncotarget. 2016;7:54392-54404 pubmed publisher
  329. Henry E, Sy C, Inclan Rico J, Espinosa V, Ghanny S, Dwyer D, et al. Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. J Exp Med. 2016;213:1663-73 pubmed publisher
  330. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed publisher
  331. Damgaard R, Walker J, Marco Casanova P, Morgan N, Titheradge H, Elliott P, et al. The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity. Cell. 2016;166:1215-1230.e20 pubmed publisher
  332. Moodley D, Yoshida H, Mostafavi S, Asinovski N, Ortiz Lopez A, Symanowicz P, et al. Network pharmacology of JAK inhibitors. Proc Natl Acad Sci U S A. 2016;113:9852-7 pubmed publisher
  333. Meliopoulos V, Van De Velde L, Van De Velde N, Karlsson E, Neale G, Vogel P, et al. An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens. PLoS Pathog. 2016;12:e1005804 pubmed publisher
  334. Ramo K, Sugamura K, Craige S, Keaney J, Davis R. Suppression of ischemia in arterial occlusive disease by JNK-promoted native collateral artery development. elife. 2016;5: pubmed publisher
  335. You L, Li L, Zou J, Yan K, Belle J, Nijnik A, et al. BRPF1 is essential for development of fetal hematopoietic stem cells. J Clin Invest. 2016;126:3247-62 pubmed publisher
  336. Shi Y, Wu W, Chai Q, Li Q, Hou Y, Xia H, et al. LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nat Commun. 2016;7:12369 pubmed publisher
  337. Seki T, Hosaka K, Lim S, Fischer C, Honek J, Yang Y, et al. Endothelial PDGF-CC regulates angiogenesis-dependent thermogenesis in beige fat. Nat Commun. 2016;7:12152 pubmed publisher
  338. Imhof B, Jemelin S, Ballet R, Vesin C, Schapira M, Karaca M, et al. CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation. Proc Natl Acad Sci U S A. 2016;113:E4847-56 pubmed publisher
  339. Yoshioka D, Kajiwara C, Ishii Y, Umeki K, Hiramatsu K, Kadota J, et al. Efficacy of ?-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia. Antimicrob Agents Chemother. 2016;60:6146-54 pubmed publisher
  340. Biton J, Khaleghparast Athari S, Thiolat A, Santinon F, Lemeiter D, Hervé R, et al. In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. J Immunol. 2016;197:1708-19 pubmed publisher
  341. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  342. Di Siena S, Gimmelli R, Nori S, Barbagallo F, Campolo F, Dolci S, et al. Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury. Cell Death Dis. 2016;7:e2317 pubmed publisher
  343. Eichenfield D, Troutman T, Link V, Lam M, Cho H, Gosselin D, et al. Tissue damage drives co-localization of NF-?B, Smad3, and Nrf2 to direct Rev-erb sensitive wound repair in mouse macrophages. elife. 2016;5: pubmed publisher
  344. Aryal B, Rotllan N, Araldi E, Ramírez C, He S, Chousterman B, et al. ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nat Commun. 2016;7:12313 pubmed publisher
  345. Chen S, Miyazaki M, Chandra V, Fisch K, Chang A, Murre C. Id3 Orchestrates Germinal Center B Cell Development. Mol Cell Biol. 2016;36:2543-52 pubmed publisher
  346. Lesina M, Wörmann S, Morton J, Diakopoulos K, Korneeva O, Wimmer M, et al. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J Clin Invest. 2016;126:2919-32 pubmed publisher
  347. Mothes B, Bucher K, Ammon Treiber S, Schwab M, Piekorz R, Hirsch E, et al. p110γ/δ Double-Deficiency Induces Eosinophilia and IgE Production but Protects from OVA-Induced Airway Inflammation. PLoS ONE. 2016;11:e0159310 pubmed publisher
  348. Fransén Pettersson N, Duarte N, Nilsson J, Lundholm M, Mayans S, Larefalk A, et al. A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis. PLoS ONE. 2016;11:e0159850 pubmed publisher
  349. Metz H, Kargl J, Busch S, Kim K, Kurland B, Abberbock S, et al. Insulin receptor substrate-1 deficiency drives a proinflammatory phenotype in KRAS mutant lung adenocarcinoma. Proc Natl Acad Sci U S A. 2016;113:8795-800 pubmed publisher
  350. Xia X, Yu Y, Zhang L, Ma Y, Wang H. Inhibitor of DNA binding 1 regulates cell cycle progression of endothelial progenitor cells through induction of Wnt2 expression. Mol Med Rep. 2016;14:2016-24 pubmed publisher
  351. Xiao Y, Tang J, Guo H, Zhao Y, Tang R, Ouyang S, et al. Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. Nat Med. 2016;22:906-14 pubmed publisher
  352. Terracina K, Graham L, Payne K, Manjili M, Baek A, Damle S, et al. DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer. Cancer Immunol Immunother. 2016;65:1061-73 pubmed publisher
  353. Hoppe P, Schwarzfischer M, Loeffler D, Kokkaliaris K, Hilsenbeck O, Moritz N, et al. Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios. Nature. 2016;535:299-302 pubmed publisher
  354. Lowndes M, Rotherham M, Price J, El Haj A, Habib S. Immobilized WNT Proteins Act as a Stem Cell Niche for Tissue Engineering. Stem Cell Reports. 2016;7:126-37 pubmed publisher
  355. Ibiza S, García Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature. 2016;535:440-443 pubmed publisher
  356. Kretschmer S, Pieper M, Hüttmann G, Bölke T, Wollenberg B, Marsh L, et al. Autofluorescence multiphoton microscopy for visualization of tissue morphology and cellular dynamics in murine and human airways. Lab Invest. 2016;96:918-31 pubmed publisher
  357. Clausen B, Degn M, Sivasaravanaparan M, Fogtmann T, Andersen M, Trojanowsky M, et al. Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling. Sci Rep. 2016;6:29291 pubmed publisher
  358. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed publisher
  359. Metruccio M, Evans D, Gabriel M, Kadurugamuwa J, Fleiszig S. Pseudomonas aeruginosa Outer Membrane Vesicles Triggered by Human Mucosal Fluid and Lysozyme Can Prime Host Tissue Surfaces for Bacterial Adhesion. Front Microbiol. 2016;7:871 pubmed publisher
  360. Yu Q, Song W, Wang D, Zeng Y. Identification of blood vascular endothelial stem cells by the expression of protein C receptor. Cell Res. 2016;26:1079-1098 pubmed publisher
  361. Deng Z, Rong Y, Teng Y, Zhuang X, Samykutty A, Mu J, et al. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis. Oncogene. 2017;36:639-651 pubmed publisher
  362. Matcovitch Natan O, Winter D, Giladi A, Vargas Aguilar S, Spinrad A, Sarrazin S, et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science. 2016;353:aad8670 pubmed publisher
  363. Quantius J, Schmoldt C, Vazquez Armendariz A, Becker C, El Agha E, Wilhelm J, et al. Influenza Virus Infects Epithelial Stem/Progenitor Cells of the Distal Lung: Impact on Fgfr2b-Driven Epithelial Repair. PLoS Pathog. 2016;12:e1005544 pubmed publisher
  364. Albarrán Juárez J, Kaur H, Grimm M, Offermanns S, Wettschureck N. Lineage tracing of cells involved in atherosclerosis. Atherosclerosis. 2016;251:445-453 pubmed publisher
  365. Terashima A, Okamoto K, Nakashima T, Akira S, Ikuta K, Takayanagi H. Sepsis-Induced Osteoblast Ablation Causes Immunodeficiency. Immunity. 2016;44:1434-43 pubmed publisher
  366. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed publisher
  367. Stentzel S, Teufelberger A, Nordengrün M, Kolata J, Schmidt F, Van Crombruggen K, et al. Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus. J Allergy Clin Immunol. 2017;139:492-500.e8 pubmed publisher
  368. Jia H, Sodhi C, Yamaguchi Y, Lu P, Martin L, Good M, et al. Pulmonary Epithelial TLR4 Activation Leads to Lung Injury in Neonatal Necrotizing Enterocolitis. J Immunol. 2016;197:859-71 pubmed publisher
  369. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed publisher
  370. Ruhland M, Loza A, Capietto A, Luo X, Knolhoff B, Flanagan K, et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun. 2016;7:11762 pubmed publisher
  371. Quirino G, Nascimento M, Davoli Ferreira M, Sacramento L, Lima M, Almeida R, et al. Interleukin-27 (IL-27) Mediates Susceptibility to Visceral Leishmaniasis by Suppressing the IL-17-Neutrophil Response. Infect Immun. 2016;84:2289-2298 pubmed publisher
  372. Quarta M, Brett J, DiMarco R, de Morrée A, Boutet S, Chacon R, et al. An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy. Nat Biotechnol. 2016;34:752-9 pubmed publisher
  373. Seehus C, Kaye J. In vitro Differentiation of Murine Innate Lymphoid Cells from Common Lymphoid Progenitor Cells. Bio Protoc. 2016;6: pubmed
  374. Kanda M, Nagai T, Takahashi T, Liu M, Kondou N, Naito A, et al. Leukemia Inhibitory Factor Enhances Endogenous Cardiomyocyte Regeneration after Myocardial Infarction. PLoS ONE. 2016;11:e0156562 pubmed publisher
  375. Sinclair A, Park L, Shah M, Drotar M, Calaminus S, Hopcroft L, et al. CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood. 2016;128:371-83 pubmed publisher
  376. Ricard C, Tchoghandjian A, Luche H, Grenot P, Figarella Branger D, Rougon G, et al. Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice. Sci Rep. 2016;6:26381 pubmed publisher
  377. Stein S, Mack E, Rome K, Pajcini K, Ohtani T, Xu L, et al. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL. PLoS ONE. 2016;11:e0155408 pubmed publisher
  378. Patenaude J, Perreault C. Thymic Mesenchymal Cells Have a Distinct Transcriptomic Profile. J Immunol. 2016;196:4760-70 pubmed publisher
  379. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  380. Rothhammer V, Mascanfroni I, Bunse L, Takenaka M, Kenison J, Mayo L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016;22:586-97 pubmed publisher
  381. Wen S, Dooner M, Cheng Y, Papa E, Del Tatto M, Pereira M, et al. Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells. Leukemia. 2016;30:2221-2231 pubmed publisher
  382. Reynaldi A, Smith N, Schlub T, Venturi V, Rudd B, Davenport M. Modeling the dynamics of neonatal CD8+ T-cell responses. Immunol Cell Biol. 2016;94:838-848 pubmed publisher
  383. Shiraishi M, Shintani Y, Shintani Y, Ishida H, Saba R, Yamaguchi A, et al. Alternatively activated macrophages determine repair of the infarcted adult murine heart. J Clin Invest. 2016;126:2151-66 pubmed publisher
  384. Szalay G, Martinecz B, Lénárt N, Kornyei Z, Orsolits B, Judák L, et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun. 2016;7:11499 pubmed publisher
  385. Larabee C, Hu Y, Desai S, Georgescu C, Wren J, Axtell R, et al. Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice. Mol Vis. 2016;22:332-41 pubmed
  386. Wang Y, Wang X, Flores E, Yu J, Chang S. Dysfunctional telomeres induce p53-dependent and independent apoptosis to compromise cellular proliferation and inhibit tumor formation. Aging Cell. 2016;15:646-60 pubmed publisher
  387. Pietras E, Mirantes Barbeito C, Fong S, Loeffler D, Kovtonyuk L, Zhang S, et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016;18:607-18 pubmed publisher
  388. Hull T, Boddu R, Guo L, Tisher C, Traylor A, Patel B, et al. Heme oxygenase-1 regulates mitochondrial quality control in the heart. JCI Insight. 2016;1:e85817 pubmed
  389. Song Z, Li Z, Li D, Fang W, Liu H, Yang D, et al. Seminal plasma induces inflammation in the uterus through the ?? T/IL-17 pathway. Sci Rep. 2016;6:25118 pubmed publisher
  390. Carofino B, Ayanga B, Tracey L, Brooke Bisschop T, Justice M. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL. Biol Open. 2016;5:645-53 pubmed publisher
  391. Riabov V, Yin S, Song B, Avdic A, Schledzewski K, Ovsiy I, et al. Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model. Oncotarget. 2016;7:31097-110 pubmed publisher
  392. Yin S, Jian F, Chen Y, Chien S, Hsieh M, Hsiao P, et al. Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis. Nat Commun. 2016;7:11311 pubmed publisher
  393. Lim S, Yuzhalin A, Gordon Weeks A, Muschel R. Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells. Oncogene. 2016;35:5735-5745 pubmed publisher
  394. Kurkewich J, Bikorimana E, Nguyen T, Klopfenstein N, Zhang H, Hallas W, et al. The mirn23a microRNA cluster antagonizes B cell development. J Leukoc Biol. 2016;100:665-677 pubmed
  395. Itkin T, Gur Cohen S, Spencer J, Schajnovitz A, Ramasamy S, Kusumbe A, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532:323-8 pubmed publisher
  396. Spiegel A, Brooks M, Houshyar S, Reinhardt F, Ardolino M, Fessler E, et al. Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. Cancer Discov. 2016;6:630-49 pubmed publisher
  397. Liu Q, Babadjouni R, Radwanski R, Cheng H, Patel A, Hodis D, et al. Stroke Damage Is Exacerbated by Nano-Size Particulate Matter in a Mouse Model. PLoS ONE. 2016;11:e0153376 pubmed publisher
  398. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  399. Chen W, Cao Z, Sugaya S, Lopez M, Sendra V, Laver N, et al. Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3. Nat Commun. 2016;7:11302 pubmed publisher
  400. Mall C, Sckisel G, Proia D, Mirsoian A, Grossenbacher S, Pai C, et al. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016;5:e1075114 pubmed
  401. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  402. Yosef R, Pilpel N, Tokarsky Amiel R, Biran A, Ovadya Y, Cohen S, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016;7:11190 pubmed publisher
  403. Griffiths K, Dolezal O, Cao B, Nilsson S, See H, Pfleger K, et al. i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4. J Biol Chem. 2016;291:12641-57 pubmed publisher
  404. Jiang S, Li X, Hess N, Guan Y, Tapping R. TLR10 Is a Negative Regulator of Both MyD88-Dependent and -Independent TLR Signaling. J Immunol. 2016;196:3834-41 pubmed publisher
  405. Braun J, Meixner A, Brachner A, Foisner R. The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis. PLoS ONE. 2016;11:e0152278 pubmed publisher
  406. Yang Y, Xu J, Chen H, Fei X, Tang Y, Yan Y, et al. MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells. Oncotarget. 2016;7:17520-31 pubmed publisher
  407. Peteranderl C, Morales Nebreda L, Selvakumar B, Lecuona E, Vadász I, Morty R, et al. Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection. J Clin Invest. 2016;126:1566-80 pubmed publisher
  408. Martin B, Wang C, Zhang C, Kang Z, Gulen M, Zepp J, et al. T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis. Nat Immunol. 2016;17:583-92 pubmed publisher
  409. Gomez de Agüero M, Ganal Vonarburg S, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351:1296-302 pubmed publisher
  410. Kocijancic D, Felgner S, Frahm M, Komoll R, Iljazovic A, Pawar V, et al. Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential. Oncotarget. 2016;7:22605-22 pubmed publisher
  411. Menheniott T, O Connor L, Chionh Y, Däbritz J, Scurr M, Rollo B, et al. Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression. J Clin Invest. 2016;126:1383-400 pubmed publisher
  412. McFarland B, Marks M, Rowse A, Fehling S, Gerigk M, Qin H, et al. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma. Oncotarget. 2016;7:20621-35 pubmed publisher
  413. Stempel H, Jung M, Pérez Gómez A, Leinders Zufall T, Zufall F, Bufe B. Strain-specific Loss of Formyl Peptide Receptor 3 in the Murine Vomeronasal and Immune Systems. J Biol Chem. 2016;291:9762-75 pubmed publisher
  414. Carevic M, Oz H, Fuchs K, Laval J, Schroth C, Frey N, et al. CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense. J Innate Immun. 2016;8:362-73 pubmed publisher
  415. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  416. Liu S, Wu C, Huang K, Wang C, Guan S, Chen L, et al. C/EBP homologous protein (CHOP) deficiency ameliorates renal fibrosis in unilateral ureteral obstructive kidney disease. Oncotarget. 2016;7:21900-12 pubmed publisher
  417. Wang L, Siegenthaler J, Dowell R, Yi R. Foxc1 reinforces quiescence in self-renewing hair follicle stem cells. Science. 2016;351:613-7 pubmed publisher
  418. Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Rea D, Barbieri A, et al. A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice. J Transl Med. 2016;14:58 pubmed publisher
  419. Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed publisher
  420. Xu J, Zhou L, Ji L, Chen F, Fortmann K, Zhang K, et al. The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis. Nat Commun. 2016;7:10761 pubmed publisher
  421. Yang Y, Poe J, Yang L, Fedoriw A, Desai S, Magnuson T, et al. Rad18 confers hematopoietic progenitor cell DNA damage tolerance independently of the Fanconi Anemia pathway in vivo. Nucleic Acids Res. 2016;44:4174-88 pubmed publisher
  422. Zhao W, Wang C, Liu R, Wei C, Duan J, Liu K, et al. Effect of TGF-β1 on the Migration and Recruitment of Mesenchymal Stem Cells after Vascular Balloon Injury: Involvement of Matrix Metalloproteinase-14. Sci Rep. 2016;6:21176 pubmed publisher
  423. Karmakar M, Katsnelson M, Dubyak G, Pearlman E. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP. Nat Commun. 2016;7:10555 pubmed publisher
  424. Park J, Park J, Park D, Kim D, Kim H. Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer. Stem Cells. 2016;34:1177-87 pubmed publisher
  425. Xiao J, Shao L, Shen J, Jiang W, Feng Y, Zheng P, et al. Effects of ketanserin on experimental colitis in mice and macrophage function. Int J Mol Med. 2016;37:659-68 pubmed publisher
  426. Chen J, Miyanishi M, Wang S, Yamazaki S, Sinha R, Kao K, et al. Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche. Nature. 2016;530:223-7 pubmed publisher
  427. Vila Leahey A, Rogers D, Marshall J. The impact of ranitidine on monocyte responses in the context of solid tumors. Oncotarget. 2016;7:10891-904 pubmed publisher
  428. Roffê E, Marino A, Weaver J, Wan W, de Araújo F, Hoffman V, et al. Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun. 2016;84:1123-1136 pubmed publisher
  429. Smith R, Reyes N, Khandelwal P, Schlereth S, Lee H, Masli S, et al. Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease. J Leukoc Biol. 2016;100:371-80 pubmed publisher
  430. Crompton R, Williams H, Ansell D, Campbell L, Holden K, Cruickshank S, et al. Oestrogen promotes healing in a bacterial LPS model of delayed cutaneous wound repair. Lab Invest. 2016;96:439-49 pubmed publisher
  431. Däbritz J, Judd L, Chalinor H, Menheniott T, Giraud A. Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells. Sci Rep. 2016;6:20584 pubmed publisher
  432. Howitt M, Lavoie S, Michaud M, Blum A, Tran S, Weinstock J, et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science. 2016;351:1329-33 pubmed publisher
  433. Azpilikueta A, Agorreta J, Labiano S, Pérez Gracia J, Sánchez Paulete A, Aznar M, et al. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies. J Thorac Oncol. 2016;11:524-36 pubmed publisher
  434. Wu X, Fleming A, Ricketts T, Pavel M, Virgin H, Menzies F, et al. Autophagy regulates Notch degradation and modulates stem cell development and neurogenesis. Nat Commun. 2016;7:10533 pubmed publisher
  435. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  436. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  437. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  438. Scott C, Zheng F, De Baetselier P, Martens L, Saeys Y, De Prijck S, et al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun. 2016;7:10321 pubmed publisher
  439. Baudiß K, de Paula Vieira R, Cicko S, Ayata K, Hossfeld M, Ehrat N, et al. C1P Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Preventing NF-κB Activation in Neutrophils. J Immunol. 2016;196:2319-26 pubmed publisher
  440. Chu C, Gardner P, Copland D, Liyanage S, Gonzalez Cordero A, Kleine Holthaus S, et al. Multimodal analysis of ocular inflammation using the endotoxin-induced uveitis mouse model. Dis Model Mech. 2016;9:473-81 pubmed publisher
  441. Luchsinger L, de Almeida M, Corrigan D, Mumau M, Snoeck H. Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid potential. Nature. 2016;529:528-31 pubmed publisher
  442. Montufar Solis D, Klein J. Splenic Leukocytes Traffic to the Thyroid and Produce a Novel TSHβ Isoform during Acute Listeria monocytogenes Infection in Mice. PLoS ONE. 2016;11:e0146111 pubmed publisher
  443. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  444. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  445. Leiva M, Quintana J, Ligos J, Hidalgo A. Haematopoietic ESL-1 enables stem cell proliferation in the bone marrow by limiting TGFβ availability. Nat Commun. 2016;7:10222 pubmed publisher
  446. García Prat L, Martínez Vicente M, Perdiguero E, Ortet L, Rodríguez Ubreva J, Rebollo E, et al. Autophagy maintains stemness by preventing senescence. Nature. 2016;529:37-42 pubmed publisher
  447. Arai S, Kitada K, Yamazaki T, Takai R, Zhang X, Tsugawa Y, et al. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat Med. 2016;22:183-93 pubmed publisher
  448. Gallego Ortega D, Ledger A, Roden D, Law A, Magenau A, Kikhtyak Z, et al. ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells. PLoS Biol. 2015;13:e1002330 pubmed publisher
  449. Rybalko V, Hsieh P, Merscham Banda M, Suggs L, Farrar R. The Development of Macrophage-Mediated Cell Therapy to Improve Skeletal Muscle Function after Injury. PLoS ONE. 2015;10:e0145550 pubmed publisher
  450. Ogura Y, Hindi S, Sato S, Xiong G, Akira S, Kumar A. TAK1 modulates satellite stem cell homeostasis and skeletal muscle repair. Nat Commun. 2015;6:10123 pubmed publisher
  451. Liu Q, Yang R, Huang X, Zhang H, He L, Zhang L, et al. Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes. Cell Res. 2016;26:119-30 pubmed publisher
  452. Kaplan J, Marshall M, C McSkimming C, Harmon D, Garmey J, Oldham S, et al. Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue. Mol Metab. 2015;4:779-94 pubmed publisher
  453. Ge Y, Zhang L, Nikolova M, Reva B, Fuchs E. Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21(∗) in SCC progression. Nat Cell Biol. 2016;18:111-21 pubmed publisher
  454. Cuttano R, Rudini N, Bravi L, Corada M, Giampietro C, Papa E, et al. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med. 2016;8:6-24 pubmed publisher
  455. Zhong C, Cui K, Wilhelm C, Hu G, Mao K, Belkaid Y, et al. Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment. Nat Immunol. 2016;17:169-78 pubmed publisher
  456. Cole C, Verdoni A, Ketkar S, Leight E, Russler Germain D, Lamprecht T, et al. PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia. J Clin Invest. 2016;126:85-98 pubmed publisher
  457. Kraut B, Maier H, Kókai E, Fiedler K, Boettger T, Illing A, et al. Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality. PLoS ONE. 2015;10:e0141591 pubmed publisher
  458. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed publisher
  459. Van Helden M, Goossens S, Daussy C, Mathieu A, Faure F, Marçais A, et al. Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection. J Exp Med. 2015;212:2015-25 pubmed publisher
  460. Gallego Colon E, Sampson R, Sattler S, Schneider M, Rosenthal N, Tonkin J. Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction. Mediators Inflamm. 2015;2015:484357 pubmed publisher
  461. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  462. Choukrallah M, Song S, Rolink A, Burger L, Matthias P. Enhancer repertoires are reshaped independently of early priming and heterochromatin dynamics during B cell differentiation. Nat Commun. 2015;6:8324 pubmed publisher
  463. Black L, Srivastava R, Schoeb T, Moore R, Barnes S, KABAROWSKI J. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice. J Immunol. 2015;195:4685-98 pubmed publisher
  464. Sinadinos A, Young C, Al Khalidi R, Teti A, Kalinski P, Mohamad S, et al. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy. PLoS Med. 2015;12:e1001888 pubmed publisher
  465. Varney M, Niederkorn M, Konno H, Matsumura T, Gohda J, Yoshida N, et al. Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling. J Exp Med. 2015;212:1967-85 pubmed publisher
  466. Alvarez S, Diaz M, Flach J, Rodriguez Acebes S, López Contreras A, Martinez D, et al. Replication stress caused by low MCM expression limits fetal erythropoiesis and hematopoietic stem cell functionality. Nat Commun. 2015;6:8548 pubmed publisher
  467. Matthews G, Mehdipour P, Cluse L, Falkenberg K, Wang E, Roth M, et al. Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies. Blood. 2015;126:2392-403 pubmed publisher
  468. Abboud D, Daubeuf F, Do Q, Utard V, Villa P, Haiech J, et al. A strategy to discover decoy chemokine ligands with an anti-inflammatory activity. Sci Rep. 2015;5:14746 pubmed publisher
  469. Phinney D, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix C, et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun. 2015;6:8472 pubmed publisher
  470. Jones D, Wilmore J, Allman D. Cellular Dynamics of Memory B Cell Populations: IgM+ and IgG+ Memory B Cells Persist Indefinitely as Quiescent Cells. J Immunol. 2015;195:4753-9 pubmed publisher
  471. Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias G, et al. Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation. Arthritis Rheumatol. 2016;68:449-61 pubmed publisher
  472. Liu L, Cheung T, Charville G, Rando T. Isolation of skeletal muscle stem cells by fluorescence-activated cell sorting. Nat Protoc. 2015;10:1612-24 pubmed publisher
  473. Aparicio Domingo P, Romera Hernandez M, Karrich J, Cornelissen F, Papazian N, Lindenbergh Kortleve D, et al. Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage. J Exp Med. 2015;212:1783-91 pubmed publisher
  474. Skrzypek K, Kusienicka A, Szewczyk B, Adamus T, Lukasiewicz E, Miekus K, et al. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression. Oncotarget. 2015;6:31378-98 pubmed publisher
  475. Brasseit J, Althaus Steiner E, Faderl M, Dickgreber N, Saurer L, Genitsch V, et al. CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis. Mucosal Immunol. 2016;9:689-701 pubmed publisher
  476. Hanot Mambres D, Machelart A, Vanderwinden J, De Trez C, Ryffel B, Letesson J, et al. In Situ Characterization of Splenic Brucella melitensis Reservoir Cells during the Chronic Phase of Infection in Susceptible Mice. PLoS ONE. 2015;10:e0137835 pubmed publisher
  477. Oltolina F, Zamperone A, Colangelo D, Gregoletto L, Reano S, Pietronave S, et al. Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential. PLoS ONE. 2015;10:e0137999 pubmed publisher
  478. Rathert P, Roth M, Neumann T, Muerdter F, Roe J, Muhar M, et al. Transcriptional plasticity promotes primary and acquired resistance to BET inhibition. Nature. 2015;525:543-547 pubmed publisher
  479. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed publisher
  480. Shirasuna K, Karasawa T, Usui F, Kobayashi M, Komada T, Kimura H, et al. NLRP3 Deficiency Improves Angiotensin II-Induced Hypertension But Not Fetal Growth Restriction During Pregnancy. Endocrinology. 2015;156:4281-92 pubmed publisher
  481. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  482. Fu Y, Huang C, Xu X, Gu H, Ye Y, Jiang C, et al. Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails. Cell Res. 2015;25:1013-24 pubmed publisher
  483. Crosby E, Clark M, Novais F, Wherry E, Scott P. Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major. J Immunol. 2015;195:3301-10 pubmed publisher
  484. Merches K, Khairnar V, Knuschke T, Shaabani N, Honke N, Duhan V, et al. Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa Infection. Cell Physiol Biochem. 2015;36:2379-92 pubmed publisher
  485. Eichin D, Laurila J, Jalkanen S, Salmi M. CD73 Activity is Dispensable for the Polarization of M2 Macrophages. PLoS ONE. 2015;10:e0134721 pubmed publisher
  486. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  487. Fujimura N, Xu B, Dalman J, Deng H, Aoyama K, Dalman R. CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow. Sci Rep. 2015;5:11664 pubmed publisher
  488. Ermert D, Shaughnessy J, Joeris T, Kaplan J, Pang C, Kurt Jones E, et al. Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors. PLoS Pathog. 2015;11:e1005043 pubmed publisher
  489. ELDREDGE L, Treuting P, MANICONE A, Ziegler S, Parks W, McGuire J. CD11b(+) Mononuclear Cells Mitigate Hyperoxia-Induced Lung Injury in Neonatal Mice. Am J Respir Cell Mol Biol. 2016;54:273-83 pubmed publisher
  490. Kratochvill F, Gratz N, Qualls J, Van De Velde L, Chi H, Kovarik P, et al. Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner. Cancer Res. 2015;75:3054-64 pubmed publisher
  491. Lowe K, Navarro Núñez L, Bénézech C, Nayar S, Kingston B, Nieswandt B, et al. The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. Eur J Immunol. 2015;45:2484-93 pubmed publisher
  492. Deng B, Deng W, Xiao P, Zeng K, Zhang S, Zhang H, et al. Nonadherent culture method downregulates stem cell antigen-1 expression in mouse bone marrow mesenchymal stem cells. Exp Ther Med. 2015;10:31-36 pubmed
  493. Ripperger T, Manukjan G, Meyer J, Wolter S, Schambach A, Bohne J, et al. The heteromeric transcription factor GABP activates the ITGAM/CD11b promoter and induces myeloid differentiation. Biochim Biophys Acta. 2015;1849:1145-54 pubmed publisher
  494. Di Cicco A, Petit V, Chiche A, Bresson L, Romagnoli M, Orian Rousseau V, et al. Paracrine Met signaling triggers epithelial-mesenchymal transition in mammary luminal progenitors, affecting their fate. elife. 2015;4: pubmed publisher
  495. Kim M, Taparowsky E, Kim C. Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut. Immunity. 2015;43:107-19 pubmed publisher
  496. Herz J, Johnson K, McGavern D. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med. 2015;212:1153-69 pubmed publisher
  497. Weindel C, Richey L, Bolland S, Mehta A, Kearney J, Huber B. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy. 2015;11:1010-24 pubmed publisher
  498. Zhang J, Li L, Baldwin A, Friedman A, Paz Priel I. Loss of IKKβ but Not NF-κB p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells. PLoS ONE. 2015;10:e0130441 pubmed publisher
  499. Onishi S, Adnan E, Ishizaki J, Miyazaki T, Tanaka Y, Matsumoto T, et al. Novel Autoantigens Associated with Lupus Nephritis. PLoS ONE. 2015;10:e0126564 pubmed publisher
  500. Joshi P, Waterhouse P, Kannan N, Narala S, Fang H, Di Grappa M, et al. RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1. Stem Cell Reports. 2015;5:31-44 pubmed publisher
  501. Tacke R, Hilgendorf I, Garner H, Waterborg C, Park K, Nowyhed H, et al. The transcription factor NR4A1 is essential for the development of a novel macrophage subset in the thymus. Sci Rep. 2015;5:10055 pubmed publisher
  502. Xu G, Wu H, Zhang J, Li D, Wang Y, Wang Y, et al. Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med. 2015;87:15-25 pubmed publisher
  503. Charmsaz S, Beckett K, Smith F, Bruedigam C, Moore A, Al Ejeh F, et al. EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia. PLoS ONE. 2015;10:e0130692 pubmed publisher
  504. Conde P, Rodriguez M, van der Touw W, Jimenez A, Burns M, Miller J, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015;42:1143-58 pubmed publisher
  505. Chang D, Moniz R, Xu Z, Sun J, Signoretti S, Zhu Q, et al. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo. Mol Cancer. 2015;14:119 pubmed publisher
  506. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  507. Koronyo Y, Salumbides B, Sheyn J, Pelissier L, Li S, Ljubimov V, et al. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease. Brain. 2015;138:2399-422 pubmed publisher
  508. Imai Y, Ayithan N, Wu X, Yuan Y, Wang L, Hwang S. Cutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate γδ-Low T Cells. J Immunol. 2015;195:421-5 pubmed publisher
  509. Durrans A, Gao D, Gupta R, Fischer K, Choi H, El Rayes T, et al. Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC. PLoS ONE. 2015;10:e0129123 pubmed publisher
  510. Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration. PLoS ONE. 2015;10:e0128094 pubmed publisher
  511. Holzapfel B, Hutmacher D, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-14 pubmed publisher
  512. Wang H, Hong L, Huang J, Jiang Q, Tao R, Tan C, et al. P2RX7 sensitizes Mac-1/ICAM-1-dependent leukocyte-endothelial adhesion and promotes neurovascular injury during septic encephalopathy. Cell Res. 2015;25:674-90 pubmed publisher
  513. Liang X, Ding Y, Zhang Y, Chai Y, He J, Chiu S, et al. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis. 2015;6:e1765 pubmed publisher
  514. Teo T, Her Z, Tan J, Lum F, Lee W, Chan Y, et al. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology. J Virol. 2015;89:7955-69 pubmed publisher
  515. Jacque E, Schweighoffer E, Tybulewicz V, Ley S. BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival. J Exp Med. 2015;212:883-92 pubmed publisher
  516. Shankman L, Gomez D, Cherepanova O, Salmon M, Alencar G, Haskins R, et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med. 2015;21:628-37 pubmed publisher
  517. Xue J, Sharma V, Hsieh M, Chawla A, Murali R, Pandol S, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 2015;6:7158 pubmed publisher
  518. Yang L, Carrillo M, Wu Y, DiAngelo S, Silveyra P, Umstead T, et al. SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation. PLoS ONE. 2015;10:e0126576 pubmed publisher
  519. Liechtenstein T, Perez Janices N, Blanco Luquin I, Goyvaerts C, Schwarze J, Dufait I, et al. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy. Oncoimmunology. 2014;3:e945378 pubmed
  520. Zeng S, Wang L, Li P, Wang W, Yang J. Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function. Mol Med Rep. 2015;12:2511-20 pubmed publisher
  521. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed publisher
  522. Carmi Y, Spitzer M, Linde I, Burt B, Prestwood T, Perlman N, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015;521:99-104 pubmed publisher
  523. Wang E, Kawaoka S, Roe J, Shi J, Hohmann A, Xu Y, et al. The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer. elife. 2015;4:e06377 pubmed publisher
  524. Li X, Maretzky T, Weskamp G, Monette S, Qing X, Issuree P, et al. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling. Proc Natl Acad Sci U S A. 2015;112:6080-5 pubmed publisher
  525. Moguche A, Shafiani S, Clemons C, Larson R, Dinh C, Higdon L, et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J Exp Med. 2015;212:715-28 pubmed publisher
  526. Hegde V, Singh U, Nagarkatti P, Nagarkatti M. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo. J Immunol. 2015;194:5211-22 pubmed publisher
  527. Dahlgren M, Gustafsson Hedberg T, Livingston M, Cucak H, Alsén S, Yrlid U, et al. T follicular helper, but not Th1, cell differentiation in the absence of conventional dendritic cells. J Immunol. 2015;194:5187-99 pubmed publisher
  528. Kitur K, Parker D, Nieto P, Ahn D, Cohen T, Chung S, et al. Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog. 2015;11:e1004820 pubmed publisher
  529. Huang Y, Lo P, Yen C, Nigrovic P, Chao W, Wang W, et al. Redox Regulation of Pro-IL-1β Processing May Contribute to the Increased Severity of Serum-Induced Arthritis in NOX2-Deficient Mice. Antioxid Redox Signal. 2015;23:973-84 pubmed publisher
  530. Iwai H, Funatogawa K, Matsumura K, Kato Miyazawa M, Kirikae F, Kiga K, et al. MicroRNA-155 knockout mice are susceptible to Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2015;95:246-50 pubmed publisher
  531. Rao T, Marks Bluth J, Sullivan J, Gupta M, Chandrakanthan V, Fitch S, et al. High-level Gpr56 expression is dispensable for the maintenance and function of hematopoietic stem and progenitor cells in mice. Stem Cell Res. 2015;14:307-22 pubmed publisher
  532. Lal G, Nakayama Y, Sethi A, Singh A, Burrell B, Kulkarni N, et al. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance. Transplantation. 2015;99:1817-28 pubmed publisher
  533. Koh F, Lizama C, Wong P, Hawkins J, Zovein A, Ramalho Santos M. Emergence of hematopoietic stem and progenitor cells involves a Chd1-dependent increase in total nascent transcription. Proc Natl Acad Sci U S A. 2015;112:E1734-43 pubmed publisher
  534. Lujan E, Zunder E, Ng Y, Goronzy I, Nolan G, Wernig M. Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature. 2015;521:352-6 pubmed publisher
  535. Brunner P, Glitzner E, Reininger B, Klein I, Stary G, Mildner M, et al. CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin. Exp Dermatol. 2015;24:522-8 pubmed publisher
  536. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed publisher
  537. Tesio M, Tang Y, Müdder K, Saini M, von Paleske L, Macintyre E, et al. Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway. J Exp Med. 2015;212:525-38 pubmed publisher
  538. Napier R, Norris B, Swimm A, Giver C, Harris W, Laval J, et al. Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. PLoS Pathog. 2015;11:e1004770 pubmed publisher
  539. Moalli F, Proulx S, Schwendener R, Detmar M, Schlapbach C, Stein J. Intravital and whole-organ imaging reveals capture of melanoma-derived antigen by lymph node subcapsular macrophages leading to widespread deposition on follicular dendritic cells. Front Immunol. 2015;6:114 pubmed publisher
  540. Dal Secco D, Wang J, Zeng Z, Kolaczkowska E, Wong C, Petri B, et al. A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury. J Exp Med. 2015;212:447-56 pubmed publisher
  541. Povinelli B, Kokolus K, Eng J, Dougher C, Curtin L, Capitano M, et al. Standard sub-thermoneutral caging temperature influences radiosensitivity of hematopoietic stem and progenitor cells. PLoS ONE. 2015;10:e0120078 pubmed publisher
  542. Koh H, Chang C, Jeon S, Yoon H, Ahn Y, Kim H, et al. The HIF-1/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia. Nat Commun. 2015;6:6340 pubmed publisher
  543. Hu Lieskovan S, Mok S, Homet Moreno B, Tsoi J, Robert L, Goedert L, et al. Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma. Sci Transl Med. 2015;7:279ra41 pubmed publisher
  544. Liu B, Lee J, Chen C, Hershey G, Wang Y. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J Immunol. 2015;194:3583-93 pubmed publisher
  545. Bretscher P, Egger J, Shamshiev A, Trötzmüller M, Köfeler H, Carreira E, et al. Phospholipid oxidation generates potent anti-inflammatory lipid mediators that mimic structurally related pro-resolving eicosanoids by activating Nrf2. EMBO Mol Med. 2015;7:593-607 pubmed publisher
  546. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  547. Boulay A, Mazeraud A, Cisternino S, Saubaméa B, Mailly P, Jourdren L, et al. Immune quiescence of the brain is set by astroglial connexin 43. J Neurosci. 2015;35:4427-39 pubmed publisher
  548. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  549. Li C, Cheng P, Liang M, Chen Y, Lu Q, Wang J, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest. 2015;125:1509-22 pubmed publisher
  550. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  551. Watson N, Schneider K, Massa P. SHP-1-dependent macrophage differentiation exacerbates virus-induced myositis. J Immunol. 2015;194:2796-809 pubmed publisher
  552. Gong W, Shou D, Cheng F, Shi J, Ge F, Liu D. Tolerance induced by IL-6 deficient donor heart is significantly involved in myeloid-derived suppressor cells (MDSCs). Transpl Immunol. 2015;32:72-5 pubmed publisher
  553. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  554. Gong J, Weng D, Eguchi T, Murshid A, Sherman M, Song B, et al. Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis. Oncogene. 2015;34:5460-71 pubmed publisher
  555. Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240-58 pubmed publisher
  556. Hu W, Dooley J, Chung S, Chandramohan D, Cimmino L, Mukherjee S, et al. miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a. Blood. 2015;125:2206-16 pubmed publisher
  557. Shaw A, Pickup M, Chytil A, Aakre M, Owens P, Moses H, et al. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions. PLoS ONE. 2015;10:e0117908 pubmed publisher
  558. Franckaert D, Schlenner S, Heirman N, Gill J, Skogberg G, Ekwall O, et al. Premature thymic involution is independent of structural plasticity of the thymic stroma. Eur J Immunol. 2015;45:1535-47 pubmed publisher
  559. Baillet A, Rehaume L, Benham H, O Meara C, Armitage C, Ruscher R, et al. High Chlamydia Burden Promotes Tumor Necrosis Factor-Dependent Reactive Arthritis in SKG Mice. Arthritis Rheumatol. 2015;67:1535-47 pubmed publisher
  560. Peng H, Li C, Kadow S, Henry B, Steinmann J, Becker K, et al. Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis. J Mol Med (Berl). 2015;93:675-89 pubmed publisher
  561. Zimmermann M, Aguilera F, Castellucci M, Rossato M, Costa S, Lunardi C, et al. Chromatin remodelling and autocrine TNFα are required for optimal interleukin-6 expression in activated human neutrophils. Nat Commun. 2015;6:6061 pubmed publisher
  562. Jing W, Gershan J, Weber J, Tlomak D, McOlash L, Sabatos Peyton C, et al. Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma. J Immunother Cancer. 2015;3:2 pubmed publisher
  563. Evans E, Jonason A, Bussler H, Torno S, Veeraraghavan J, Reilly C, et al. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Cancer Immunol Res. 2015;3:689-701 pubmed publisher
  564. Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K. BILL-cadherin/cadherin-17 contributes to the survival of memory B cells. PLoS ONE. 2015;10:e0117566 pubmed publisher
  565. Du J, Shen X, Hu X, Sun B, Guan W, Li S, et al. Wip1-deficient neutrophils significantly promote intestinal ischemia/reperfusion injury in mice. Curr Mol Med. 2015;15:100-8 pubmed
  566. Bergot A, Monnet N, Le Tran S, Mittal D, Al Kouba J, Steptoe R, et al. HPV16 E7 expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions. Immunol Cell Biol. 2015;93:540-7 pubmed publisher
  567. CismaÅŸiu V, Popescu L. Telocytes transfer extracellular vesicles loaded with microRNAs to stem cells. J Cell Mol Med. 2015;19:351-8 pubmed publisher
  568. Ballesteros I, Cuartero M, Moraga A, de la Parra J, Lizasoain I, Moro M. Stereological and flow cytometry characterization of leukocyte subpopulations in models of transient or permanent cerebral ischemia. J Vis Exp. 2014;: pubmed publisher
  569. Leon Rico D, Fernández García M, Aldea M, Sánchez R, Peces Barba M, Martínez Palacio J, et al. Comparison of haematopoietic stem cell engraftment through the retro-orbital venous sinus and the lateral vein: alternative routes for bone marrow transplantation in mice. Lab Anim. 2015;49:132-41 pubmed publisher
  570. Khaled W, Choon Lee S, Stingl J, Chen X, Raza Ali H, Rueda O, et al. BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells. Nat Commun. 2015;6:5987 pubmed publisher
  571. Sullivan B, Teijaro J, de la Torre J, Oldstone M. Early virus-host interactions dictate the course of a persistent infection. PLoS Pathog. 2015;11:e1004588 pubmed publisher
  572. Djukic M, Sostmann N, Bertsch T, Mecke M, Nessler S, Manig A, et al. Vitamin D deficiency decreases survival of bacterial meningoencephalitis in mice. J Neuroinflammation. 2015;12:208 pubmed publisher
  573. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  574. Krysiak K, Tibbitts J, Shao J, Liu T, Ndonwi M, Walter M. Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells. Exp Hematol. 2015;43:319-30.e10 pubmed publisher
  575. Sakaguchi S, Hombauer M, Hassan H, Tanaka H, Yasmin N, Naoe Y, et al. A novel Cd8-cis-regulatory element preferentially directs expression in CD44hiCD62L+ CD8+ T cells and in CD8αα+ dendritic cells. J Leukoc Biol. 2015;97:635-44 pubmed publisher
  576. Su X, Zhang L, Ye J, Yang L, Li Y, Wang Y. Bone marrow mesenchymal stem cells suppress ascitogenous hepatoma progression in BALB/c mouse through reducing myeloid-derived suppressor cells. Biomed Mater Eng. 2015;25:167-77 pubmed publisher
  577. Karamitros D, Patmanidi A, Kotantaki P, Potocnik A, Bähr Ivacevic T, Benes V, et al. Geminin deletion increases the number of fetal hematopoietic stem cells by affecting the expression of key transcription factors. Development. 2015;142:70-81 pubmed publisher
  578. Evrard M, Chong S, Devi S, Chew W, Lee B, Poidinger M, et al. Visualization of bone marrow monocyte mobilization using Cx3cr1gfp/+Flt3L-/- reporter mouse by multiphoton intravital microscopy. J Leukoc Biol. 2015;97:611-9 pubmed publisher
  579. Nacer A, Movila A, Sohet F, Girgis N, Gundra U, Loke P, et al. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier. PLoS Pathog. 2014;10:e1004528 pubmed publisher
  580. Naik A, Hawwari A, Krangel M. Specification of Vδ and Vα usage by Tcra/Tcrd locus V gene segment promoters. J Immunol. 2015;194:790-4 pubmed publisher
  581. Fontana M, Baccarella A, Pancholi N, Pufall M, Herbert D, Kim C. JUNB is a key transcriptional modulator of macrophage activation. J Immunol. 2015;194:177-86 pubmed publisher
  582. Her Z, Teng T, Tan J, Teo T, Kam Y, Lum F, et al. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response. EMBO Mol Med. 2015;7:24-41 pubmed publisher
  583. Vela Ramirez J, Goodman J, Boggiatto P, Roychoudhury R, Pohl N, Hostetter J, et al. Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles. AAPS J. 2015;17:256-67 pubmed publisher
  584. Schliehe C, Flynn E, Vilagos B, Richson U, Swaminanthan S, Bosnjak B, et al. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat Immunol. 2015;16:67-74 pubmed publisher
  585. van Blijswijk J, Schraml B, Rogers N, Whitney P, Zelenay S, Acton S, et al. Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells. J Immunol. 2015;194:307-15 pubmed publisher
  586. Lieber S, Scheer F, Finkernagel F, Meissner W, Giehl G, Brendel C, et al. The inverse agonist DG172 triggers a PPARβ/δ-independent myeloid lineage shift and promotes GM-CSF/IL-4-induced dendritic cell differentiation. Mol Pharmacol. 2015;87:162-73 pubmed publisher
  587. Plosa E, Young L, Gulleman P, Polosukhin V, Zaynagetdinov R, Benjamin J, et al. Epithelial β1 integrin is required for lung branching morphogenesis and alveolarization. Development. 2014;141:4751-62 pubmed publisher
  588. Lim A, Shin K, Zhao C, Kawano S, Beachy P. Spatially restricted Hedgehog signalling regulates HGF-induced branching of the adult prostate. Nat Cell Biol. 2014;16:1135-45 pubmed publisher
  589. Fu C, Odegaard J, Hsieh M. Macrophages are required for host survival in experimental urogenital schistosomiasis. FASEB J. 2015;29:193-207 pubmed publisher
  590. Sakamoto H, Takeda N, Arai F, Hosokawa K, García P, Suda T, et al. Determining c-Myb protein levels can isolate functional hematopoietic stem cell subtypes. Stem Cells. 2015;33:479-90 pubmed publisher
  591. Morales D, Monte K, Sun L, Struckhoff J, Agapov E, Holtzman M, et al. Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice. J Virol. 2015;89:337-49 pubmed publisher
  592. McDonnell A, Lesterhuis W, Khong A, Nowak A, Lake R, Currie A, et al. Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur J Immunol. 2015;45:49-59 pubmed publisher
  593. Guttman O, Yossef R, Freixo Lima G, Rider P, Porgador A, Lewis E. α1-Antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet β-cells in favor of protection from autoimmune diabetes. Immunology. 2014;: pubmed publisher
  594. Xia H, Ren X, Bolte C, Ustiyan V, Zhang Y, Shah T, et al. Foxm1 regulates resolution of hyperoxic lung injury in newborns. Am J Respir Cell Mol Biol. 2015;52:611-21 pubmed publisher
  595. Zasłona Z, Przybranowski S, Wilke C, Van Rooijen N, Teitz Tennenbaum S, Osterholzer J, et al. Resident alveolar macrophages suppress, whereas recruited monocytes promote, allergic lung inflammation in murine models of asthma. J Immunol. 2014;193:4245-53 pubmed publisher
  596. Jacque E, Schweighoffer E, Visekruna A, Papoutsopoulou S, Janzen J, Zillwood R, et al. IKK-induced NF-κB1 p105 proteolysis is critical for B cell antibody responses to T cell-dependent antigen. J Exp Med. 2014;211:2085-101 pubmed publisher
  597. Cao Y, Slaney C, Bidwell B, Parker B, Johnstone C, Rautela J, et al. BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity. Cancer Res. 2014;74:5091-102 pubmed publisher
  598. Wang W, Kissig M, Rajakumari S, Huang L, Lim H, Won K, et al. Ebf2 is a selective marker of brown and beige adipogenic precursor cells. Proc Natl Acad Sci U S A. 2014;111:14466-71 pubmed publisher
  599. Praet J, Santermans E, Reekmans K, De Vocht N, Le Blon D, Hoornaert C, et al. Histological characterization and quantification of cellular events following neural and fibroblast(-like) stem cell grafting in healthy and demyelinated CNS tissue. Methods Mol Biol. 2014;1213:265-83 pubmed publisher
  600. Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X, et al. Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Res. 2014;24:1050-66 pubmed publisher
  601. Cremasco V, Woodruff M, Onder L, Cupovic J, Nieves Bonilla J, Schildberg F, et al. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells. Nat Immunol. 2014;15:973-81 pubmed publisher
  602. Sauter K, Pridans C, Sehgal A, Bain C, Scott C, Moffat L, et al. The MacBlue binary transgene (csf1r-gal4VP16/UAS-ECFP) provides a novel marker for visualisation of subsets of monocytes, macrophages and dendritic cells and responsiveness to CSF1 administration. PLoS ONE. 2014;9:e105429 pubmed publisher
  603. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  604. Flach J, Bakker S, Mohrin M, Conroy P, Pietras E, Reynaud D, et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature. 2014;512:198-202 pubmed publisher
  605. Pisano F, Heine W, Rosenheinrich M, Schweer J, Nuss A, Dersch P. Influence of PhoP and intra-species variations on virulence of Yersinia pseudotuberculosis during the natural oral infection route. PLoS ONE. 2014;9:e103541 pubmed publisher
  606. Kim K, Skora A, Li Z, Liu Q, Tam A, Blosser R, et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells. Proc Natl Acad Sci U S A. 2014;111:11774-9 pubmed publisher
  607. Ostapoff K, Cenik B, Wang M, Ye R, Xu X, Nugent D, et al. Neutralizing murine TGF?R2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. Cancer Res. 2014;74:4996-5007 pubmed publisher
  608. Reeh K, Cardenas K, Bain V, Liu Z, LAURENT M, Manley N, et al. Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis. Development. 2014;141:2950-8 pubmed publisher
  609. Chung Y, Kim E, Abdel Wahab O. Femoral bone marrow aspiration in live mice. J Vis Exp. 2014;: pubmed publisher
  610. Price P, Luckow B, Torres Domínguez L, Brandmüller C, Zorn J, Kirschning C, et al. Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara. J Virol. 2014;88:10840-50 pubmed publisher
  611. Knoop K, McDonald K, McCrate S, McDole J, Newberry R. Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon. Mucosal Immunol. 2015;8:198-210 pubmed publisher
  612. Radovanovic I, Leung V, Iliescu A, Bongfen S, Mullick A, Langlais D, et al. Genetic control of susceptibility to Candida albicans in SM/J mice. J Immunol. 2014;193:1290-300 pubmed publisher
  613. Collins C, Wang J, Miao H, Bronstein J, Nawer H, Xu T, et al. C/EBP? is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis. Proc Natl Acad Sci U S A. 2014;111:9899-904 pubmed publisher
  614. Madireddi S, Eun S, Lee S, Nemčovičová I, Mehta A, Zajonc D, et al. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. J Exp Med. 2014;211:1433-48 pubmed publisher
  615. Franklin B, Bossaller L, De Nardo D, Ratter J, Stutz A, Engels G, et al. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat Immunol. 2014;15:727-37 pubmed publisher
  616. Zhou Q, Ho A, Schlitzer A, Tang Y, Wong K, Wong F, et al. GM-CSF-licensed CD11b+ lung dendritic cells orchestrate Th2 immunity to Blomia tropicalis. J Immunol. 2014;193:496-509 pubmed publisher
  617. Mise Omata S, Alles N, Fukazawa T, Aoki K, Ohya K, Jimi E, et al. NF-?B RELA-deficient bone marrow macrophages fail to support bone formation and to maintain the hematopoietic niche after lethal irradiation and stem cell transplantation. Int Immunol. 2014;26:607-18 pubmed publisher
  618. Weston W, Zayas J, Perez R, George J, Jurecic R. Dynamic equilibrium of heterogeneous and interconvertible multipotent hematopoietic cell subsets. Sci Rep. 2014;4:5199 pubmed publisher
  619. Geem D, Medina Contreras O, McBride M, Newberry R, Koni P, Denning T. Specific microbiota-induced intestinal Th17 differentiation requires MHC class II but not GALT and mesenteric lymph nodes. J Immunol. 2014;193:431-8 pubmed publisher
  620. Wang J, Eguchi K, Matsumoto S, Fujiu K, Komuro I, Nagai R, et al. The ?-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling. PLoS ONE. 2014;9:e96286 pubmed publisher
  621. Zhao C, Gillette D, Li X, Zhang Z, Wen H. Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation. J Biol Chem. 2014;289:17020-9 pubmed publisher
  622. Petrakova O, Terskikh V, Chernioglo E, Ashapkin V, Bragin E, Shtratnikova V, et al. Comparative analysis reveals similarities between cultured submandibular salivary gland cells and liver progenitor cells. Springerplus. 2014;3:183 pubmed publisher
  623. Morshed M, Hlushchuk R, Simon D, Walls A, Obata Ninomiya K, Karasuyama H, et al. NADPH oxidase-independent formation of extracellular DNA traps by basophils. J Immunol. 2014;192:5314-23 pubmed publisher
  624. Meraz I, Hearnden C, Liu X, Yang M, Williams L, Savage D, et al. Multivalent presentation of MPL by porous silicon microparticles favors T helper 1 polarization enhancing the anti-tumor efficacy of doxorubicin nanoliposomes. PLoS ONE. 2014;9:e94703 pubmed publisher
  625. Xu Y, Hyun Y, Lim K, Lee H, Cummings R, Gerber S, et al. Optogenetic control of chemokine receptor signal and T-cell migration. Proc Natl Acad Sci U S A. 2014;111:6371-6 pubmed publisher
  626. Dupont C, Christian D, Selleck E, Pepper M, Leney Greene M, Harms Pritchard G, et al. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathog. 2014;10:e1004047 pubmed publisher
  627. Saulep Easton D, Vincent F, Le Page M, Wei A, Ting S, Croce C, et al. Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia. Leukemia. 2014;28:2005-15 pubmed publisher
  628. Sauter K, Pridans C, Sehgal A, Tsai Y, Bradford B, Raza S, et al. Pleiotropic effects of extended blockade of CSF1R signaling in adult mice. J Leukoc Biol. 2014;96:265-74 pubmed publisher
  629. Martin R, Saleem S, Folgosa L, Zellner H, Damle S, Nguyen G, et al. Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells. J Leukoc Biol. 2014;96:151-9 pubmed publisher
  630. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  631. Sousa Victor P, Gutarra S, García Prat L, Rodriguez Ubreva J, Ortet L, Ruiz Bonilla V, et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature. 2014;506:316-21 pubmed publisher
  632. Weber B, Schuster S, Zysset D, Rihs S, Dickgreber N, Schürch C, et al. TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS Pathog. 2014;10:e1003900 pubmed publisher
  633. Misumi I, Whitmire J. B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J Immunol. 2014;192:1597-608 pubmed publisher
  634. Costa R, Bergwerf I, Santermans E, De Vocht N, Praet J, Daans J, et al. Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain. Cell Transplant. 2015;24:223-33 pubmed publisher
  635. Driskell R, Lichtenberger B, Hoste E, Kretzschmar K, Simons B, Charalambous M, et al. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature. 2013;504:277-281 pubmed publisher
  636. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  637. Salem H, Trojanowski B, Fiedler K, Maier H, Schirmbeck R, Wagner M, et al. Long-term IKK2/NF-?B signaling in pancreatic ?-cells induces immune-mediated diabetes. Diabetes. 2014;63:960-75 pubmed publisher
  638. Gujar S, Clements D, Dielschneider R, Helson E, Marcato P, Lee P. Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms. Br J Cancer. 2014;110:83-93 pubmed publisher
  639. Gorina R, Lyck R, Vestweber D, Engelhardt B. ?2 integrin-mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood-brain barrier. J Immunol. 2014;192:324-37 pubmed publisher
  640. Iwata A, Kawashima S, Kobayashi M, Okubo A, Kawashima H, Suto A, et al. Th2-type inflammation instructs inflammatory dendritic cells to induce airway hyperreactivity. Int Immunol. 2014;26:103-14 pubmed publisher
  641. Lafkas D, Rodilla V, Huyghe M, Mourao L, Kiaris H, Fre S. Notch3 marks clonogenic mammary luminal progenitor cells in vivo. J Cell Biol. 2013;203:47-56 pubmed publisher
  642. Povinelli B, Nemeth M. Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem Cells. 2014;32:105-15 pubmed publisher
  643. Satpathy A, Briseño C, Lee J, Ng D, Manieri N, Kc W, et al. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol. 2013;14:937-48 pubmed publisher
  644. Pioli P, Dahlem T, Weis J, Weis J. Deletion of Snai2 and Snai3 results in impaired physical development compounded by lymphocyte deficiency. PLoS ONE. 2013;8:e69216 pubmed publisher
  645. Conine S, Cross J. MIF deficiency does not alter glucose homeostasis or adipose tissue inflammatory cell infiltrates during diet-induced obesity. Obesity (Silver Spring). 2014;22:418-25 pubmed publisher
  646. Christoforou N, Liau B, Chakraborty S, Chellapan M, Bursac N, Leong K. Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues. PLoS ONE. 2013;8:e65963 pubmed publisher
  647. Stoilova B, Kowenz Leutz E, Scheller M, Leutz A. Lymphoid to myeloid cell trans-differentiation is determined by C/EBP? structure and post-translational modifications. PLoS ONE. 2013;8:e65169 pubmed publisher
  648. Redecke V, Wu R, Zhou J, Finkelstein D, Chaturvedi V, High A, et al. Hematopoietic progenitor cell lines with myeloid and lymphoid potential. Nat Methods. 2013;10:795-803 pubmed publisher
  649. Ke F, Bouillet P, Kaufmann T, Strasser A, Kerr J, Voss A. Consequences of the combined loss of BOK and BAK or BOK and BAX. Cell Death Dis. 2013;4:e650 pubmed publisher
  650. Kim M, Kang S, Park J, Yanagisawa M, Kim C. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology. 2013;145:396-406.e1-10 pubmed publisher
  651. Martinod K, Demers M, Fuchs T, Wong S, Brill A, Gallant M, et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci U S A. 2013;110:8674-9 pubmed publisher
  652. Gerber S, Sedlacek A, Cron K, Murphy S, Frelinger J, Lord E. IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor. Am J Pathol. 2013;182:2345-54 pubmed publisher
  653. Vink P, Smout W, Driessen Engels L, de Bruin A, Delsing D, Krajnc Franken M, et al. In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation. PLoS ONE. 2013;8:e57348 pubmed publisher
  654. Roehrich M, Spicher A, Milano G, Vassalli G. Characterization of cardiac-resident progenitor cells expressing high aldehyde dehydrogenase activity. Biomed Res Int. 2013;2013:503047 pubmed publisher
  655. Koning J, Kooij G, de Vries H, Nolte M, Mebius R. Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol. 2013;4:49 pubmed publisher
  656. Kobayashi A, Donaldson D, Erridge C, Kanaya T, Williams I, Ohno H, et al. The functional maturation of M cells is dramatically reduced in the Peyer's patches of aged mice. Mucosal Immunol. 2013;6:1027-37 pubmed publisher
  657. Powell N, Walker A, Stolarczyk E, Canavan J, Gökmen M, Marks E, et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity. 2012;37:674-84 pubmed publisher
  658. Jenkins C, Shevchuk O, Giambra V, Lam S, Carboni J, Gottardis M, et al. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein. Exp Hematol. 2012;40:715-723.e6 pubmed publisher
  659. Botelho F, Bauer C, Finch D, Nikota J, Zavitz C, Kelly A, et al. IL-1?/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS ONE. 2011;6:e28457 pubmed publisher
  660. McPhee C, Sproule T, Shin D, Bubier J, Schott W, Steinbuck M, et al. MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis. J Immunol. 2011;187:4695-704 pubmed publisher
  661. Ripich T, Jessberger R. SWAP-70 regulates erythropoiesis by controlling ?4 integrin. Haematologica. 2011;96:1743-52 pubmed publisher
  662. Hemmers S, Teijaro J, Arandjelovic S, Mowen K. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE. 2011;6:e22043 pubmed publisher
  663. Qian B, Li J, Zhang H, Kitamura T, Zhang J, Campion L, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475:222-5 pubmed publisher
  664. Tousif S, Singh Y, Prasad D, Sharma P, Van Kaer L, Das G. T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection. PLoS ONE. 2011;6:e19864 pubmed publisher
  665. Weishaupt H, Attema J. A Method to Study the Epigenetic Chromatin States of Rare Hematopoietic Stem and Progenitor Cells; MiniChIP-Chip. Biol Proced Online. 2010;12:1-17 pubmed publisher
  666. Ludwig A, Otto G, Riento K, Hams E, Fallon P, Nichols B. Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitment. J Cell Biol. 2010;191:771-81 pubmed publisher
  667. Zavitz C, Bauer C, Gaschler G, Fraser K, Strieter R, Hogaboam C, et al. Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza. J Immunol. 2010;184:2001-13 pubmed publisher
  668. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed publisher
  669. Guibal F, Alberich Jorda M, Hirai H, Ebralidze A, Levantini E, Di Ruscio A, et al. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood. 2009;114:5415-25 pubmed publisher
  670. Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G. Myeloid cells contribute to tumor lymphangiogenesis. PLoS ONE. 2009;4:e7067 pubmed publisher
  671. Carlow D, Gold M, Ziltener H. Lymphocytes in the peritoneum home to the omentum and are activated by resident dendritic cells. J Immunol. 2009;183:1155-65 pubmed publisher
  672. Horman S, Velu C, Chaubey A, Bourdeau T, Zhu J, Paul W, et al. Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood. 2009;113:5466-75 pubmed publisher
  673. Tambuyzer B, Bergwerf I, De Vocht N, Reekmans K, Daans J, Jorens P, et al. Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol Cell Biol. 2009;87:267-73 pubmed publisher
  674. Kanwar N, Fayyazi A, Backofen B, Nitsche M, Dressel R, von Mollard G. Thymic alterations in mice deficient for the SNARE protein VAMP8/endobrevin. Cell Tissue Res. 2008;334:227-42 pubmed publisher
  675. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, et al. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res. 2008;18:846-57 pubmed publisher
  676. Waskow C, Liu K, Darrasse Jèze G, Guermonprez P, Ginhoux F, Merad M, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol. 2008;9:676-83 pubmed publisher
  677. Culshaw S, Millington O, Brewer J, McInnes I. Murine neutrophils present Class II restricted antigen. Immunol Lett. 2008;118:49-54 pubmed publisher
  678. Wanasen N, Xin L, Soong L. Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int J Parasitol. 2008;38:417-29 pubmed
  679. Jeannet G, Scheller M, Scarpellino L, Duboux S, Gardiol N, Back J, et al. Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood. 2008;111:142-9 pubmed
  680. Laurie K, Blundell M, Baxendale H, Howe S, Sinclair J, Qasim W, et al. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector. Gene Ther. 2007;14:1623-31 pubmed
  681. van der Marel A, Samsom J, Greuter M, van Berkel L, O Toole T, Kraal G, et al. Blockade of IDO inhibits nasal tolerance induction. J Immunol. 2007;179:894-900 pubmed
  682. Huang B, Zhao J, Shen S, Li H, He K, Shen G, et al. Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res. 2007;67:4346-52 pubmed
  683. Chang S, Wang K, Lu Y, Yang L, Chen W, Lin Y, et al. Characterization of early gamma interferon (IFN-gamma) expression during murine listeriosis: identification of NK1.1+ CD11c+ cells as the primary IFN-gamma-expressing cells. Infect Immun. 2007;75:1167-76 pubmed
  684. HogenEsch H, Dunham A, Seymour R, Renninger M, Sundberg J. Expression of chitinase-like proteins in the skin of chronic proliferative dermatitis (cpdm/cpdm) mice. Exp Dermatol. 2006;15:808-14 pubmed
  685. Grisaru D, Pick M, Perry C, Sklan E, Almog R, Goldberg I, et al. Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses. J Immunol. 2006;176:27-35 pubmed
  686. Schneider B, Fine J, Tiidus P. Indices of leukocyte infiltration and muscle recovery after eccentric contraction-induced injury in young and adult male mice. Orthop Nurs. 2005;24:399-405 pubmed
  687. Gupta R, Karpatkin S, Basch R. Hematopoiesis and stem cell renewal in long-term bone marrow cultures containing catalase. Blood. 2006;107:1837-46 pubmed
  688. Fan J, Li Y, Vodovotz Y, Billiar T, Wilson M. Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. Am J Physiol Lung Cell Mol Physiol. 2006;290:L738-L746 pubmed
  689. Lu M, Tayu R, Ikawa T, Masuda K, Matsumoto I, Mugishima H, et al. The earliest thymic progenitors in adults are restricted to T, NK, and dendritic cell lineage and have a potential to form more diverse TCRbeta chains than fetal progenitors. J Immunol. 2005;175:5848-56 pubmed
  690. Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin D, et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 2005;19:2005-7 pubmed
  691. Iwasaki H, Mizuno S, Mayfield R, Shigematsu H, Arinobu Y, Seed B, et al. Identification of eosinophil lineage-committed progenitors in the murine bone marrow. J Exp Med. 2005;201:1891-7 pubmed
  692. Nakae S, Suto H, Kakurai M, Sedgwick J, Tsai M, Galli S. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci U S A. 2005;102:6467-72 pubmed
  693. Eruslanov E, Lyadova I, Kondratieva T, Majorov K, Scheglov I, Orlova M, et al. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun. 2005;73:1744-53 pubmed
  694. Noel J, Guo X, Wells Byrum D, Schwemberger S, Caldwell C, Ogle C. Effect of thermal injury on splenic myelopoiesis. Shock. 2005;23:115-22 pubmed
  695. Mischenko V, Kapina M, Eruslanov E, Kondratieva E, Lyadova I, Young D, et al. Mycobacterial dissemination and cellular responses after 1-lobe restricted tuberculosis infection of genetically susceptible and resistant mice. J Infect Dis. 2004;190:2137-45 pubmed
  696. Zheng S, Jiang J, Shen H, Chen Y. Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J Immunol. 2004;173:5652-8 pubmed
  697. Prockop S, Petrie H. Regulation of thymus size by competition for stromal niches among early T cell progenitors. J Immunol. 2004;173:1604-11 pubmed
  698. Smith P, Walsh C, Mangan N, Fallon R, Sayers J, McKenzie A, et al. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol. 2004;173:1240-8 pubmed
  699. Seroogy C, Soares L, Ranheim E, Su L, Holness C, Bloom D, et al. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J Immunol. 2004;173:79-85 pubmed
  700. Yuan Y, Shen H, Franklin D, Scadden D, Cheng T. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol. 2004;6:436-42 pubmed
  701. de Haas C, Veldkamp K, Peschel A, Weerkamp F, Van Wamel W, Heezius E, et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med. 2004;199:687-95 pubmed
  702. Morin J, Faideau B, Gagnerault M, Lepault F, Boitard C, Boudaly S. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice. Clin Exp Immunol. 2003;134:388-95 pubmed
  703. León B, Martinez del Hoyo G, Parrillas V, Vargas H, Sánchez Mateos P, Longo N, et al. Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells. Blood. 2004;103:2668-76 pubmed
  704. Power U, Plotnicky H, Blaecke A, Nguyen T. The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B. Vaccine. 2003;22:168-76 pubmed
  705. Morin J, Chimènes A, Boitard C, Berthier R, Boudaly S. Granulocyte-dendritic cell unbalance in the non-obese diabetic mice. Cell Immunol. 2003;223:13-25 pubmed
  706. Brown C, Blaho V, Loiacono C. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J Immunol. 2003;171:893-901 pubmed
  707. Lan F, Zeng D, Higuchi M, Higgins J, Strober S. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol Blood Marrow Transplant. 2003;9:355-63 pubmed
  708. Melani C, Chiodoni C, Forni G, Colombo M. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood. 2003;102:2138-45 pubmed
  709. Plotnicky H, Siegrist C, Aubry J, Bonnefoy J, Corvaia N, Nguyen T, et al. Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate. Vaccine. 2003;21:2651-60 pubmed
  710. Saio M, Radoja S, Marino M, Frey A. Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J Immunol. 2001;167:5583-93 pubmed
  711. Lan F, Zeng D, Higuchi M, Huie P, Higgins J, Strober S. Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells. J Immunol. 2001;167:2087-96 pubmed
  712. Klinguer C, Beck A, de Lys P, Bussat M, Blaecke A, Derouet F, et al. Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigens. Vaccine. 2001;19:4236-44 pubmed
  713. Goetsch L, Plotnicky Gilquin H, Aubry J, de Lys P, Haeuw J, Bonnefoy J, et al. BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in mice. Vaccine. 2001;19:4036-42 pubmed
  714. de Oca R, Buendia A, Del Rio L, Sanchez J, Salinas J, Navarro J. Polymorphonuclear neutrophils are necessary for the recruitment of CD8(+) T cells in the liver in a pregnant mouse model of Chlamydophila abortus (Chlamydia psittaci serotype 1) infection. Infect Immun. 2000;68:1746-51 pubmed
  715. Whalen M, Carlos T, Dixon C, Robichaud P, Clark R, Marion D, et al. Reduced brain edema after traumatic brain injury in mice deficient in P-selectin and intercellular adhesion molecule-1. J Leukoc Biol. 2000;67:160-8 pubmed
  716. Saitoh T, Morimoto K, Kumagai T, Tsuboi I, Aikawa S, Horie T. Comparison of erythropoietic response to androgen in young and old senescence accelerated mice. Mech Ageing Dev. 1999;109:125-39 pubmed
  717. Lee S, Wang Y, Milbrandt J. Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transplantation factor NGFI-A (EGR1). Mol Cell Biol. 1996;16:4566-72 pubmed
  718. Palfree R, Dumont F, Hammerling U. Ly-6A.2 and Ly-6E.1 molecules are antithetical and identical to MALA-1. Immunogenetics. 1986;23:197-207 pubmed
  719. Lewinsohn D, Bargatze R, Butcher E. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J Immunol. 1987;138:4313-21 pubmed
  720. Jutila M, Kroese F, Jutila K, Stall A, Fiering S, Herzenberg L, et al. Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur J Immunol. 1988;18:1819-26 pubmed
  721. Codias E, Cray C, Baler R, Levy R, Malek T. Expression of Ly-6A/E alloantigens in thymocyte and T-lymphocyte subsets: variability related to the Ly-6a and Ly-6b haplotypes. Immunogenetics. 1989;29:98-107 pubmed